ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
INTRODUCTION
This Management’s Discussion and Analysis (“MD&A”) should be read together with other information, including the Company’s audited consolidated financial statements and accompanying notes as of and for the years ended December 31, 2022 and 2021 included elsewhere in this Annual Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
In addition to historical data, this discussion contains forward-looking statements about our business, operations and financial performance based on current expectations that involve risks, uncertainties and assumptions. Our actual results may differ materially from those in this discussion as a result of various factors, including but not limited to those discussed in Part 1, Item 1A, “Risk Factors” in this Annual Report.
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of Sarbanes-Oxley, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.
The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
The Company will remain an emerging growth company until the earlier of (1) the last day of the Company’s fiscal year following the fifth anniversary of the date of the first sale of common equity securities of the Company pursuant to an effective registration statement under the Securities Act, (2) the last day of the fiscal year in which the Company has total annual gross revenue of at least $1.07 billion, (3) the last day of the fiscal year in which the Company is deemed to be a “large accelerated filer,” as defined in Rule 12b-2 under the Exchange Act, and (4) the date on which the Company has, during the previous three year period, issued more than $1.0 billion in nonconvertible debt.
BUSINESS OVERVIEW
We are a consumer-focused cannabis company based in the United States focused on the recreational and wellness markets. Our operations in California are focused on building winning brands supported by our omni-channel ecosystem. Our platform was designed to create the most socially responsible and culturally impactful cannabis company in the United States, producing consistent, well-priced products and culturally relevant brands that are distributed to third-party retailers as well as direct-to-consumer via our delivery service and strategically located storefront retail locations across California. A full portfolio of products and brands that appeal to a broad range of user groups, need-states and occasions, offered at many price points, and with various brand value propositions, are produced at a high caliber of quality. We believe our delivery and storefront retail outlets will allow us to achieve high gross-margins on many of our products, forge one-on-one relationships between our brands and consumers and collect proprietary consumer data and insights.
As part of our cost reduction initiatives, we recently took the following actions:
| · | Pause of In-House Cultivation Activities. In mid-September 2022, we paused our in-house cultivation activities in response to the availability of lower cost flower that meets our quality specifications for our first party brands. |
| · | Sale of Bulk Wholesale Business. On October 31, 2022, we finalized the sale of our bulk wholesale business (SISU Extraction LLC) for $317,000 cash. In addition, the purchaser of our bulk wholesale business entered into a multi-strategic supply agreement providing us with the right, but not the obligation, to purchase cannabis oil and flower brokerage services from the business at preferred terms through October 2024.s. |
| · | Outsourcing of Manufacturing. During October 2022, product manufacturing was outsourced to third-party processors, which the Company expects will achieve an average of 27% cost savings on these products. In addition to margin improvement, we expect to benefit from strong R&D capabilities of its third-party processors to produce innovative products for our future. |
| · | Supply Chain. On November 18, 2022, we began our transformation of the supply chain team, moving from an internal distribution model to an external drop ship model to all TPCO stores and wholesale account stores. These changes began with the reduction of our labelling and serialization team, as all first party product began moving through NABIS, a leading cannabis wholesale platform in California, in mid-December 2022. By the end of 2022, we reduced the team of 43 to 12 FTEs, amounting to approximately $2.2 million in annualized payroll savings. |
| · | Optimization of Delivery Footprint. In response to changes to California’s cannabis delivery regulations to increase the allowed delivery “case pack value” limit that took effect in November 2022, we have acted to optimize our delivery footprint. Under prior regulations, delivery drivers were allowed to carry a maximum of $5,000 worth of product in a vehicle, of which a maximum of $3,000 of which was permitted to be product that was not part of an order made before the driver left the delivery depot. The new regulations have doubled the “case pack value” limit to $10,000, all of which can be product not part of a previously made order. In response to these new regulations, we have elected to dispose of select redundant delivery depot locations, including Culver City, Chula Vista and Sacramento operations, as many geographic regions can now be more efficiently managed. We continue to have a dedicated delivery depot in Brisbane. These dispositions resulted in $500,000 in gross sale proceeds and annual cost savings of $1.8 million. |
| · | Workforce Reduction. We continue to consolidate operational functions within the organization, which we expect to lead to further cost reductions overall. Including an estimated $4 million in annual payroll savings expected to be achieved by pausing cultivation in mid-September 2022. As of December 31, 2022, we had reduced our workforce by 40% from the beginning of 2022 and expect to realize annual payroll savings of approximately $17 million. |
While we are focused on the recreational and wellness markets, a small portion (estimated to be less than 1%) of our revenues is derived Medical-Use Cannabis.
Our operational footprint spans production and manufacturing, brands, retail and delivery. Our management team and directors bring together deep expertise in cannabis, consumer packaged goods, investing and finance, from start-ups to publicly traded companies. We aim to leverage the collective industry experience of our management and directors.
Following our exit from the bulk wholesale business, we view our business as having one sales channel: omni-channel retail, comprised of brick and mortar retail, e-commerce pick up & delivery, as well as the sale of various branded wholesale products. As of December 31, 2022, we operate twelve omni-channel retail locations and one stand-alone delivery depot. We operate four store brands, Caliva, Deli by Caliva, Coastal and Calma.
Our continuing operations revenue for the year ended December 31, 2022 was $83,637,407 compared to $79,924,941 in the comparative year ended December 31, 2021 representing growth of 4.6%, respectively.
As we continue to scale and integrate our business, we are incurring operating losses. Our operating losses for the year ended December 31, 2022 totaled $242,938,787, (including an impairment loss of $130,566,825), compared to a loss of $733,885,024 (including an impairment loss of $575,498,897) in the comparative year ended December 31, 2021. We continue to actively evaluate additional cost reductions and business optimization to reduce our cash burn in the near term.
Our financial results for the period ended December 31, 2021 did not include operating results from January 1, 2021 to January 15, 2021 due to the fact that the Qualifying Transaction, pursuant to which our business operations began, closed on January 15, 2021. Accordingly, our results of operations are not necessarily comparable between the year ended December 31, 2022 and the year ended December 31, 2021.
Through a combination of (i) professional leadership, (ii) omni-channel operations, (iii) technology and data driven practices, (iv) brand and product expertise, and (v) social justice and equity advocacy, we intend to set the example globally as a best-in-class cannabis operation.
Growth Strategy
Below is a summary of the key components of The Parent Company’s growth strategy:
| · | Branded Product: We believe there are additional opportunities to expand The Parent Company’s brand portfolio through innovation and acquisitions. |
| · | Omni-channel Access: We believe that The Parent Company’s omni-channel platform is a rapidly and efficiently scalable way to directly reach cannabis consumers throughout California than brick-and-mortar retail expansion alone. We also believe that an omnichannel platform, when coupled with a integrated supply chain such as The Parent Company’s, allows for greater product margins due to the full capture of the price to consumer as well as low input and production costs. |
Factors Affecting Our Performance
The Company’s performance and future success depends on a number of factors. These factors are also subject to a number of inherent risks and challenges, some of which are discussed below.
Branding
We have built our brand with a focus on the growing direct to consumer (“DTC”) market. We understand that it is critical to establish trust at all levels of our operations, starting with an executive team and board of directors that believe in “doing business the right way”, focusing on long-term shareholder value and creating trust with our various stakeholders. We strive to prioritize our consumers and our employees (who we refer to as “associates”). We establish trust with our consumers through their experience, which encompasses not only our award-winning products but the consumer’s full buying experience. At The Parent Company, we make information on the products that consumers choose readily available, including the ability to interact with our associates at not only our retail locations, but also curbside as well as through phone and video consultations. The Parent Company’s brand strategy is a “House of Brands” strategy, providing the ability to expand our product lines to meet changing consumer tastes and preferences.
Regulation
The Company is subject to the local and federal laws in the jurisdictions in which it operates. Outside of the United States, the Company’s products may be subject to tariffs, treaties and various trade agreements as well as laws affecting the importation of consumer goods. The Parent Company holds all required licenses for the production and distribution of its products in the jurisdictions in which it operates and continuously monitors changes in laws, regulations, treaties and agreements. The Company is licensed to cultivate, manufacture, distribute and sell wholesale and retail cannabis and cannabis products. The Company operates in, and/or has ownership interests in businesses operating in, California, pursuant to the California Medicinal and Adult-Use Cannabis Regulation and Safety Act.
Product Innovation and Consumer Trends
The Company’s business is subject to changing consumer trends and preferences, which is dependent, in part, on continued consumer interest in new products. The success of new product offerings depends upon a number of factors, including The Parent Company’s ability to: (i) accurately anticipate customer needs; (ii) develop new products that meet these needs; (iii) successfully commercialize new products; (iv) price products competitively; (v) produce and deliver products in sufficient volumes and on a timely basis; and (vi) differentiate product offerings from those of competitors.
COVID-19
In March 2020, the World Health Organization categorized coronavirus disease 2019 (“COVID-19”) as a pandemic. COVID-19 continues to impact the United States and other countries across the world, and the duration and severity of its effects are currently unknown. While the impacts of COVID-19 have lessened in recent months, the Company continues to implement and evaluate actions to maintain its financial position and support the continuity of its business and operations in the face of this pandemic and other events.
The Company’s priorities during the COVID-19 pandemic and any future pandemic are protecting the health and safety of its employees and its customers, following the recommended actions of government and health authorities. In the future, a resurgence of COVID-19 or a new pandemic in the United States may cause demand for the Company’s products and services if, for example, the pandemic results in a recessionary economic environment or potential new restrictions on business operations or the movement of individuals.
The COVID-19 outbreak in the United States caused business disruption both to the Company and throughout its customer base and supply chain through mandated and voluntary closings of many businesses.
We took the following steps in response to the COVID-19 pandemic:
| · | Issued a remote work directive for all non-essential employees; |
| · | Instituted a mandatory face mask policy in all The Parent Company locations and for all customer deliveries; |
| · | Implemented staggered work schedules, employee breaks and redesigned workstations and processes to minimize employee interaction and ensure appropriate social distancing; |
| · | Minimized the number of essential employees moving between The Parent Company locations; |
| · | Banned all non-essential contractors, vendors and visitors from our locations to reduce flow of traffic into and out of our facilities, as well as encouraged meetings with third parties to be virtual; |
| · | Enhanced sanitation of work areas, both in terms of breadth and depth of cleanings, including industrial cleaning and sanitizing protocols upon detection of a COVID-19 positive test; |
| · | Required employees to stay home if not feeling well, informing employees of government and health authority guidelines, and facilitating testing; |
| · | Implemented contact tracing system and mandatory 14-day quarantines for all workers potentially exposed to someone testing positive for COVID- 19 and any employees returning from out of country visits; |
| · | Issued directives to customer-facing teams in retail and delivery with regard to frequent cleaning, social distancing, and customer safety; |
| · | Suspended all but critical business travel; and |
| · | Enhanced communication creating a 24-hour Employee Hotline, a COVID-19 resource, policy and information page on The Parent Company’s intranet, frequent employee communications and training. |
Currently, our business is largely unaffected by COVID-19, due to the significant decrease in the number of cases that have developed where we have facilities.
HIGHLIGHTS FOR THE YEAR ENDED DECEMBER 31, 2022
Strengthened Management Team
The Company strengthened its leadership team during 2022 with the additions of Esther Song (Chief Marketing Officer), Rozlyn Lipsey (EVP Operations and Wholesale) and Mindi Basha (VP/General Manager Retail).
The Company eliminated its Corporate Development department given the change in focus from a California cannabis market consolidation strategy to focus on cost efficiencies/profitability of its existing assets. Readers should refer to the detailed list cost reduction initiatives in the Business Overview section of this MD&A.
Revenue Growth and Gross Margin Improvement Initiatives
To drive revenue growth and margin improvement in stores, the Company:
| · | Focused on increasing new and returning traffic by introducing and expanding high quality, limited batch Flower brands which include: BLEM, Teds Budz, Alien Labs, Connected, Fig Farms and Marathon; |
| · | Focused on increasing our average basket size by introducing and expanding Ounces and Half Ounces to our Flower assortment; |
| · | Continued to focus on curating a localized assortment that is relevant and consistently appealing; |
| · | Rolled out Treez point of sale system in all locations. Treez is a leading commerce platform for cannabis retailers; |
| · | Significantly increased exposure and advertising on Weedmaps, e.g., push messaging, side banners, improved placement on search pages and programmatic marketing. Weedmaps is a third party platform for users interested in purchasing cannabis; |
| · | Held several vendor supported promotions for various brand launches; |
| · | Hired street teams to help localize brand awareness and purchased significant billboard space; |
| · | Built out a robust product demonstration schedule to develop brand engagement with customers and increase sell through; |
| · | Opened the Coastal Concord location during September 2022; |
| · | Closed unproductive delivery depots in San Luis Obispo and Chula Vista; and |
| · | Revised operational processes to direct ship from third party vendors to our store locations to get products from our vendors onto store shelves faster. |
Product Updates
The Company developed a plan to consolidate TPCO brands down to five first party brands: Caliva, Cruisers, Mirayo by Santana and Chill and Monogram.
The Company launched “RCVRY”, a premium cannabis product in September 2022 at our Calma location. RCVRY is a brand collaboration featuring Nordan Shat aka “Faze Rain” from the FaZe Clan (NASDAQ: FAZE) gaming community with a fan base of over 510 million across combined social platforms. Our RCVRY cannabis launch coincided with Nordan’s “public resurfacing” following his accident that left him temporarily paralyzed. Nordan is currently filming and releasing content across his social channels that follow his road to recovery (RCVRY).
Revised Strategic Agreement with ROC Nation, SC Branding and Affiliates
On December 29, 2022, the Company and certain of its subsidiaries (Caliva, TPCO-US, and NC3), each as entered into the Roc Modification Agreement with Roc Nation. In addition, on December 29, 2022 the Company and certain of its subsidiaries entered into a series of agreements with SC Branding and certain of SC Brandings’ affiliates, including (a) the Termination Agreement, by and between the Company and SC Branding, (b) the Services Agreement, (c) the Brand Transfer Agreement, by and among the Company, Caliva, TPCO-US, and NC3, on the one hand, and SC Branding and Mother Room, on the other hand, and (d) the License Agreement, by and between Mother Room and TPCO-US.
The Roc Modification Agreement supplants the Roc Binding Heads of Terms. The Roc Modification Agreement, among other things, terminated various ongoing Roc Nation service obligations and eliminated future TPCO equity contributions to Roc Nation pursuant to the Binding Heads of Terms. Furthermore, in connection with the Roc Modification Agreement (i) Roc Nation agreed to surrender to the Company 4,865,939 Common Shares, (ii) Roc Nation and the Company agreed to a three-year plan of collaboration with respect to resolving issues of social equity associated with harms created by the prohibition of cannabis and (iii) Roc Nation undertook to introduce various Roc Nation partners and artists to the Company over a three-year period.
Under the SC Branding Agreements, among other things, (A) the parties terminated the Brand Strategy Agreement, (B) the parties cancelled the Company’s obligation to make all future annual payments pursuant to such Brand Strategy Agreement, (C) the parties created a three-year plan of collaboration with respect to resolving issues of social equity associated with harms created by the prohibition of cannabis, (D) the Company and certain of its subsidiaries transferred all rights to the Monogram brand to Mother Room, and (E) Mother Room granted to TPCO-US a license to use the Monogram brand in connection with the legal cannabis businesses in California for an eight-year term, subject to termination under certain conditions. In addition, pursuant to the Brand Transfer Agreement, SC Branding and certain of its affiliates agreed to surrender to the Company 2,255,300 Common Shares.
Closing of Coastal Acquisition
On November 14, 2022, we completed the acquisition of 100% of the equity of Coastal Holding Company, LLC, a California retail dispensary and delivery operator (“Coastal Holding”) by issuing approximately 24,999,999 shares of Coast L Acquisition Corp., a wholly owned subsidiary of TPCO. The shares of Coast L Acquisition Corp. are exchangeable on a one-for-one basis into Common Shares. We also paid an additional $3.75 million upon closing and assumed approximately $1.8 million of debt.
Completion of Acquisition of Calma West Hollywood
During the three months ended September 30, 2022, we acquired the 15% of the equity of Calma West Hollywood (“Calma”) that we did not own in exchange for 1,762,495 Common Shares.
Social Equity
Through December 31, 2022, we have invested approximately $1,300,000 in three investments being Stanton Brands (dba Josephine & Billie’s), Peakz LLC and Digistrains.
During the first quarter of 2022, we entered into a 50/50 agreement with Peakz NFT, LLC, an entity formed by social equity entrepreneur Jessie Grundy, to develop and launch a collection of cannabis-focused non-fungible token’s (“NFT’s”) referred to as “Digistrains”. The Company invested $150,000 to seed the initiative (the “Initial Capital Contribution”) and expects the Digistrain NFT collection to be launched in the near future. Any distributions from this initiative must first be utilized to repay the Initial Capital Contribution before being shared amongst members of the joint venture.
On July 1, 2022, we agreed to make a follow-on $200,000 investment in our existing Josephine & Billie’s investment, bringing our total investment to $700,000. Women-founded and led, Josephine and Billie’s is LA’s first cannabis speakeasy that gives Women of Color a tailored cannabis experience. We support Josephine and Billie’s mission to be inclusive, communal and put the needs of Women of Color at the forefront. The Parent Company is proud to make this follow-on investment to provide Josephine & Billie’s the funds needed to help build a sustainable business.
We have repositioned our social equity venture fund to become the centralized owner of all corporate social responsibility activities undertaken with the mission to provide Black and underrepresented minorities with the foundation to succeed in the legal cannabis industry through education, advocacy and access to capital.
Sale and Leaseback of Pullman Property
During the first quarter of 2022, we completed the sale and leaseback of our property on Pullman Avenue in San Jose, California. We received $6,000,000 up front and a $500,000 promissory note receivable over five years. We leased back the space for a ten year term with an option to terminate early after five years and with two five-year options to extend the term at a annual base rent of $552,500.
SUBSEQUENT EVENTS
Shares Issued
Subsequent to December 31, 2022, the Company issued 165,217 shares for RSUs and PSUs that were vested.
Return of Shares
On January 5, 2023, 7,121,239 Common Shares of the Company were returned to treasury in connection with the revised strategic agreement with ROC Nation, SC Branding and Affiliates.
Sale of Culver City
On February 22, 2023, the Company finalized the sale of Culver City for $350,000 cash.
Proposed Business Combination with Gold Flora, LLC
On February 21, 2023, the Company entered into an agreement to combine with Gold Flora, a leading vertically integrated California cannabis company, in an all-stock merger. Under the terms of the merger agreement, the Company’s shareholders will own approximately 49%, and Gold Flora holders will own approximately 51%, of the outstanding common equity of the combined company on a pro forma basis upon consummation of the business combination.
Upon completion of the transaction, Troy Datcher will be named Chairman of the Board and Laurie Holcomb, the Chief Executive Officer of Gold Flora, will be named Chief Executive Officer of the combined company.
Key Transaction Benefits & Strategic Rationale
| · | Increased size and scale to become a leading operator in the world's largest cannabis market. The combined company is expected to operate a footprint of 20 retail stores, 12 house brands, 3 distribution centers, and 1 manufacturing facility and 6 cultivation facilities, providing the size and scale to position the combined company as a leader in California. |
| | |
| · | Establishing a strongly positioned vertically-integrated platform to achieve financial and operational efficiency, as one of the largest indoor cultivators and retail operators in California. The combined company will have an indoor cultivation canopy of approximately 72,000 square feet, with the opportunity to expand to a further approximately 240,000 square feet, critical to controlling its supply chain and inventory levels while providing consistent high-quality flower, as well as flower-driven products that leverage an exceptional proprietary genetics library to deliver exclusive offerings that align with consumer demands. |
| | |
| · | Significant synergies expected to drive margin improvement and enhance profitability across all verticals. Through the streamlining of retail operations, utilizing scale to access bulk purchasing power, and eliminating third-party contracts, the combined company is expected to achieve annualized cost savings of between $20 and $25 million, to further improve gross margin and profitability while delivering value for shareholders. |
| | |
| · | Reduction in third-party costs through supply-chain optimization. The combined company will reduce third-party contracts when strategically and cost effectively appropriate by utilizing the capabilities of Gold Flora and controlling its value chain. |
| | |
| · | Combined company is expected to be well-positioned as a top 10 brand portfolio by revenue. As two of the premier operators in the state, the Business Combination will result in a diversified and highly complementary customer product offering, with a variety of form factors and brands for differentiated consumer profiles. Additionally, with only 13% overlap in current company retail store footprints, there is a significant opportunity for cross-selling brands into diverse customer bases to drive organic growth. |
| | |
| · | Enhanced financial profile with strong balance sheet. The combined company would have pro forma revenue of $151.9 million for the nine-month period ended December 31, 2022, with a gross margin of 28%. Providing a robust foundation to accelerate growth, the combined company will be well-positioned to capitalize on the market opportunities ahead as a leading public cannabis company in California. |
Proposed Transaction Summary
The Business Combination will be completed, subject to the Merger Agreement, by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia), whereby a newly formed British Columbia corporation ("Newco "), created to manage and hold the combined business of The Parent Company and Gold Flora, will, directly and indirectly, acquire all of the issued and outstanding Common Shares and all of the issued and outstanding membership units in the capital of Gold Flora ("Gold Flora Units"). Newco will then domesticate in the United States as a Delaware corporation pursuant to Section 388 of the Delaware General Corporation Law.
Subject to the terms and conditions set forth in the Business Combination Agreement, the Plan of Arrangement and the Plan of Merger, holders of TPCO Common Shares will receive one Newco Share for each TPCO Share held and holders of Gold Flora Units will receive 1.5233 Newco Shares for each Gold Flora Unit held, resulting in the issuance of an aggregate of approximately 312,138,271 New Parent Shares. The Business Combination values Gold Flora at $1.50 per Gold Flora Unit and The Parent Company at $0.9847 per TPCO Share.
Following completion of the Business Combination, current holders of TPCO Common Shares will hold approximately 49% of New Parent and current holders of Gold Flora Units will hold approximately 51% of New Parent.
In connection with the Business Combination, TPCO US Holding LLC, a direct and wholly-owned subsidiary of TPCO, and Gold Flora entered into a working capital facility agreement, pursuant to which the Lender has agreed to advance to Gold Flora in a principal amount of up to $5,000,000, which shall bear interest at a rate of 10% per annum, and shall be secured by certain assets of Gold Flora. The outstanding balance of the loan will become due and payable if the Business Combination Agreement is terminated, subject to certain conditions.
In connection with the Business Combination, Newco will redomicile to the United Stated as a Delaware corporation pursuant to Section 388 of the Delaware General Corporation Law and will operate as Gold Flora Corporation. Newco will remain a reporting issuer in Canada and the United States and, subject to receipt of all requisite stock exchange approvals, it is expected that the Newco Shares will be listed on the NEO Exchange Inc. and on the OTCQX Best Market tier of the electronic over-the-counter marketplace operated by OTC Markets Group Inc.
The Parent Company has entered into voting and support agreements with each of its directors and officers and certain shareholders holding an aggregate of approximately 11% of the issued and outstanding TPCO Common Shares, pursuant to which these parties have agreed, subject to certain rights of withdrawal, to vote in favor of the Business Combination and not to dispose of their TPCO Common Shares.
Gold Flora has entered into voting and support agreements with each manager and the majority holder of its membership interests holding an aggregate of 75.9% of the issued and outstanding Gold Flora Units, pursuant to which these parties have agreed, subject to certain rights of withdrawal, to vote in favor of the Business Combination and not to dispose of their Gold Flora Units.
The Business Combination contains certain customary provisions, including covenants in respect of non-solicitation of alternative business combination proposals for The Parent Company and Gold Flora and a reciprocal termination fee of $4,000,000, payable to either the Company or Gold Flora in certain circumstances. See Item 1. Business—Proposed Business Combination with Gold Flora-- Certain Other Terms of the Business Combination Agreement.”
In connection with the Business Combination, the Company anticipates filing a proxy statement and management information circular (the "Circular") in connection with an annual general and special meeting of holders of TPCO Common Shares (the "Meeting") expected to be held in the second quarter of this year (unless the U.S. Securities and Exchange Commission elects to review the preliminary Circular, in which case the Meeting is likely to be held in early in the third quarter of this year) to approve the Business Combination.
Approvals
The Business Combination is expected to close before the end of the third quarter of 2023, following the satisfaction or waiver of closing conditions including, among others, approval by two-thirds of the votes cast by the shareholders of The Parent Company at the Meeting, the approval of the Supreme Court of British Columbia, and the approval of the NEO Exchange.
RESULTS OF OPERATIONS
| | December 31, 2022 | | | December 31, 2021 | |
| | | | | | |
Sales, net of discounts | | $ | 83,637,407 | | | $ | 79,924,941 | |
Cost of sales | | | 57,627,364 | | | | 66,906,654 | |
Gross profit | | | 26,010,043 | | | | 13,018,287 | |
| | | | | | | | |
Impairment loss | | | 130,566,825 | | | | 575,498,897 | |
Operating expenses | | | 138,381,437 | | | | 171,404,414 | |
| | | | | | | | |
Loss from operations | | | (242,938,219 | ) | | | (733,885,024 | ) |
| | | | | | | | |
Other income (expense) | | | | | | | | |
Interest income | | | 845,863 | | | | 1,244,606 | |
Interest expense | | | (4,928,475 | ) | | | (5,155,217 | ) |
Gain on debt forgiveness | | | - | | | | 3,358,686 | |
Loss on disposal of assets | | | (5,091,541 | ) | | | (2,447,985 | ) |
Credit losses and changes in fair value of investments | | | (947,813 | ) | | | (1,250,990 | ) |
Change in fair value of contingent consideration | | | (967,726 | ) | | | 229,819,070 | |
Other income | | | 1,360,724 | | | | 3,572,217 | |
| | | | | | | | |
Loss before income taxes | | | (252,667,187 | ) | | | (504,744,637 | ) |
| | | | | | | | |
Income tax recovery (expense) | | | 14,967,779 | | | | 6,418,167 | |
Loss and comprehensive loss from continuing operations | | | (237,699,408 | ) | | | (498,326,470 | ) |
| | | | | | | | |
Loss from discontinued operations, net of income tax | | | (5,087,408 | ) | | | (88,705,864 | ) |
Loss from disposal of discontinued operations, net of income tax recovery of $8,856,409 | | | (151,971 | ) | | | - | |
Net loss from discontinued operations | | $ | (5,239,379 | ) | | $ | (88,705,864 | ) |
| | | | | | | | |
Loss and comprehensive loss attributable to shareholders of the company | | $ | (242,631,834 | ) | | $ | (587,060,124 | ) |
Loss and comprehensive loss attributable to redeemable non-controlling interest | | | (306,953 | ) | | | 27,790 | |
Net loss | | $ | (242,938,787 | ) | | $ | (587,032,334 | ) |
| | | | | | | | |
Per share – basic and diluted | | | | | | | | |
Loss per share from continuing operations | | $ | (2.31 | ) | | $ | (5.25 | ) |
Loss per share from discontinued operations | | | (0.05 | ) | | | (0.93 | ) |
Loss per share | | $ | (2.36 | ) | | $ | (6.18 | ) |
Weighted average number of common shares | | | 102,632,433 | | | | 95,006,080 | |
Discontinued Operations – Bulk Wholesale Business
The Company was successful in disposing of its bulk wholesale business on October 31, 2022 which will reduce complexity, prioritize higher-margin activities and conserve cash. The bulk wholesale business generated revenue from the sale of bulk flower and oil produced in-house. As such, the bulk wholesale business has been presented as discontinued operations in our financial statements. All comparative information has been restated to remove the bulk wholesale discontinued operations results practically meaning that in our Statement of Operations, we no longer show the revenues and costs of the bulk wholesale business consolidated with our continuing operations but rather the just the net losses incurred from this business below loss from continuing operations (i.e., discontinued operations net of tax loss of $5,087,408 for the year ended December 31, 2022 compared to a discontinued operations net of tax loss of $88,705,864 in the year ended December 31, 2021). The Company believes exiting this business will reduce operating losses going forward.
Sales Revenue
The Company’s sales revenues for the year ended December 31, 2022 was $83,637,407 compared to $79,924,941 in the previous year representing growth of 4.6%.
Our results for the year ended December 31, 2022 include the various omni-channel retail growth acquisitions we made during 2021 including: Martian Delivery, LLC (“Martian Delivery”) (during the third quarter of 2021), Kase’s Journey Inc. (“Kase’s Journey”) (during the third quarter of 2021), Calma and Coastal (both during the fourth quarter of 2021). The consolidation of these entities in 2022 offset a decrease in same store revenue and average order volume at several retail locations that are presented in our results for the year ended December 31, 2021.
Following our exit from the bulk wholesale business, we view our business as having one sales channel: omni-channel retail comprised of brick and mortar retail, e-commerce pick up & delivery, as well as the sale of various branded wholesale products. The Company directly sells first party and selected third party products into dispensaries across California, leveraging in-house sales teams, as well as the two wholesale distribution centers in San Jose and Costa Mesa, respectively. As previously announced, the Company has transitioned its wholesale distribution activities to Nabis, a leading cannabis wholesale platform in California.
As of December 31, 2022, we operate twelve omni-channel retail locations and one stand-alone delivery depot. We operate four store brands, Caliva, Deli by Caliva, Coastal and Calma.
Gross Profit
Gross Profit reflects our revenue less our cost of sales, which consist of costs primarily consisting of labor, materials, consumable supplies, overhead, amortization of production equipment, shipping, packaging and other expenses.
The Company’s continuing operations gross profit for the year ended December 31, 2022 was $26,010,043 (30.4%) compared with $13,018,287 (16.3%) in the year ended December 31, 2021. The significantly improved gross margins represent the results of the various margin enhancing initiatives the Company implemented during 2022 as described in the Business Overview section of this MD&A.
Operating Expenses
| | December 31, 2022 | | | December 31, 2021 | |
General and administrative | | $ | 42,170,219 | | | $ | 42,395,204 | |
Allowance for accounts receivable and notes receivable | | | 3,216,310 | | | | 3,933,081 | |
Sales and marketing | | | 12,679,477 | | | | 42,413,733 | |
Salaries and benefits | | | 39,441,476 | | | | 35,119,133 | |
Share-based compensation | | | 6,009,593 | | | | 20,456,297 | |
Lease expense | | | 8,068,405 | | | | 4,647,233 | |
Depreciation of property plant and equipment | | | 3,953,038 | | | | 3,213,376 | |
Amortization of intangible assets | | | 22,842,919 | | | | 19,226,357 | |
| | $ | 138,381,437 | | | $ | 171,404,414 | |
Operating expenses primarily include salaries and benefits, professional fees, rent and facilities expenses, travel-related expenses, advertising and promotion expenses, licenses, fees and taxes, office supplies and pursuit expenses related to outside services, stock-based compensation and other general and administrative expenses.
For the year ended December 31, 2022, the Company recorded operating expenses of $138,381,437 compared with $171,404,414 for the year ended December 31, 2021.
General and administrative costs were $42,170,219 in the year ended December 31, 2022 compared with $42,395,204 for the year ended December 31, 2021. The $224,985 or 0.5% decrease in general administrative expenses is due mainly to cost containment efforts offset partially by the full year consolidation of the Company’s 2021 acquisitions (including Coastal and Calma) which increased the size of the Company.
The allowance for doubtful accounts was $3,216,310 in the year ended December 31, 2022 compared with $3,933,081 in the comparative year ended December 31, 2021. The $716,771 decrease in the allowance reflects management’s estimates for credit losses on various trade receivables being comparatively lower in the current year than the prior year which included a larger provision for the Mosaic.Ag matter as described in the Commitments and Contingencies section of this MD&A.
Sales and marketing costs were $12,679,477 in the year ended December 31, 2022 compared with $42,413,733 in the comparative year ended December 31, 2021. The $29,734,256 decrease is mainly attributable to the fact that the 2021 comparative period included $25,000,000 of sales & marketing expense paid in shares to Roc Nation under the marketing agreement that became effective January 19, 2021.
Salaries and benefits totaled $39,441,476 in the year ended December 31, 2022 and $35,119,133 in the year ended December 31, 2021. The increase of $4,322,343 (12.3%) is the result of the consolidation of additional head count acquired via the Coastal Holding, Martian Delivery, Kase’s Journey and Calma acquisitions, and severances expenses incurred for restructuring the business for longer term cost efficiencies.
Share based compensation totaled $6,009,593 in the year ended December 31, 2022 compared with $20,456,297 in the year ended December 31, 2021. Share based compensation is a non-cash expense and fluctuates with the number of restricted stock units (“RSUs”) granted in a period and the stock price. The decrease in stock-based compensation expense was primarily attributable to the significant number of RSUs granted in connection with the Qualifying Transaction during 2021, as well as the fact that the market price of our Common Shares is lower in 2022 than it was in 2021.
Lease expense totaled $8,068,405 in the year ended December 31, 2022 and $4,647,233 in the year ended December 31, 2021. The $3,421,172 increase reflect the numerous acquisitions made during 2021 which are consolidated in the financial results for the year ended December 31, 2022 whereby the Company increased the number of lease properties and its California footprint, as well as the Pullman property sale and lease back arrangement as previously disclosed.
Depreciation of property, plant & equipment totaled $3,953,038 compared with $3,213,376 in the year ended December 31, 2021. Depreciation is a non-cash expense and the $739,662 increase in the expense in the 2022 period represents the higher property, plant & equipment asset base owned by the Company at December 31, 2022 compared to December 31, 2021 due to the various acquisitions made in 2021.
Amortization of intangible assets totaled $22,842,919 compared with $19,226,357 in the year ended December 31, 2021. Amortization is a non-cash expense. The $3,616,562 increase in amortization expense is due to additional intangible assets acquired as part of the various acquisitions in 2021.
Non-Cash Impairment
In accordance with Accounting Standard Codification (ASC) Topic 350, the Company is required to assess its goodwill and other indefinite-lived intangible assets for impairment annually or in between tests if events or changes in circumstances indicate the carrying value of its assets may not be recovered. Further, under ASC 360, the Company is required to assess definite lived-intangible assets and long-lived assets whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.
Impairment charges totaled $130,566,825 in the year ended December 31, 2022 compared with $575,498,897 in the year ended December 31, 2021. As part of the annual impairment assessment, the Company’s future forecasts considered changes in cash flow estimates due to lower cannabis industry growth rate assumptions and cost pressures due to higher U.S. inflation. While the Company remains optimistic that cannabis legalization will occur, our expected future cash flows reflect the current tax and regulatory environment. The issues faced by the Company are not unique to our operations as the entire California cannabis market has been impacted. The Company continues to focus on activities to create long-term shareholder value and restructure its business to reduce its operating costs.
The following is a detailed summary of the impairment losses recorded by the Company:
| | December 31, 2022 | | | December 31, 2021 | |
Right-of-use assets (i) | | $ | 4,307,578 | | | $ | - | |
Impairment (ii) | | | 119,443,343 | | | | 567,947,515 | |
Impairment prior to classification as held for sale | | | 6,815,904 | | | | 1,995,945 | |
Non-THC business | | | - | | | | 5,555,437 | |
| | $ | 130,566,825 | | | $ | 575,498,897 | |
(i) Right of use assets – During the year ended December 31, 2022, the Company recorded impairment of $4,307,578 related to properties which are no longer being used by the Company.
(ii) Impairment of long-lived assets – At each reporting period end, the Company considers if there have been any triggers that indicate that its long-lived assets are not recoverable. Based on the softening of the California cannabis market and cost pressures due to higher US inflation during the three months ended September 30, 2022, the Company determined that an impairment test was appropriate.
The following table outlines the impairment of long-lived assets by class of asset, recognized during the year ended December 31, 2022, as a result of impairment testing:
Asset | | Carrying value before impairment | | | Carrying value after impairment | | | Total impairment loss | |
Right of use assets | | $ | 1,680,224 | | | $ | 825,424 | | | $ | 854,800 | |
License | | | 52,304,385 | | | | 9,699,829 | | | | 42,604,556 | |
Brand | | | 78,189,441 | | | | 23,624,000 | | | | 54,565,441 | |
Goodwill | | | 21,418,546 | | | | - | | | | 21,418,546 | |
| | $ | 153,592,596 | | | $ | 34,149,253 | | | $ | 119,443,343 | |
Other Items
Interest Income
In the year ended December 31, 2022, the Company record interest income of $845,863 on its cash balances compared with $1,244,606 in the year ended December 31, 2021. The lower interest income is due to lower cash balances during 2022 offset to some extent by higher interest rates.
Interest Expense
In the year ended December 31, 2022, the Company recorded interest expense of $4,928,475 compared with $5,155,217 in the year ended December 31, 2021. The majority of the interest expense relates to interest expense on lease accounting for the Company’s right of use leases.
Gain on debt forgiveness
In the year ended December 31, 2022, the Company recorded a gain on debt forgiveness of $Nil compared with $3,358,686 in the year ended December 31, 2021. The gain in 2021 was realized on the forgiveness of Payroll Protection Program (PPP) loans.
Loss on disposal of assets
In the year ended December 31, 2022, the Company recorded a loss of $5,091,541 on disposal of assets compared with a loss of $2,447,985 in the year ended December 31, 2021. The majority of the current year loss includes a loss of $4,832,891 recognized on the restructuring of the Roc Binding Heads of Terms and Brand Strategy Agreement which resulted in the disposal of the Monogram brand and simultaneous entering into an eight-year license agreement. The majority of the prior year loss on disposal of assets is from the non-THC business.
Credit losses and change in fair value of investments at fair value through profit and loss
In the year ended December 31, 2022, the Company recorded a change in fair value of $947,813 (loss) on its marketable securities compared with $1,250,990 in the comparative year ended December 31, 2021.
Change in fair value of contingent consideration
In year ended December 31, 2022, the Company recorded a loss on the change in the fair value of contingent consideration of $967,726 compared with $229,819,070 gain in the year ended December 31, 2021. The contingent consideration related to acquisitions is fair valued at each reporting period based on the stock amounts committed and gains / losses will be recorded in the statement of operations and comprehensive income (loss).
Other income
In the year ended December 31, 2022, the Company recorded other income of $1,360,724 compared with $3,572,217 in the year ended December 31, 2021. Other income includes items such as legal settlements, sublease income, movements on provisions among other items.
Discontinued Operations
The Company recorded a net of tax loss from discontinued operations (its bulk wholesale business) of $5,087,408 for the year ended December 31, 2022 compared to a net of tax loss $88,705,864 in the year ended December 31, 2021. The much larger losses in the comparative period ended December 31, 2021 is primarily due to larger impairment losses recorded in this period.
Net loss
In the year ended December 31, 2022, the Company recorded a net loss of $242,938,787 compared with a net loss of $587,032,334 in the year ended December 31, 2021. The large variation in net losses recorded is due mainly to non-cash impairment losses of $130,566,825 in the year ended December 31, 2022 ($575,498,897 December 31, 2021).
MANAGEMENT’S USE OF NON-GAAP FINANCIAL MEASURES
This MD&A contains certain financial performance measures, including “EBITDA” and “Adjusted EBITDA,” that are not recognized under GAAP and do not have a standardized meaning prescribed by GAAP. As a result, these measures may not be comparable to similar measures presented by other companies. For a reconciliation of these measures to the most directly comparable financial information presented in the Financial Statements in accordance with GAAP, see the section entitled “Reconciliation of Non-GAAP Measures” of this MD&A.
EBITDA
We believe EBITDA is a useful measure to assess the performance of the Company as it provides more meaningful operating results by excluding the effects of expenses that are not reflective of our underlying business performance and other one-time or non-recurring expenses. We define EBITDA as net income (loss) before (i) depreciation and amortization; (ii) income taxes; and (iii) interest expense and debt amortization.
Adjusted EBITDA
We believe Adjusted EBITDA is a useful measure to assess the performance of the Company as it provides more meaningful operating results by excluding the effects of expenses that are not reflective of our underlying business performance and other one-time or non-recurring expenses. We define Adjusted EBITDA as EBITDA adjusted to exclude extraordinary items, non-recurring items and, other non-cash items, including, but not limited to (i) stock-based compensation expense, (ii) fair value change in contingent consideration and investments measured at Fair Value Through Profit and Loss (“FVTPL”) (iii) non-recurring legal and professional fees, human-resources, inventory and collections-related expenses, (iv) non-recurring tax charges (v) intangible and goodwill impairments and loss on disposal of assets, (vi) transaction costs related to merger and acquisition activities, and (vii) non-cash sales and marketing expenses.
| | Year-ended | |
| | December 31, 2022 | | | December 31, 2021 | |
| | | | | | |
Net loss and comprehensive loss from continuing | | $ | (237,699,408 | ) | | $ | (498,326,470 | ) |
Income taxes from continuing operations | | | (14,967,779 | ) | | | (6,418,167 | ) |
Depreciation and amortization from continuing operations | | | 26,795,957 | | | | 22,439,733 | |
Interest expense from continuing operations | | | 4,928,475 | | | | 5,155,217 | |
EBITDA | | | (220,942,755 | ) | | | (477,149,687 | ) |
Adjustments: | | | | | | | | |
Share based compensation expense | | | 6,009,593 | | | | 20,456,297 | |
Other non-recurring items: | | | | | | | | |
Fair value change of contingent consideration | | | 967,726 | | | | (229,819,070 | ) |
Change in fair value of investments at FVTPL | | | 947,813 | | | | 1,250,990 | |
Loss on disposal of assets | | | 5,091,541 | | | | 2,447,985 | |
Impairment loss | | | 130,566,825 | | | | 575,498,897 | |
Other taxes | | | - | | | | 2,243,441 | |
De-SPAC costs | | | - | | | | 5,341,154 | |
Restructuring costs | | | 5,566,058 | | | | 3,878,782 | |
Sales and marketing expense | | | - | | | | 30,166,667 | |
Adjusted EBITDA | | $ | (71,793,199 | ) | | $ | (65,684,544 | ) |
EBITDA
The Company’s EBITDA loss for the year ended December 31, 2022 was $220,942,755 compared $477,149,687 in the comparative year ended December 31, 2021. The large decrease in EBITDA loss is due mainly to non-cash impairment expenses which are included in the calculation of EBITDA (impairment of $130,566,825 in the year ended December 31, 2022 compared with $575,498,897 for the year ended December 31, 2021).
Adjusted EBITDA
The Company’s Adjusted EBITDA loss was $71,793,199 for the year ended December 31, 2022 compared with $65,684,544 in the comparative year ended December 31, 2021. The Company’s adjusted EBITDA loss for 2022 calendar year increased over 2021 due to the integration of the numerous acquisitions made in 2021. The Company implemented significant restructuring efforts during 2022 as described earlier in this MD&A with the goal of reducing adjusted EBITDA losses going forward.
LIQUIDITY AND CAPITAL RESOURCES
We manage liquidity risk by reviewing, on an ongoing basis, our sources of liquidity and capital requirements. As at December 31, 2022, the Company had cash and cash equivalents of $93,697,529 compared with cash and cash equivalents of $165,310,609 as at December 31, 2021. Cash and cash equivalents are predominately invested in liquid securities issued by the United States government.
In evaluating our capital requirements, including the impact, if any, on our business from the COVID-19 pandemic, and our ability to fund the execution of our strategy, we believe we have adequate available liquidity to enable us to meet our working capital and other operating requirements, fund growth initiatives and capital expenditures, settle our liabilities and repay scheduled principal and interest payments on debt for at least the next twelve months.
Our objective is to generate sufficient cash to fund our operating requirements and expansion plans. Since the closing of the Qualifying Transaction on January 15, 2021, we have incurred net operating losses. However, management is confident in the Company’s ability to grow revenue and reach long- term profitability. We also expect to have access to public capital markets through our listing on the NEO Exchange, and continue to review and pursue selected external financing sources to ensure adequate financial resources. These potential sources include, but are not limited to (i) obtaining financing from traditional or non-traditional investment capital organizations; (ii) obtaining funding from the sale of our Common Shares or other equity or debt instruments; and (iii) obtaining debt financing with lending terms that more closely match our business model and capital needs. There can be no assurance that we will gain adequate market acceptance for our products or be able to generate sufficient positive cash flow to achieve our business plans, that additional capital or other types of financing will be available when needed, or that these financings will be on terms favorable to the Company or at all.
We expect to continue funding operating losses as we integrate and optimize operations with our available cash. Therefore, we are subject to risks including, but not limited to, our inability to raise additional funds through debt and/or equity financing to support our continued development, including capital expenditure requirements, operating requirements and to meet our liabilities and commitments as they come due.
The Company made the strategic decision to exit its low margin bulk wholesale business during the third quarter of 2022 to reduce complexity, prioritize higher-margin activities and conserve cash. As such, this bulk wholesale business has been presented as discontinued operations commencing in the third quarter of 2022 in our financial statements including in the statement of cash flow. During the year ended December 31, 2022, discontinued operations used cash of $5,375,734 compared with a use of cash of $7,430,934 in the comparative year ended December 31, 2021. The divestment of the bulk wholesale business was completed n October 31, 2022. The Company expects this divestment will reduce its operating cash burn rate going forward.
CASH FLOW
(in United States dollars) | | December 31, 2022 | | | December 31, 2021 | |
| | | | | | |
Cash provided by (used in) | | | | | | |
Operating activities | | | | | | |
Net loss from continuing operations | | $ | (237,699,408 | ) | | $ | (498,326,470 | ) |
Adjustments for items not involving cash | | | | | | | | |
Impairment loss | | | 130,566,825 | | | | 575,498,897 | |
Interest expense | | | 4,928,475 | | | | 5,183,817 | |
Interest income | | | (133,744 | ) | | | (1,149,041 | ) |
Loss on disposal of assets | | | 5,091,541 | | | | 2,447,985 | |
Loss on lease termination | | | (117,806 | ) | | | - | |
Allowance for accounts receivable and notes receivable | | | 2,273,302 | | | | 4,396,783 | |
Gain on debt forgiveness | | | - | | | | (3,358,686 | ) |
Credit losses and changes in fair value of investments | | | 947,813 | | | | 1,250,990 | |
Depreciation and amortization | | | 26,795,957 | | | | 22,439,733 | |
Shares issued for long-term strategic contracts | | | - | | | | 25,000,000 | |
Share-based compensation expense, net of withholding tax settlement | | | 5,474,533 | | | | 19,663,385 | |
Non-cash marketing expense | | | 3,718,402 | | | | 5,166,666 | |
Non-cash operating lease expense | | | 6,857,552 | | | | 4,507,630 | |
Fair value change of contingent consideration | | | 967,726 | | | | (229,819,070 | ) |
Deferred income tax recovery | | | (32,326,433 | ) | | | (5,590,409 | ) |
Repayment of operating lease liabilities | | | (6,707,387 | ) | | | (4,836,963 | ) |
Net changes in non-cash working capital items | | | 22,889,489 | | | | (43,417,594 | ) |
Net cash used in continued operating activities | | | (66,473,163 | ) | | | (120,942,347 | ) |
Net cash used in discontinued operating activities | | | (5,375,734 | ) | | | (7,430,934 | ) |
Total operating activities | | | (71,848,897 | ) | | | (128,373,281 | ) |
| | | | | | | | |
Financing activities | | | | | | | | |
Repayment of consideration payable | | | (1,533,333 | ) | | | (1,034,417 | ) |
Repayment of finance lease liabilities | | | (4,490,443 | ) | | | (4,385,528 | ) |
Proceeds from private placement | | | - | | | | 51,635,000 | |
Redemption of Class A restricted voting shares | | | - | | | | (264,318,686 | ) |
Proceeds from exercise of options | | | - | | | | 12,972 | |
Repurchase of shares | | | - | | | | (6,542,196 | ) |
Repayment of line of credit | | | - | | | | (1,000,000 | ) |
Total financing activities | | | (6,023,776 | ) | | | (225,632,855 | ) |
| | | | | | | | |
Investing activities | | | | | | | | |
Net cash paid in the Qualifying Transaction | | | - | | | | (28,143,886 | ) |
Net cash paid in other business combinations | | | - | | | | (20,612,867 | ) |
Purchases of property and equipment | | | (3,322,873 | ) | | | (9,359,417 | ) |
Advances for investments and note receivables | | | (350,000 | ) | | | (5,650,000 | ) |
Proceeds (advances) from investments at fair value through profit or loss | | | 304,052 | | | | (1,000,000 | ) |
Net cash paid for the acquisition of NCI | | | (8,430,000 | ) | | | - | |
Proceeds from notes receivable | | | 1,759,318 | | | | 374,984 | |
Proceeds from sale of assets, net of selling costs | | | 6,401,402 | | | | 11,068,537 | |
Net cash used in continued investing activities | | | (3,638,101 | ) | | | (53,322,649 | ) |
Net cash from (used in) discontinued investing activities | | | 316,005 | | | | (400,942 | ) |
Total investing activities | | | (3,322,096 | ) | | | (53,723,591 | ) |
| | | | | | | | |
Net change in cash during the period | | | (81,194,769 | ) | | | (407,729,727 | ) |
| | | | | | | | |
Cash, restricted cash and restricted cash equivalents | | | | | | | | |
Beginning of year | | $ | 174,892,298 | | | $ | 582,622,025 | |
End of year | | $ | 93,697,529 | | | $ | 174,892,298 | |
| | | | | | | | |
Cash | | | 93,697,529 | | | | 165,310,609 | |
Restricted cash and restricted cash equivalents | | | - | | | | 9,581,689 | |
Cash, restricted cash and restricted cash equivalents | | $ | 93,697,529 | | | $ | 174,892,298 | |
Operating Activities
Cash used in continued operating activities in the year ended December 31, 2022 totaled $66,473,163 as compared to cash used in continued operating activities of $120,942,347 in the comparative year ended December 31, 2021. In the year ended December 31, 2022, the cash used in operating activities represents an average operating cash burn rate of $5,539,431 per month compared to $10,078,529 per month in the comparative period. The significant reduction in cash used in operating activities is due to the various restructuring efforts as described earlier in this MD&A and significantly less cash tied up in working capital on our balance sheet due to the cultivation pause and outsourcing of manufacturing. This restructuring allowed for $22,889,489 of cash to be released from working capital in 2022 compared to a use of $43,417,594 of cash for of working capital in 2021.
The Company is evaluating a number of options to improve operating results including: subleasing excess real estate, combining operations for lower performing locations, closing or disposing of non-core assets, and general and administrative cost reductions.
Cash used in discontinued operating activities in the year ended December 31, 2022 totaled $5,375,731 compared with cash used in discontinued operating activities of $7,430,934 in the comparative year ended December 31, 2021.
Financing Activities
Cash used in financing activities totaled $6,023,776 in the year ended December 31, 2022 compared with cash used of $225,632,855 in the comparative year ended December 31, 2021. In the year ended December 31, 2022, the Company settled $4,490,443 lease liabilities associated with its real estate, $1,153,333 of consideration payable primarily related to its 2021 entry into a purchase agreement to acquire oastal Holding and related Coastal MSAs. The year end December 31, 2021 includes a payment of $264,318,686 in connection with the redemption of Class A restricted voting shares on closing the Qualifying Transaction which was the reason for the majority of the net cash outflow.
Investing Activities
Cash used in investing activities totaled $3,638,101 in the year ended December 31, 2022 compared with cash used of $53,322,649 in the comparative year ended December 31, 2021. In the year ended December 31, 2022, the Company invested $150,000 in its social equity venture investment in Digistrains and $200,000 in Josephine & Billies, received $6,401,402 of proceeds from the sale of property, plant and equipment primarily associated with the sale and leaseback transaction at its Pullman property, and invested $3,322,873 in property plant and equipment to support its operations and paid cash of $8,430,000 to acquire the non-controlling interests ($3,750,000 for Coastal and $4,680,000 for Varda). The comparative year ended December 31, 2021 includes $48,756,753 of cash paid for acquisitions as the major use of cash.
CONTRACTUAL OBLIGATIONS
Lease Obligations
The Company leases real estate used for dispensaries, production plants, and corporate offices. Lease terms for real estate generally range from 1 to 14.75 years. Most leases include options to renew for varying terms at the Company’s sole discretion. Certain leases include escalation clauses or payment of executory costs such as property taxes, utilities, or insurance and maintenance. Rent expense for leases with escalation clauses is accounted for on a straight-line basis over the lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The maturity of the contractual undiscounted lease liabilities as of December 31, 2022:
| | Operating Lease | | | Finance Lease | |
| | | | | | |
2023 | | $ | 5,521,022 | | | $ | 4,625,156 | |
2024 | | | 5,002,948 | | | | 4,763,910 | |
2025 | | | 5,139,443 | | | | 4,906,828 | |
2026 | | | 5,288,213 | | | | 5,054,033 | |
2027 | | | 4,775,402 | | | | 5,205,654 | |
Thereafter | | | 18,295,466 | | | | 59,679,244 | |
Total undiscounted lease liabilities | | | 44,022,494 | | | | 84,234,825 | |
Marketing Agreement (“MA”)
The Company had engaged a third-party for strategic and promotional services. During the year ended December 31, 2021, the Company issued 2,376,425 Common Shares in settlement of the initial $25,000,000. As the shares vested immediately, the full amount of the $25,000,000 was recognized as an expense in operating expenses during the year ended December 31, 2021.
The Company was obligated to issue shares to the value of $1,875,000 quarterly over the second and third year of the contract. During year ended December 31, 2022, the Company issued 7,355,453 Common Shares to settle the first year of quarterly payments. These Common Shares are restricted under applicable US securities laws.
The Company recognized an expense of $3,718,402 during the year ended December 31, 2022 (December 31, 2021 - $5,166,666) in operating expenses as a sales and marketing expense. As of December 31, 2022, the cash-settled liability is $nil (December 31, 2021 - $5,166,666).
Brand Strategy Agreement (“BSA”)
The Company was party to the BSA, whereby the Company received the services of Shawn C. Carter p/k/a JAY-Z’s related promotion and advertising for the remaining non-cancellable period of 5 years. The Company was committed to settle $21,500,000 in either cash or Common Shares at the option of the counterparty over the remaining non-cancellable period. The Company was recognizing the cost associated with the arrangement over the same period it was receiving services.
During the year ended December 31, 2022, the Company recognized an expense of $4,416,667 (December 31, 2021 - $4,183,565) in operating expenses related to this arrangement and $nil in accounts payable and accrued liabilities as of December 31, 2022 (December 31, 2021 - $2,183,565). During the year ended December 31, 2022, the Company made a cash payment of $3,000,000 (December 31, 2021 - $nil).
On December 29, 2022, the Company entered into modification agreements (the "Modification Agreements") to restructure the relationship between the Company and the counterparties to each of the MA and BSA. As part of the restructured arrangements, the Company is no longer obligated to issue additional shares or cash related to the long-term strategic contracts, and the counterparties agreed to return 7,121,239 Common Shares of the Company to treasury. In addition, ownership of the brand "Monogram" was transferred to an entity designated by one of the counterparties. The Company was provided with an exclusive and royalty-free eight-year license to commercialize Monogram in California. The Company recognized a loss on disposal of assets of $4,832,891 related to the Modification Agreements which is included in loss on disposal of assets in the consolidated statement of operations and comprehensive loss.
COMMITMENTS AND CONTINGENCIES
California operating licenses
The Company's primary activity is engaging in state-legal commercial cannabis business, including the cultivation, manufacture, distribution, and sale of cannabis and cannabis products pursuant to California law. However, this activity is not in compliance with the United States Controlled Substances Act, or the CSA. The Company's assets are potentially subject to seizure or confiscation by Federal governmental agencies, and the Company could face criminal and civil penalties for noncompliance with the CSA, although such events would be without relevant precedent. Management of the Company believes the Company is in compliance with all California and local jurisdiction laws and monitor the regulatory environment on an ongoing basis along with counsel to ensure the continued compliance with all applicable laws and licensing agreements.
The Company's operation is sanctioned by the State of California and local jurisdictions. There have been no instances of federal interference with those who adhere to State of California and local laws and regulations regarding commercial cannabis activities. Due to the uncertainty surrounding the Company's noncompliance with the CSA, the potential liability from any noncompliance cannot be reasonably estimated and the Company may be subject to regulatory fines, penalties or restrictions in the future.
Effective January 1, 2018, the State of California allowed for adult use cannabis sales. Beginning on January 1, 2018, the State began issuing temporary licenses that expired 120 days after issuance for retail, distribution, manufacturing and cultivation permits. Temporary licenses could be extended in 90-day increments by the State upon submission of an annual license application. All temporary licenses had been granted extensions by the State during 2018.
In September 2019, Senate Bill 1459 (SB 1459) was enacted which enabled state licensing authorities to issue provisional licenses through 2021. A provisional license could be issued if an applicant submitted a completed annual license application to the Bureau of Cannabis Control. A completed application for purposes of obtaining a provisional license is not the same as a sufficient application to obtain an annual license. The provisional cannabis license, which is valid for 12 months from the date issued, is said to be in between a temporary license and an annual license and allows a cannabis business to operate as they would under local and state regulations.
Licensees issued a provisional license are expected to be diligently working toward completing all annual license requirements in order to maintain a provisional license. The Company obtained its provisional licenses in 2019 and continues to work with the State of California to obtain annual licensing.
The Company's prior licenses obtained from the local jurisdictions it operated in have been continued by such jurisdictions and are necessary to obtain State licensing.
The Company has received annual licenses from each local jurisdiction in which it actively operates. Although the Company believes it will continue to receive the necessary licenses from the State and applicable local jurisdictions to conduct its business in a timely fashion, there is no guarantee its clients will be able to do so and any failure of its clients receive necessary licenses may have a negative effect on the Company’s business and results of operations.
Other legal matters
From time to time in the normal course of business, the Company may be subject to legal matters such as threatened or pending claims or proceedings. The Company is not currently a party to any material legal proceedings or claims, nor are we aware of any pending or threatened litigation or claims that could have a material adverse effect on our business, operating results, cash flows or financial condition should such litigation or claim be resolved unfavorably.
Mosaic.Ag
On May 17, 2021, the Company announced that it had entered into a series of arrangements to obtain the rights to four acres of land that is licensed for outdoor grow from a consortium of experienced cannabis farms affiliated with Mosaic.Ag, In addition, in connection with each of the four acres of land, the Company entered into a cultivation and supply agreement with Mosaic.Ag to cultivate cannabis on its behalf for a period of at least three years, with options to extend each of the four agreements up to five years.
The purchase price for Mosaic.Ag under the arrangements was $6,000,000 in cash, $2,500,000 in Common Shares when the transaction closed, and up to 1,309,263 Common Shares subject to earnouts. The upfront payment of $5,650,000, net of a holdback amount of $350,000, was (and continues to be) secured by a promissory note. The closing of the transaction was dependent on the satisfaction of various closing conditions, which were not met by the second quarter of 2022, as required by the Membership Interest Purchase Agreement. Futher, Mosiac.Ag was unable to produce sufficient quantities of biomass according to Company quality standards and pursuant to the cultivation supply agreements, leading to an overpayment under those agreements and a refund due to the Company of approximately $1,490,000 in cash. The Company noticed termination of the arrangements on June 30, 2022, and requested that Mosaic.Ag present an acceptable restructure to the arrangements and/or a payback plan for the owed refund and for the upfront payment under the promissory note. Mosaic.Ag has contested certain of the Company’s positions and has claimed an inability to pay the owed cash amounts. For the foregoing reasons, the Company filed a lawsuit against Mosaic.Ag and related individuals on December 16, 2022, in the Superior Court of California, County of Santa Clara, alleging breach of contract and asking for declaratory relief. Defendants have not yet responded to the complaint.
Social equity fund
The Company formed SEV in 2021 as its social equity investment vehicle. The Company intends to fund SEV with $10,000,000 and contribute 2% of its net income to allow SEV to make further social equity investments. During the year ended December 31, 2022, SEV made two social equity investments totaling $350,000 (December 31, 2021 - SEV made two social equity investments totaling $1,000,000).
COVID-19
In March 2020, the World Health Organization categorized COVID-19 as a pandemic. COVID‑19 continues to impact the U.S. and other countries across the world. While the impacts of COVID-19 have lessened in recent months, the outbreak of COVID-19 severely impacted global economic activity and caused significant volatility and negative pressure in financial markets. The Company continues to implement and evaluate actions to maintain its financial position and support the continuity of its business and operations in the face of COVID-19, potential future pandemics and other events.
The Company’s priorities during the COVID-19 pandemic continue to be protecting the health and safety of its employees and its customers, following the recommended actions of government and health authorities. In the future, COVID-19 or future pandemics may cause reduced demand for the Company’s products and services if, for example, the pandemic results in a recessionary economic environment or potential new restrictions on business operations or the movement of individuals.
The COVID-19 outbreak in the United States caused business disruption both to the Company and throughout its customer base and supply chain through mandated and voluntary closings of many businesses. It is unclear the extent to which this disruption negatively impacted the Company’s operating results. The Company has taken, important steps to protect its employees, customers and business operations since the beginning of the pandemic.
The Company has incurred incremental costs to implement proactive measures to prevent the spread of COVID-19. Additionally, the Company closely monitors its supply chain and third-party product availability in light of the pandemic. To date, the business has not experienced negative consequences due to interruptions in its supply chain. However, the Company continues to undertake preemptive measures to ensure alternate supply sources as needed.
Inflation
The Company is not immune to the widespread cost inflation experienced in the United States and many parts of the world. The Company intends to continue to work to improve its gross margins despite cost inflation through market pricing, greater cost efficiencies, advantageous vendor partnerships, and other measures.
OFF-BALANCE SHEET ARRANGEMENTS
As of the date hereof the Company does not have any off-balance sheet financing arrangements and has not guaranteed any debt or commitments of other entities or entered into any options on non-financial assets.
SHARE CAPITAL AND CAPITAL MANAGEMENT
As of December 31, 2022, the Company had 107,516,333 Common Shares and 35,837,500 Common Share purchase warrants (the “Warrants”) issued and outstanding. The Warrants are exercisable at an exercise price of $11.50 and will expire on January 15, 2026. The Company may accelerate the expiry date of the outstanding Warrants (excluding the Warrants held by Subversive Capital Sponsor LLC in certain circumstances) by providing 30 days’ notice, if and only if, the closing price of the Common Shares equals or exceeds $18.00 per Common Share (as adjusted for stock splits or combinations, stock dividends, extraordinary dividends, reorganizations and recapitalizations) for any 20 trading days within a 30-trading day period.
The Company has an equity incentive plan (the “Equity Incentive Plan”) that permits the grant of stock options, RSUs, deferred share units, performance share units (“PSUs”) and stock appreciation rights to non-employee directors and any employee, officer, consultant, independent contractor or advisor providing services to the Company or any affiliate. As of December 31, 2022, a total of 3,093,992 RSUs and 2,325,000 PSUs were outstanding under the Equity Incentive Plan.
Prior to closing of the Qualifying Transaction, Caliva maintained the CMG Partners, Inc. 2019 Stock Option and Grant Plan (the “Caliva EIP”), which permitted awards of common stock in Caliva. In connection with the Qualifying Transaction, Caliva and the Company agreed that the Company would maintain the Caliva EIP and that outstanding awards thereunder will entitle the holder to receive Common Shares. As of December 31, 2022, there were 367,179 options to purchase up to 367,179 Common Shares under the Caliva EIP outstanding with a weighted average exercise price of $7.20 per share. No further awards will be granted under the Caliva EIP.
Prior to closing of the Qualifying Transaction, LCV maintained the Amended and Restated 2018 Equity Incentive Plan (the “LCV Equity Plan”) which authorized LCV to grant to its employees, directors and consultants stock options and other equity-based awards. In connection with the Qualifying Transaction, LCV and the Company agreed that the Company would maintain the LCV Equity Plan and that outstanding awards thereunder will entitle the holder to receive Common Shares. At December 31, 2022, there were 9,206 options to purchase up to 9,206 Common Shares under the LCV Equity Plan outstanding with a weighted average exercise price of $26.74 per share. No further awards will be granted under the LCV Equity Plan.
The Company manages its capital with the following objectives:
| · | To ensure sufficient financial flexibility to achieve the ongoing business objectives including of future growth opportunities, and pursuit of accretive acquisitions; and |
| · | To maximize shareholder return through enhancing the share value. |
The Company considers its capital to be total equity. The Company manages capital through its financial and operational forecasting processes. The Company reviews its working capital and forecasts its future cash flows based on operating expenditures, and other investing and financing activities. Selected information is provided to the Company Board. The Company’s capital management objectives, policies and processes have remained unchanged during the year ended December 31, 2022 and year ended December 31, 2021. The Company is not subject to any external capital requirements.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make judgments, estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements. Although these estimates are based on management’s best knowledge of the amount, event or actions, actual results may differ from those estimates. Estimates and judgments are continuously evaluated and are based on management’s experience and other factors, including expectations of future events that management considers to be reasonable.
See Note 3: Significant Accounting Policies to the consolidated financial statements included in this Annual Report on Form 10-K for further information.
Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.
Variable interest entities
The Company assesses all variable interests in entities and uses judgment when determining if the Company is the primary beneficiary. Other qualitative factors that are considered include decision-making responsibilities, the VIE capital structure, risk and rewards sharing, contractual agreements with the VIE, voting rights and the level of involvement of other parties. .
Business combinations
In determining the fair value of net identifiable assets acquired in a business combination, including any acquisition-related contingent consideration, estimates including market based and appraisal values are used. One of the most significant areas of judgment and estimation relates to the determination of the fair value of these assets and liabilities, including the fair value of contingent consideration, if applicable. If any intangible assets are identified, depending on the type of intangible asset and the complexity of determining its fair value, an independent external valuation expert may develop the fair value, using appropriate valuation techniques, which are generally based on a forecast of the total expected future net cash flows. These valuations are linked closely to the assumptions made by management regarding the future performance of the assets concerned and any changes in the discount rate applied. In addition, management applies judgment in determining the amount, if any, that leases acquired in a business combination are off-market resulting in an adjustment to the right-of-use assets. In particular, management’s judgment is used in determining the premium over basic market rents that would be applied by a lessor where the leased premise is being used for cannabis-related businesses. Finally, determining whether amounts should be included as part of consideration requires judgment.
Leases
The Company applies judgment in determining whether a contract contains a lease and whether a lease is classified as an operating lease or a finance lease. The Company determines the lease term as the non-cancellable term of the lease, which may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The lease term is used in determining classification between operating lease and finance lease, calculating the lease liability and determining the incremental borrowing rate.
The Company has several lease contracts that include extension and termination options. The Company applies judgment in evaluating whether it is reasonably certain to exercise the option to renew or terminate the lease. That is, it considers all relevant factors that create an economic incentive for it to exercise either the renewal or termination. After the commencement date of the lease, the Company reassesses the lease term if there is a significant event or change in circumstances that is within its control and affects its ability to exercise or not to exercise the option to renew or to terminate (e.g., construction of significant leasehold improvements or significant customization to the leased asset).
The Company also applies judgment in allocating the consideration in a contract between lease and non-lease components. It considers whether the Company can benefit from the right-of-use asset either on its own or together with other resources and whether the asset is highly dependent on or highly interrelated with another right-of-use asset.
The Company is required to discount lease payments using the rate implicit in the lease if that rate is readily available. If that rate cannot be readily determined, the lessee is required to use its incremental borrowing rate. The Company generally uses the incremental borrowing rate when initially recording real estate leases. Information from the lessor regarding the fair value of underlying assets and initial direct costs incurred by the lessor related to the leased assets is not available. The Company determines the incremental borrowing rate as the interest rate the Company would pay to borrow over a similar term the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.
Stock-based compensation
In determining the fair value of stock-based payments, the Company makes assumptions, such as the expected life of the award, the volatility of the Company’s stock price, the risk-free interest rate, and the rate of forfeitures.
Goodwill
Goodwill is tested for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of goodwill may have been impaired. In order to determine that the value of goodwill may have been impaired, the Company performs a qualitative assessment to determine whether it is more-likely-than-not that the reporting unit’s fair value is less than its carrying value, indicating the potential for goodwill impairment. A number of factors, including historical results, business plans, forecasts and market data are used to determine the fair value of the reporting unit. Changes in the conditions for these judgments and estimates can significantly affect the assessed value of goodwill.
Long-lived assets
Depreciation and amortization of property and equipment, right-of-use assets and intangible assets are dependent upon estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that consider factors such as economic and market conditions and the useful lives of assets. The Company uses judgment in: (i) assessing whether there are impairment triggers affecting long-lived assets, (ii) determining the asset groups and (iii) determining the recoverable amount and if necessary, estimating the fair value.
Fair value measurement
The Company uses valuation techniques to determine the fair value of financial instruments (where active market quotes are not available) and non- financial assets. This involves developing estimates and assumptions consistent with how market participants would price the instrument. The Company bases its assumptions on observable data as far as possible, but this is not always available. In that case, the Company uses the best information available. Estimated fair values may vary from the actual prices that would be achieved in an arm’s length transaction at the reporting date.
Deferred tax assets and uncertain tax positions
The Company recognizes deferred tax assets and liabilities based on the differences between the financial statement carrying amounts and the respective tax bases of its assets and liabilities. The Company measures deferred tax assets and liabilities using current enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. The Company routinely evaluates the likelihood of realizing the benefit of its deferred tax assets and may record a valuation allowance if, based on all available evidence, it determines that some portion of the tax benefit will not be realized.
In evaluating the ability to recover deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax-planning strategies and results of operations. In projecting future taxable income, the Company considers historical results and incorporates assumptions about the amount of future state, federal and foreign pretax operating income adjusted for items that do not have tax consequences. The Company’s assumptions regarding future taxable income are consistent with the plans and estimates that are used to manage its underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income/(loss). The income tax expense, deferred tax assets and liabilities and liabilities for unrecognized tax benefits reflect the Company’s best assessment of estimated current and future taxes to be paid. Deferred tax asset valuation allowances and liabilities for unrecognized tax benefits require significant judgment regarding applicable statutes and their related interpretation, the status of various income tax audits and the Company’s particular facts and circumstances. Although the Company believes that the judgments and estimates discussed herein are reasonable, actual results, including forecasted COVID-19 business recovery, could differ, and the Company may be exposed to losses or gains that could be material. To the extent the Company prevails in matters for which a liability has been established or is required to pay amounts in excess of the established liability, the effective income tax rate in a given financial statement period could be materially affected.
Accounting standards issued but not yet effective
Allowance for credit losses
In September 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance was subsequently amended by ASU 2018-19, Codification Improvements, ASU 2019- 04, Codification Improvements, ASU 2019-05, Targeted Transition Relief, ASU 2019-10, Effective Dates, and ASU 2019-11, Codification Improvements. These ASUs are effective for Smaller Reporting Companies for fiscal years beginning after December 15, 2022, including interim periods therein. The Company is currently evaluating the effect of adopting this ASU.
Business combinations
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”). The amendments in this update require contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, Revenue from Contracts with Customers, as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date. These ASUs are effective for Smaller Reporting Companies for fiscal years beginning after December 15, 2023, including interim periods therein. This ASU is currently not expected to have a material impact on the consolidated financial statements.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
The financial statements required by this item and the reports of the independent accountants thereon required by Item 15(a)(2) appear on pages F-2 to F-48. See accompanying Index to the Consolidated Financial Statements on page F-1.
Consolidated financial statements
TPCO Holding Corp.
For the years ended December 31, 2022 and 2021
Contents
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
TPCO Holding Corp.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheet of TPCO Holding Corp. (the “Company”) as of December 31, 2022, the related consolidated statements of operations and comprehensive loss, changes in shareholders’ (deficit) equity and cash flows for the year ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operations and its cash flows for the year ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.
As described in Note 7, the sale of the Company’s bulk wholesale business closed on October 31, 2022. As a result, the business revenues and expenses were classified as discontinued operations and the related assets and liabilities were classified as held for sale and discontinued operations in the financial statements as of December 31, 2021, which are shown comparatively. Except for the effects of the retrospective presentation for discontinued operations, we were not engaged to audit, review, or apply any procedures to the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the year then ended, other than stated above and, accordingly, we do not express an opinion or any other form of assurance about whether such financial position have been fairly stated as of December 31, 2021. Those balances were audited by MNP LLP.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ Marcum LLP
Marcum LLP
We have served as the Company’s auditor since 2022.
New York, NY
April 3, 2023
![tpco_10kimg7.jpg](https://content.edgar-online.com/edgar_conv_img/2023/04/03/0001654954-23-004186_tpco_10kimg7.jpg)
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of TPCO Holding Corp.
Opinion on the Consolidated Financial Statements
We have audited, before the effects of the adjustments to retrospectively apply the change in accounting described in Note 7 – Assets held for sale and discontinued operations, the accompanying consolidated balance sheet of TPCO Holding Corp. (the “Company”) as of December 31, 2021 and the related consolidated statements of operations and comprehensive loss, shareholders’ (deficit) equity, and cash flows for the year ended December 31, 2021, and the related notes (collectively referred to as the “consolidated financial statements”). The 2021 financial statements before the effects of the adjustments discussed in Note 7 are not presented in the consolidated financial statements.
In our opinion, the 2021 consolidated financial statements, before the effects of the adjustments to retrospectively apply the change in accounting described in Note 7 – Assets held for sale and discontinued operations, present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2021, and the results of its consolidated operations and its consolidated cash flows for the year ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.
Marcum LLP audited the adjustments to retrospectively apply the change in accounting described in Note 7 – Assets held for sale and discontinued operations. We were not engaged to audit, review, or apply any procedures to those adjustments, and accordingly, we do not express an opinion or any other form of assurance about whether those adjustments are appropriate and have been properly applied.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
Toronto, Canada March 31, 2022 | /s/ MNP LLP Chartered Professional Accountants Licensed Public Accountants |
We have served as the Company’s auditor since 2020.
MNP LLP | |
1 Adelaide Street East, Suite 1900, Toronto ON, M5C 2V9 | 1.877.251.2922 T: 416.596.1711 F: 416.596.7894 |
TPCO Holding Corp. Consolidated balance sheets (in United States dollars) |
As at | | | Note | | | December 31, 2022 | | | December 31, 2021 | |
Assets | | | | | | | | | | |
Current | | | | | | | | | | |
Cash | | | | | | $ | 93,697,529 | | | $ | 165,310,609 | |
Restricted cash and restricted cash equivalents | | | | | | | - | | | | 9,581,689 | |
Accounts receivable, net | | | 30 | | | | 1,205,700 | | | | 4,705,563 | |
Income tax receivable | | | | | | | - | | | | 1,322,340 | |
Inventory | | | 4 | | | | 8,727,858 | | | | 22,196,981 | |
Notes and other receivables, net | | | 5 | | | | 108,957 | | | | 4,732,617 | |
Prepaid expenses and other current assets | | | 6 | | | | 8,368,495 | | | | 11,940,043 | |
Assets held for sale and discontinued operations | | | 7 | | | | 6,102,764 | | | | 5,042,670 | |
Total current assets | | | | | | | 118,211,303 | | | | 224,832,512 | |
| | | | | | | | | | | | |
Investments | | | 8 | | | | 1,478,204 | | | | 2,500,069 | |
Security deposits | | | | | | | 1,181,078 | | | | 1,119,754 | |
Prepaid expenses and other assets | | | | | | | 844,239 | | | | 756,968 | |
Notes and other receivables, net | | | 5 | | | | 518,846 | | | | - | |
Property and equipment | | | 9 | | | | 15,146,084 | | | | 22,159,470 | |
Right-of-use assets – operating | | | 10 | | | | 20,689,086 | | | | 27,662,847 | |
Right-of-use assets – finance | | | 10 | | | | 23,070,846 | | | | 24,639,605 | |
Intangible assets | | | 11 | | | | 99,378,098 | | | | 212,587,865 | |
Goodwill | | | 11 | | | | - | | | | 44,051,645 | |
Assets held for sale and discontinued operations | | | 7 | | | | - | | | | 11,144,254 | |
Total assets | | | | | | $ | 280,517,784 | | | $ | 571,454,989 | |
| | | | | | | | | | | | |
Liabilities | | | | | | | | | | | | |
Current | | | | | | | | | | | | |
Accounts payable and accrued liabilities | | | 12 | | | $ | 24,560,359 | | | $ | 41,625,317 | |
Consideration payable – current portion | | | | | | | 5,777,943 | | | | 7,496,240 | |
Operating lease liability – current portion | | | 10 | | | | 2,355,174 | | | | 3,177,666 | |
Finance lease liability – current portion | | | 10 | | | | 156,184 | | | | 13,712 | |
Cash settled share-based payments | | | 13 | | | | - | | | | 5,166,666 | |
Note payable | | | | | | | 931,103 | | | | - | |
Contingent consideration | | | 30 | | | | 1,611,843 | | | | 943,131 | |
Liabilities held for sale and discontinued operations | | | 7 | | | | 1,309,077 | | | | 264,044 | |
Total current liabilities | | | | | | | 36,701,683 | | | | 58,686,776 | |
| | | | | | | | | | | | |
Operating lease liabilities | | | 10 | | | | 24,803,815 | | | | 27,142,326 | |
Finance lease liabilities | | | 10 | | | | 36,618,530 | | | | 36,774,714 | |
Consideration payable | | | | | | | 383,334 | | | | 1,827,515 | |
Deferred tax liabilities | | | 14 | | | | 20,972,629 | | | | 43,847,866 | |
Liabilities held for sale and discontinued operations | | | 7 | | | | - | | | | 644,219 | |
Total liabilities | | | | | | | 119,479,991 | | | | 168,923,416 | |
| | | | | | | | | | | | |
Mezzanine equity | | | | | | | | | | | | |
Redeemable non-controlling interest | | | 15 | | | | - | | | | 41,456,387 | |
Total mezzanine equity | | | | | | | - | | | | 41,456,387 | |
| | | | | | | | | | | | |
Shareholders’ equity | | | | | | | | | | | | |
Common shares, no par value, unlimited Common shares authorized 107,516,333 issued and outstanding at December 31, 2022 and 97,065,092 at December 31, 2021 | | | 16 | | | | - | | | | - | |
Additional paid in capital | | | | | | | 996,697,299 | | | | 954,102,859 | |
Non-controlling interest | | | | | | | 1 | | | | - | |
Accumulated deficit | | | | | | | (835,659,507 | ) | | | (593,027,673 | ) |
Total shareholders’ equity | | | | | | | 161,037,793 | | | | 361,075,186 | |
Total liabilities, mezzanine equity and shareholders’ equity | | | | | | $ | 280,517,784 | | | $ | 571,454,989 | |
Commitments and contingencies (Note 29)
Subsequent events (Note 33)
See accompanying notes to the consolidated financial statements
TPCO Holding Corp. Consolidated statements of operations and comprehensive loss (in United States dollars) |
| | | Note | | | December 31, 2022 | | | December 31, 2021 | |
| | | | | | | | | | |
Sales, net of discounts | | | | | | $ | 83,637,407 | | | $ | 79,924,941 | |
Cost of sales | | | | | | | 57,627,364 | | | | 66,906,654 | |
Gross profit | | | | | | | 26,010,043 | | | | 13,018,287 | |
| | | | | | | | | | | | |
Impairment loss | | | 18 | | | | 130,566,825 | | | | 575,498,897 | |
Operating expenses | | | 19 | | | | 138,381,437 | | | | 171,404,414 | |
| | | | | | | | | | | | |
Loss from operations | | | | | | | (242,938,219 | ) | | | (733,885,024 | ) |
| | | | | | | | | | | | |
Other income (expense) | | | | | | | | | | | | |
Interest income | | | | | | | 845,863 | | | | 1,244,606 | |
Interest expense | | | | | | | (4,928,475 | ) | | | (5,155,217 | ) |
Gain on debt forgiveness | | | | | | | - | | | | 3,358,686 | |
Loss on disposal of assets | | | 22 | | | | (5,091,541 | ) | | | (2,447,985 | ) |
Credit losses and changes in fair value of investments | | | 8 | | | | (947,813 | ) | | | (1,250,990 | ) |
Change in fair value of contingent consideration | | | 30 | | | | (967,726 | ) | | | 229,819,070 | |
Other income | | | | | | | 1,360,724 | | | | 3,572,217 | |
| | | | | | | | | | | | |
Loss before income taxes | | | | | | | (252,667,187 | ) | | | (504,744,637 | ) |
| | | | | | | | | | | | |
Income tax recovery (expense) | | | 14 | | | | 14,967,779 | | | | 6,418,167 | |
Loss and comprehensive loss from continuing operations | | | | | | | (237,699,408 | ) | | | (498,326,470 | ) |
| | | | | | | | | | | | |
Loss from discontinued operations, net of income tax | | | 7 | | | | (5,087,408 | ) | | | (88,705,864 | ) |
Loss from disposal of discontinued operations, net of income tax recovery of $8,856,409 | | | 7 | | | | (151,971 | ) | | | - | |
Net loss from discontinued operations | | | | | | $ | (5,239,379 | ) | | $ | (88,705,864 | ) |
| | | | | | | | | | | | |
Loss and comprehensive loss attributable to shareholders of the company | | | | | | $ | (242,631,834 | ) | | $ | (587,060,124 | ) |
Loss and comprehensive loss attributable to redeemable non-controlling interest | | | 15 | | | | (306,953 | ) | | | 27,790 | |
Net loss | | | | | | $ | (242,938,787 | ) | | $ | (587,032,334 | ) |
| | | | | | | | | | | | |
Per share – basic and diluted | | | | | | | | | | | | |
Loss per share from continuing operations | | | 20 | | | $ | (2.31 | ) | | $ | (5.25 | ) |
Loss per share from discontinued operations | | | 20 | | | | (0.05 | ) | | | (0.93 | ) |
Loss per share | | | 20 | | | $ | (2.36 | ) | | $ | (6.18 | ) |
Weighted average number of common shares | | | 20 | | | | 102,632,433 | | | | 95,006,080 | |
See accompanying notes to the consolidated financial statements
TPCO Holding Corp. Consolidated statements of changes in shareholders’ (deficit) equity (in United States dollars) |
| | | Note | | | Common Shares | | | Number of Warrants | | | Class B Shares | | | Common Shares to be Issued (issued/ returned) | | | Additional Paid in Capital | | | Accumulated Deficit | | | Non-controlling interest | | | Total | |
Balance December 31, 2020 | | | | | | | - | | | | 35,837,500 | | | | 15,218,750 | | | | - | | | $ | (21,886,268 | ) | | $ | (6,463,606 | ) | | $ | - | | | $ | (28,349,874 | ) |
Conversion to Class B shares | | | 16 | | | | 14,655,547 | | | | - | | | | (14,655,547 | ) | | | - | | | | - | | | | - | | | | - | | | | - | |
Founders’ shares forfeited | | | 16 | | | | - | | | | - | | | | (563,203 | ) | | | - | | | | (496,057 | ) | | | 496,057 | | | | - | | | | - | |
Shares issued in a private placement | | | 16 | | | | 6,313,500 | | | | - | | | | - | | | | - | | | | 63,135,000 | | | | - | | | | - | | | | 63,135,000 | |
Conversion of Class A restricted voting shares | | | 16 | | | | 31,407,336 | | | | - | | | | - | | | | - | | | | 318,303,338 | | | | - | | | | - | | | | 318,303,338 | |
Shares issued for long-term strategic contracts | | | 13 | | | | 2,376,425 | | | | - | | | | - | | | | - | | | | 25,000,000 | | | | - | | | | - | | | | 25,000,000 | |
Shares issued in the Qualifying Transaction | | | 16 | | | | 42,891,175 | | | | - | | | | - | | | | 272,104 | | | | 546,447,112 | | | | - | | | | - | | | | 546,447,112 | |
Shares issued to extinguish liabilities in the Qualifying Transaction | | | 16,26 | | | | 336,856 | | | | - | | | | - | | | | - | | | | 4,264,597 | | | | - | | | | - | | | | 4,264,597 | |
Shares to be issued to settle contingent consideration | | | 30 | | | | 24,584 | | | | - | | | | - | | | | 309,284 | | | | 1,957,045 | | | | - | | | | - | | | | 1,957,045 | |
Contingent shares to be issued in the Qualifying Transaction | | | 26 | | | | - | | | | - | | | | - | | | | 187,380 | | | | 2,372,231 | | | | - | | | | - | | | | 2,372,231 | |
Contingent shares issued in the Qualifying Transaction | | | 16 | | | | 25,000 | | | | - | | | | - | | | | (25,000 | ) | | | - | | | | - | | | | - | | | | - | |
Replacement options issued in a business acquisition | | | 27 | | | | - | | | | - | | | | - | | | | - | | | | 3,489,501 | | | | - | | | | - | | | | 3,489,501 | |
Shares issued in other business combinations | | | 27 | | | | 458,898 | | | | - | | | | - | | | | - | | | | 1,468,474 | | | | - | | | | - | | | | 1,468,474 | |
Shares repurchased under share repurchase agreements | | | 17 | | | | (1,725,000 | ) | | | - | | | | - | | | | - | | | | (7,055,250 | ) | | | - | | | | - | | | | (7,055,250 | ) |
Shares repurchased under NCIB | | | 16 | | | | (157,600 | ) | | | - | | | | - | | | | - | | | | (603,165 | ) | | | - | | | | - | | | | (603,165 | ) |
Shares issued for options exercised | | | 16 | | | | 3,313 | | | | - | | | | - | | | | - | | | | 12,972 | | | | - | | | | - | | | | 12,972 | |
Shares issued for RSUs vested | | | 16 | | | | 455,058 | | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | |
Tax settlements associated with RSUs | | | 21 | | | | - | | | | - | | | | - | | | | - | | | | (1,080,071 | ) | | | - | | | | - | | | | (1,080,071 | ) |
Modification of RSUs | | | 21 | | | | - | | | | - | | | | - | | | | - | | | | 3,451,365 | | | | - | | | | - | | | | 3,451,365 | |
Share-based compensation | | | 21 | | | | - | | | | - | | | | - | | | | - | | | | 15,322,035 | | | | - | | | | - | | | | 15,322,035 | |
Net income | | | | | | | - | | | | - | | | | - | | | | - | | | | - | | | | (587,060,124 | ) | | | - | | | | (587,060,124 | ) |
Balance December 31, 2021 | | | | | | | 97,065,092 | | | | 35,837,500 | | | | - | | | | 743,768 | | | $ | 954,102,859 | | | $ | (593,027,673 | ) | | | - | | | | 361,075,186 | |
Shares issued for long-term strategic contract | | | 13 | | | | 7,355,453 | | | | - | | | | - | | | | - | | | | 5,763,858 | | | | - | | | | - | | | | 5,763,858 | |
Shares issued in a business acquisition | | | 15,27 | | | | 1,762,425 | | | | - | | | | - | | | | - | | | | 1,500,000 | | | | - | | | | - | | | | 1,500,000 | |
Shares issued to settle contingent consideration | | | 30 | | | | 560,365 | | | | - | | | | - | | | | (295,751 | ) | | | 299,014 | | | | - | | | | - | | | | 299,014 | |
Shares issued for RSUs vested | | | 21 | | | | 773,848 | | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | |
Tax settlements associated with RSUs | | | 21 | | | | - | | | | - | | | | - | | | | - | | | | (535,060 | ) | | | - | | | | - | | | | (535,060 | ) |
Share-based compensation | | | 21 | | | | - | | | | - | | | | - | | | | - | | | | 6,009,593 | | | | - | | | | - | | | | 6,009,593 | |
Shares returned to Treasury | | | | | | | (850 | ) | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | |
Shares to be returned to Treasury | | | 13 | | | | - | | | | - | | | | - | | | | (7,121,239 | ) | | | (1,495,460 | ) | | | - | | | | - | | | | (1,495,460 | ) |
Acquisition of redeemable NCI | | | 15 | | | | - | | | | - | | | | - | | | | - | | | | 31,052,495 | | | | - | | | | 1 | | | | 31,052,496 | |
Net loss | | | | | | | - | | | | - | | | | - | | | | - | | | | - | | | | (242,631,834 | ) | | | - | | | | (242,631,834 | ) |
Balance December 31, 2022 | | | | | | | 107,516,333 | | | | 35,837,500 | | | | - | | | | (6,673,222 | ) | | $ | 996,697,299 | | | $ | (835,659,507 | ) | | $ | 1 | | | $ | 161,037,793 | |
See accompanying notes to the consolidated financial statements
TPCO Holding Corp. Consolidated statements of cash flows |
(in United States dollars) | | | Note | | | December 31, 2022 | | | December 31, 2021 | |
| | | | | | | | | | |
Cash provided by (used in) | | | | | | | | | | |
Operating activities | | | | | | | | | | |
Net loss from continuing operations | | | | | | $ | (237,699,408 | ) | | $ | (498,326,470 | ) |
Adjustments for items not involving cash | | | | | | | | | | | | |
Impairment loss | | | 18 | | | | 130,566,825 | | | | 575,498,897 | |
Interest expense | | | | | | | 4,928,475 | | | | 5,183,817 | |
Interest income | | | | | | | (133,744 | ) | | | (1,149,041 | ) |
Loss on disposal of assets | | | 22 | | | | 5,091,541 | | | | 2,447,985 | |
Loss on lease termination | | | 10 | | | | (117,806 | ) | | | - | |
Allowance for accounts receivable and notes receivable | | | | | | | 2,273,302 | | | | 4,396,783 | |
Gain on debt forgiveness | | | | | | | - | | | | (3,358,686 | ) |
Credit losses and changes in fair value of investments | | | 8 | | | | 947,813 | | | | 1,250,990 | |
Depreciation and amortization | | | 19 | | | | 26,795,957 | | | | 22,439,733 | |
Shares issued for long-term strategic contracts | | | | | | | - | | | | 25,000,000 | |
Share-based compensation expense, net of withholding tax settlement | | | | | | | 5,474,533 | | | | 19,663,385 | |
Non-cash marketing expense | | | 13 | | | | 3,718,402 | | | | 5,166,666 | |
Non-cash operating lease expense | | | 10 | | | | 6,857,552 | | | | 4,507,630 | |
Fair value change of contingent consideration | | | 30 | | | | 967,726 | | | | (229,819,070 | ) |
Deferred income tax recovery | | | 14 | | | | (32,326,433 | ) | | | (5,590,409 | ) |
Repayment of operating lease liabilities | | | | | | | (6,707,387 | ) | | | (4,836,963 | ) |
Net changes in non-cash working capital items | | | 23 | | | | 22,889,489 | | | | (43,417,594 | ) |
Net cash used in continued operating activities | | | | | | | (66,473,163 | ) | | | (120,942,347 | ) |
Net cash used in discontinued operating activities | | | | | | | (5,375,734 | ) | | | (7,430,934 | ) |
Total operating activities | | | | | | | (71,848,897 | ) | | | (128,373,281 | ) |
| | | | | | | | | | | | |
Financing activities | | | | | | | | | | | | |
Repayment of consideration payable | | | | | | | (1,533,333 | ) | | | (1,034,417 | ) |
Repayment of finance lease liabilities | | | 10 | | | | (4,490,443 | ) | | | (4,385,528 | ) |
Proceeds from private placement | | | | | | | - | | | | 51,635,000 | |
Redemption of Class A restricted voting shares | | | | | | | - | | | | (264,318,686 | ) |
Proceeds from exercise of options | | | | | | | - | | | | 12,972 | |
Repurchase of shares | | | | | | | - | | | | (6,542,196 | ) |
Repayment of line of credit | | | | | | | - | | | | (1,000,000 | ) |
Total financing activities | | | | | | | (6,023,776 | ) | | | (225,632,855 | ) |
| | | | | | | | | | | | |
Investing activities | | | | | | | | | | | | |
Net cash paid in the Qualifying Transaction | | | 26 | | | | - | | | | (28,143,886 | ) |
Net cash paid in other business combinations | | | 27 | | | | - | | | | (20,612,867 | ) |
Purchases of property and equipment | | | | | | | (3,322,873 | ) | | | (9,359,417 | ) |
Advances for investments and note receivables | | | | | | | (350,000 | ) | | | (5,650,000 | ) |
Proceeds (advances) from investments at fair value through profit or loss | | | | | | | 304,052 | | | | (1,000,000 | ) |
Net cash paid for the acquisition of NCI | | | | | | | (8,430,000 | ) | | | - | |
Proceeds from notes receivable | | | | | | | 1,759,318 | | | | 374,984 | |
Proceeds from sale of assets, net of selling costs | | | | | | | 6,401,402 | | | | 11,068,537 | |
Net cash used in continued investing activities | | | | | | | (3,638,101 | ) | | | (53,322,649 | ) |
Net cash from (used in) discontinued investing activities | | | | | | | 316,005 | | | | (400,942 | ) |
Total investing activities | | | | | | | (3,322,096 | ) | | | (53,723,591 | ) |
| | | | | | | | | | | | |
Net change in cash during the period | | | | | | | (81,194,769 | ) | | | (407,729,727 | ) |
| | | | | | | | | | | | |
Cash, restricted cash and restricted cash equivalents | | | | | | | | | | | | |
Beginning of year | | | | | | $ | 174,892,298 | | | $ | 582,622,025 | |
End of year | | | | | | $ | 93,697,529 | | | $ | 174,892,298 | |
| | | | | | | | | | | | |
Cash | | | | | | | 93,697,529 | | | | 165,310,609 | |
Restricted cash and restricted cash equivalents | | | | | | | - | | | | 9,581,689 | |
Cash, restricted cash and restricted cash equivalents | | | | | | $ | 93,697,529 | | | $ | 174,892,298 | |
Supplemental cash-flow information (Note 23)
See accompanying notes to the consolidated financial statements
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
1. Nature of operations
TPCO Holding Corp. (“TPCO” or the “Company”) was a special purpose acquisition corporation incorporated on June 17, 2019 under the laws of the Province of British Columbia for the purpose of effecting, directly or indirectly, an acquisition of one or more businesses or assets, by way of merger, amalgamation, arrangement, share exchange, asset acquisition, share purchase, reorganization, or any other similar business combinations involving the Company (a “Qualifying Transaction”). As more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, the Company completed the Qualifying Transaction on January 15, 2021 and at which time the Company changed its name to TPCO Holding Corp.
The Company’s registered office is located at 595 Burrard Street, Suite 2600, P.O. Box 49314, Vancouver, BC, V7X 1L3, Canada, and the Company’s head office is located at 1550 Leigh Avenue, San Jose, California, 95125, United States of America. Commencing on the date of the Qualifying Transaction, the Company became integrated as a cultivator, retailer, manufacturer and distributor of adult use cannabis products through the sale to omni-channel retail and wholesale customers under the “Medical Marijuana Programs Act” and the proposition 64 “The Adult Use of Marijuana Act”.
2. Basis of presentation
These consolidated financial statements reflect the accounts of the Company and were prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for financial information.
These consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will continue in operation for the foreseeable future and, accordingly, will be able to realize its assets and discharge its liabilities in the normal course of operations as they come due.
These consolidated financial statements are presented in U.S. dollars, which is also the Company’s and its subsidiaries’ functional currency.
i) Basis of consolidation
These consolidated financial statements include the accounts of the Company and all subsidiaries. Subsidiaries are entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest entity. Subsidiaries are fully consolidated from the date control is transferred to the Company and are de-consolidated from the date control ceases. All intercompany accounts and transactions have been eliminated on consolidation. The consolidated financial statements include all the assets, liabilities, revenues, expenses and cash flows of the Company and its subsidiaries after eliminating intercompany balances and transactions.
ii) Variable interest entities (“VIEs”)
A VIE is an entity that does not have sufficient equity at risk to finance its activities without additional subordinated financial support or is structured such that equity investors lack the ability to control the entity's activities or do not substantially participate in the gains and losses of the entity. Upon inception of a contractual agreement, and thereafter, if a reconsideration event occurs, the Company performs an assessment to determine whether the arrangement contains a variable interest in an entity and whether that entity is a VIE. The primary beneficiary of a VIE is the party that has both the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. Where the Company concludes that it is the primary beneficiary of a VIE, the Company consolidates the accounts of that VIE.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
2. Basis of presentation (continued)
These consolidated financial statements include the accounts of the Company and the following entities which are subsidiaries of the Company:
Subsidiaries | | Jurisdiction of incorporation | | Ownership interest December 31, 2022 | | Ownership interest December 31, 2021 |
TPCO US Holding LLC | | Delaware | | 100% | | 100% |
Social Equity Ventures LLC | | California | | 100% | | 100% |
CMG Partners, Inc. | | Delaware | | 100% | | 100% |
well. By Caliva e-commerce, LLC | | California | | 100% | | 100% |
Live Zola, LLC | | California | | 100% | | 100% |
NC3 Systems, Inc. | | California | | 100% | | 100% |
NC4 Systems, Inc. | | California | | 100% | | 100% |
NC5 Systems, Inc. | | California | | 100% | | 100% |
NC6 Systems, Inc. | | California | | 100% | | 100% |
Caliva CADECC1, LLC | | California | | 100% | | 100% |
Caliva CARERC1, LLC | | California | | 100% | | 100% |
Caliva CAMISJ2, Inc. | | California | | 100% | | 100% |
OG California Branding, Inc. | | California | | 100% | | 100% |
G & C Staffing, LLC | | California | | 100% | | 100% |
Alpha Staffing, LLC | | California | | 100% | | 100% |
Caliva CAREWH1, LLC | | California | | 100% | | 100% |
Caliva CARECE1, LLC | | California | | 100% | | 100% |
Caliva CADESA1, LLC | | California | | 100% | | 100% |
Caliva CADEEM1, LLC | | California | | 100% | | 100% |
Caliva CAREST1, LLC | | California | | 100% | | 100% |
Caliva MSA, LLC | | California | | 100% | | 100% |
Kase’s Journey, Inc. | | California | | 100% | | 100% |
Sturdivant Ventures, LLC | | California | | 100% | | 100% |
LCV Holdings, HMB, LLC | | California | | 100% | | 100% |
LCV Holdings SISU 710, LLC | | California | | 100% | | 100% |
Fluid South, Inc. | | California | | 100% | | 100% |
Capitol Cocoa, Inc. | | California | | 100% | | 100% |
Varda Inc. | | California | | 100% | | 9.5% |
Caliva CADINH1, Inc. | | California | | 100% | | 0% |
Coast L Acquisition Corp1 | | California | | 90.2% | | 100% |
Coastal Dispensary, LLC | | California | | 90.2% | | 0% |
Coastal Delivery Service, LLC | | California | | 90.2% | | 0% |
Coastal Retail Lompoc, LLC | | California | | 90.2% | | 0% |
Southern California Collective, Inc. | | California | | 90.2% | | 0% |
Releaf Alternative Inc. | | California | | 90.2% | | 0% |
Coastal Retail Concord, LLC | | California | | 90.2% | | 0% |
Coastal Delivery SLO, LLC | | California | | 90.2% | | 0% |
Left Coast Ventures, Inc. | | Delaware | | 90.2% | | 100% |
Coastal MergerSub 2, LLC | | California | | 90.2% | | 0% |
Coastal Manufacturing LLC | | California | | 90.2% | | 0% |
Coastal Distribution LLC | | California | | 90.2% | | 0% |
Jamaba Properties LLC | | California | | 90.2% | | 0% |
Calma WeHo LLC | | California | | 85% | | 85% |
Caliva CAREDELA1, LLC | | California | | 42% | | 42% |
well. By Caliva LLC | | California | | 0% | | 100% |
well. By Caliva Centers | | California | | 0% | | 100% |
Fresh Options, LLC | | California | | 0% | | 100% |
Martian Delivery, LLC | | California | | 0% | | 100% |
Rever Holdings, LLC | | California | | 0% | | 100% |
Eko Holdings, LLC | | California | | 0% | | 100% |
Lief Holdings, LLC | | California | | 0% | | 100% |
SISU Extraction, LLC | | California | | 0% | | 100% |
1 Refer to Note 27 for further details.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
2. Basis of presentation (continued)
iii) Use of estimates
The preparation of these consolidated financial statements and accompanying notes in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates.
iv) Emerging growth company
The Company is an “Emerging Growth Company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it has taken advantage of certain exemptions from various reporting requirements that are not applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a Company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
3. Significant accounting policies
(a) Foreign currency transactions and translation
Foreign currency transactions are translated into the functional currency using exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the remeasurement of monetary items denominated in foreign currency at year-end exchange rates are recognized in profit or loss.
(b) Cash
Cash is comprised of bank balances held in banks and cash held at the Company’s operating premises in California.
(c) Restricted cash and restricted cash equivalents
The Company classifies restricted cash and restricted cash equivalents outside of cash when it is not available for general use in operations. Restricted cash equivalents include highly liquid investments with original maturities of less than three months. As at December 31, 2022, $Nil of restricted cash was held in escrow (December 31, 2021 - $1,496,875).
(d) Accounts receivable, notes receivable and allowance for credit losses
Net accounts receivable and notes receivables are stated at the amount management expects to collect from outstanding balances. The allowance for doubtful accounts is based on historical experience and management's evaluation of outstanding receivables at the end of the period. Receivables are written off when deemed uncollectible.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(e) Inventories
Biological assets consist of cannabis on plants. The costs of growing cannabis, including but not limited to labor, utilities, nutrition and irrigation determined at normal capacity, are capitalized into inventory until the time of harvest.
Raw material inventory consists of acquired biomass for use in manufactured products and is initially valued at cost.
Work-in-process consists of cannabis and manufactured products which are in process and not yet ready for re-sale at which point they are transferred to finished goods. Costs capitalized to work-in-process include direct labor and overhead determined at normal capacity.
Inventories of finished goods and packaging supplies purchased from third parties are initially valued at cost, and subsequently at the lower of cost and net realizable value. The Company measures inventory cost of third-party products and manufactured products using the first-in first-out method.
The cost of finished goods for manufactured products includes manufacturing costs such as materials, labor, depreciation expense on right-of-use assets involved in cultivation and processing, packaging, labelling, inspection and overhead determined at normal capacity to turn raw materials into finished goods.
All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of sales on the consolidated statements of operations and comprehensive loss at the time cannabis products are sold.
Net realizable value is the estimated selling price in the ordinary course of business, less the estimated costs to sell. The Company reviews inventories for obsolete, redundant and slow-moving goods and any such inventories identified are written down to net realizable value.
(f) Property and equipment
Property and equipment are recorded at cost less accumulated depreciation. Major additions and improvements are capitalized, while maintenance and repairs are expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized in the consolidated statements of operations and comprehensive loss.
Depreciation is calculated on a straight-line basis over the expected useful lives of the assets, which are as follows:
Leasehold improvements | | Shorter of lease term or estimated useful life |
Production equipment | | 1 - 7 years |
Furniture and fixtures | | 2 - 7 years |
Office equipment | | 2 - 7 years |
Vehicles | | 3 - 7 years |
Building | | 30 years |
An asset’s residual value, useful life and depreciation method are reviewed at each financial year-end and adjusted if appropriate. Depreciation of property and equipment commences when the asset is available for use.
Property and equipment acquired in a business combination is depreciated over the remaining useful life of the asset.
Gains and losses on disposal of an item of property and equipment are determined by comparing the proceeds from disposal with the carrying amount of the item and are recognized in the consolidated statements of operations and comprehensive loss.
(g) Intangible assets
Intangible assets with finite lives are stated at the amount initially recognized less accumulated amortization and accumulated impairment losses. Intangible assets with finite life are amortized on a straight-line basis as follows:
License | | Greater of lease term or estimated useful life |
Cultivation network | | 7 years |
Brand | | 5 – 20 years |
Customer relationship | | 9 years |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(g) Intangible assets(continued)
The estimated useful life and amortization method are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.
(h) Goodwill
Goodwill represents the excess of the purchase price paid for the acquisition of an entity over the fair value of the net tangible and intangible assets acquired. Goodwill is either assigned to a specific reporting unit or allocated between reporting units based on a reasonable and supportable basis.
A reporting unit is an operating segment, or a business unit one level below that operating segment, for which discrete financial information is prepared and regularly reviewed by segment management. Goodwill is not subject to amortization and is tested annually for impairment, or more frequently if events or changes in circumstances indicate that goodwill may be impaired. The Company reviews goodwill annually at fiscal year-end or at interim periods if events or circumstances indicate the carrying value may not be recoverable.
The Company assesses the fair values of its intangible assets, and its reporting units for goodwill testing purposes, as necessary, using an income-based approach. Under the income-based approach, fair value is based on the present value of estimated future cash flows.
The Company assesses goodwill for impairment annually in the third quarter, or more frequently if events or changes in circumstances indicate that it might be impaired by comparing its carrying value to the reporting unit’s fair value. Refer to Note 18 for goodwill impairment recognized during the years ended December 31, 2022 and 2021.
The Company may elect to first perform a qualitative assessment to determine whether it is more-likely-than-not that the reporting unit’s fair value is less than its carrying value indicating the potential for goodwill impairment. If factors indicate this is the case, then a quantitative test is performed and an impairment is recorded for any excess carrying value above the reporting unit’s fair value, not to exceed the amount of goodwill.
(i) Business combinations
The Company accounts for business combinations using the acquisition method when it has obtained control. The Company measures goodwill as the fair value of the consideration transferred including the fair value of any non-controlling interest recognized, less the net recognized amount of the identifiable assets acquired and liabilities assumed, all measured at their fair value as at the acquisition date. Transaction costs, other than those associated with the issue of debt or equity securities, that the Company incurs in connection with a business combination are expensed as incurred.
Any contingent consideration is measured at fair value at the acquisition date. If the contingent consideration is classified as equity it is not remeasured. Otherwise, subsequent changes in the fair value of the contingent consideration are recognized in earnings.
The Company recognizes indemnification assets acquired in a business combination at the same time that it recognizes the indemnified item, measured on the same basis as the indemnified item, subject to the need for the valuation allowance for uncollectible amounts.
When the initial accounting for a business combination has not been finalized by the end of the reporting period in which the transaction occurs, the Company reports provisional amounts. Provisional amounts are adjusted during the measurement period, which does not exceed one year from the acquisition date. These adjustments, or recognition of additional assets or liabilities, reflect new information obtained about facts and circumstances that existed at the acquisition date that, if known, would have affected the amounts recognized at that date
(j) Investments in non-marketable securities
Investments in equity securities of nonpublic entities without readily determinable fair values are carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(k) Impairment of long-lived assets
The Company reviews long-lived assets, including property and equipment and definite life intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (“asset group”). When indicators of potential impairment are present the Company prepares a projected undiscounted cash flow analysis for the respective asset or asset group. If the sum of the undiscounted cash flows is less than the carrying value of the asset or asset group, an impairment loss is recognized equal to the excess of the carrying value over the fair value, if any. Fair value can be determined using a market approach, income approach or cost approach. Recognized impairment losses are not reversed.
(l) Share-based compensation
The Company has an equity incentive plan which includes issuances of incentive share options, nonqualified share options, share appreciation rights, restricted share units, deferred share units and performance share units. From time to time, the Company also enters into share-based compensation arrangements with non-employees. The accounting for these arrangements is consistent with those of employees.
The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense on a graded basis over the vesting period. The amount recognized as an expense is net of estimated forfeitures, such that the amount ultimately recognized is based on the number of awards that ultimately vest. The Company estimates forfeitures based on historical forfeiture trends. If actual forfeiture rates are not consistent with the Company's estimates, the Company may be required to increase or decrease compensation expenses in future periods.
Share-based payment awards that are subject to market-based performance conditions consider the market-based performance condition in the valuation on the grant date. Compensation cost is not adjusted if the market condition is not met, so long as the requisite service is provided. If the market condition is met prior to the end of the service period, the Company would immediately recognize any unrecognized compensation cost based on the grant date fair value.
For share-based payment awards that are subject to performance-based conditions, the Company records compensation expense over the estimated service period once the achievement of the performance-based milestone is considered probable. At each reporting date, the Company assesses whether achievement of a milestone is considered probable, and if so, records compensation expense based on the portion of the service period elapsed to date with respect to that milestone, with a cumulative catch-up, net of estimated forfeitures. The Company recognizes remaining compensation expense with respect to a milestone, if any, over the remaining estimated service period.
The Company measures cash-settled share-based payments as liabilities at fair value. At each reporting date, obligations related to cash-settled share-based plans are re-measured at fair value with reference to the fair value of the Company’s share price and the number of units that have been vested. The corresponding share-based compensation expense or recovery is recognized on a graded basis over the vesting period.
The fair value of the share options granted are measured using the Black Scholes option pricing model, taking into account the terms and conditions upon which the share options were granted.
For share-based compensation granted to non-employees, the compensation expense is measured at the fair value of the equity instruments granted and recognized as the services are received.
(m) Revenue recognition
The Company earns revenue from the sale of cannabis. The Company has a diverse customer base in the state of California.
The Company recognizes revenue to depict the transfer of promised goods or services to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.
In order to recognize revenue, the Company applies the following five (5) steps:
1) Identify the contract with a customer
2) Identify the performance obligation(s)
3) Determine the transaction price
4) Allocate the transaction price to the performance obligations(s)
5) Recognize revenue when/as performance obligations(s) are satisfied
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(m) Revenue recognition (continued)
Revenue from the sale of cannabis to customers is recognized at a point in time when control over the goods has transferred to the customer. This corresponds with when the Company satisfies its performance obligation. Revenue is recorded net of any point of sale discounts provided to the customer. The Company’s revenues are principally derived from arrangements with fixed consideration. Variable consideration, if any, is not material.
The majority of the Company’s revenue is cash at point of sale. Payment is due upon transferring the goods or providing services to the customer or within a specified time period permitted under the Company’s credit policy. In those cases where the Company provides goods or services on credit, the Company considers whether or not collection is probable in determining if a contract exists under ASC 606 Revenue from Contracts with Customers. Costs associated with goods or services are expensed in the year performance obligations are satisfied.
The Company has a customer loyalty program whereby customers are awarded points with online delivery purchases. Once a customer achieves a certain point level, points can be used to pay for the purchase of product, up to a maximum number of points per transaction. Points expire after 6 months of no activity in a customer’s account.
Unredeemed awards are recorded as deferred revenue. At the time customers redeem points, the redemption is recorded as an increase to revenue. Deferred revenue is included in other accrued expenses within accounts payable and accrued liabilities.
The Company's Return Policy conforms to the Medicinal and Adult-Use Cannabis Regulation and Safety Act (“MAUCRSA”), which was signed into law in September 2017 and creates the general framework for the regulation of commercial medicinal and adult-use cannabis in California. The Company determined that no provision for returns or refunds was necessary as at December 31, 2022 and 2021.
Sales of products are for cash or otherwise agreed-upon credit terms. The Company’s payment terms vary by customer; however, the time period between when revenue is recognized and when payment is due is not significant. The Company estimates and reserves for its bad debt exposure based on its experience with past due accounts and collectability, write-off history, the aging of accounts receivable and an analysis of customer data.
(n) Leases
Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets are classified as a finance lease or an operating lease. A finance lease is a lease in which 1) ownership of the property transfers to the lessee by the end of the lease term; 2) the lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise; 3) the lease is for a major part of the remaining economic life of the underlying asset; 4) the present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already included in the lease payments equals or exceeds substantially all of the fair value; or 5) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. Leases that do not meet the finance lease criteria are classified as operating leases.
ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. The ROU assets also include any lease payments made and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.
For finance leases, lease expenses are the sum of interest on the lease obligations and amortization of the ROU assets. ROU assets are amortized based on the lesser of the lease term and the useful life of the leased asset according to the property and equipment accounting policy. If ownership of the ROU assets transfers to the Company at the end of the lease term or if the Company is reasonably certain to exercise a purchase option, amortization is calculated using the estimated useful life of the leased asset, according to the property and equipment accounting policy. For operating leases, the lease expenses are generally recognized on a straight-line basis over the lease term and recorded in operating expenses in the statements of net loss and comprehensive loss.
The Company has elected to apply the practical expedient in ASC 842 Leases, for each class of underlying asset, except real estate leases, to not separate non-lease components from the associated lease components of the lessee’s contract and account for both components as a single lease component. Additionally, for certain equipment leases, the Company applies a portfolio approach to effectively account for the operating lease ROU assets and liabilities.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(n) Leases (continued)
The Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less that do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise. Short-term leases include real estate and vehicles and are not significant in comparison to the Company’s overall lease portfolio. The Company continues to recognize the lease payments associated with these leases as expenses on a straight-line basis over the lease term.
Sale lease back
From time to time, the Company may enter into sale-leaseback transactions pursuant to which the Company sells a property to a third party and agrees to lease the property back for a certain period of time. To determine whether the transfer of the property should be accounted for as a sale, the Company evaluates whether it has transferred control to the third party in accordance with the revenue recognition guidance set forth in ASC 606 - Revenue.
If the transfer of the asset is deemed to be a sale at market terms, the Company recognizes the transaction price for the sale based on the proceeds, derecognizes the carrying amount of the underlying asset and recognizes a gain or loss in the consolidated statements of operations and comprehensive loss for any difference between the carrying value of the asset and the transaction price. The Company then accounts for the leaseback in accordance with its lease accounting policy.
If the transfer of the asset is determined not to be a sale at market terms, the Company accounts for the transaction as a financing arrangement, and accordingly no sale is recognized. The Company retains the historical costs of the property and the related accumulated depreciation on its books and continues to depreciate the property over the lesser of its remaining useful life or its initial lease term. The asset is presented within property and equipment, net on the consolidated balance sheets. All proceeds from these transactions are accounted for as finance obligations and presented as non-current obligation on the consolidated balance sheets. A portion of the lease payments is recognized as a reduction of the financing obligation and a portion is recognized as interest expense based on an imputed interest rate.
(o) Income taxes
Income taxes are comprised of current and deferred taxes. These taxes are accounted for using the liability method. Current tax is recognized in connection with income for tax purposes, unrealized tax benefits and the recovery of tax paid in a prior period and measured using the enacted tax rates and laws applicable to the taxation period during which the income for tax purposes arose. Deferred tax is recognized on the difference between the carrying amount of an asset or a liability, as reflected in the financial statements, and the corresponding tax base, used in the computation of income for tax purposes ("temporary difference") and measured using the enacted tax rates and laws as at the balance sheet date that are expected to apply to the income that the Company expects to arise for tax purposes in the period during which the difference is expected to reverse. Management assesses the likelihood that a deferred tax asset will be realized, and a valuation allowance is provided to the extent that it is more likely than not that all or a portion of a deferred tax asset will not be realized. The determination of both current and deferred taxes reflects the Company's interpretation of the relevant tax rules and judgment.
An unrealized tax benefit may arise in connection with a period that has not yet been reviewed by the relevant tax authority. A change in the recognition or measurement of an unrealized tax benefit is reflected in the period during which the change occurs.
Income taxes are recognized in the consolidated statement of operations and comprehensive loss, except when they relate to an item that is recognized in other comprehensive loss or directly in equity, in which case, the taxes are also recognized in other comprehensive loss or directly in equity respectively. Where income taxes arise from the initial accounting for a business combination, these are included in the accounting for the business combination.
Interest and penalties in respect of income taxes are not recognized in the consolidated statement of operations and comprehensive loss as a component of income taxes but as a component of interest expense.
As the Company operates in the cannabis industry, it is subject to the limits of U.S. Internal Revenue Code (“U.S. IRC”) Section 280E (“Section 280E”) under which the Company is only allowed to deduct expenses directly related to the cost of producing the products or cost of production.
The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(o) Income taxes (continued)
Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense (recovery) in the consolidated statements of operations and comprehensive loss.
(p) Advertising
The Company expenses advertising costs when the advertising first takes place. Advertising expense was approximately $2,885,629 for the year ended December 31, 2022 (December 31, 2021 - $3,369,772).
(q) Fair value
Fair value is the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. Fair value measurements for invested assets are categorized into levels within a fair value hierarchy based on the nature of the valuation inputs (Levels 1, 2 or 3). The three levels are defined based on the observability of significant inputs to the measurement, as follows:
| · | Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities; |
| · | Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and |
| · | Level 3: one or more significant inputs used in a valuation technique are unobservable in determining fair values of the asset or liability. |
Determination of fair value and the resulting hierarchy requires the use of observable market data whenever available. The classification of an asset or liability in the hierarchy is based upon the lowest level of input that is significant to the measurement of fair value.
The carrying value of the Company’s cash, restricted cash and restricted cash equivalents, accounts receivable, notes and other receivables, other current assets, security deposits, accounts payable and accrued expenses and consideration payable approximate their fair value due to their short-term nature.
Contingent consideration, investments at fair value through profit or loss and share repurchase liabilities are measured at fair value on a recurring basis.
(r) Cost of sales
Cost of sales represents costs directly related to the acquisition of third-party products, and manufacturing and distribution of the Company’s products. Primary costs include cost of third-party inventories and in the case of manufactured products, includes raw materials, packaging, direct labor, overhead, shipping and handling, the depreciation of right-of-use assets, and cultivation taxes and tariffs. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance and property taxes. Cost of sales also includes inventory valuation adjustments. The Company recognizes the cost of sales as the associated revenues are recognized.
(s) Earnings (loss) per share
Basic earnings (loss) per share (“Basic EPS”) is calculated by dividing the net earnings available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share (“Diluted EPS”) is calculated using the treasury method of calculating the weighted average number of common shares outstanding. The treasury method assumes that outstanding share options with an average exercise price below the market price of the underlying shares are exercised, and the assumed proceeds are used to repurchase common shares of the Company at the average price of the common shares for the period.
(t) Operating segments
Operating segments are components of the Company that engage in business activities which generate revenues and incur expenses (including intercompany revenues and expenses related to transactions conducted with other components of the Company). The operations of an operating segment are distinct, and the operating results are regularly reviewed by the CODM for the purposes of resource allocation decisions and assessing its performance.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(t) Operating segments (continued)
The Company has assessed the above criteria and has determined that the entity as a whole is one operating segment comprising of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the State of California.
(u) Assets classified as held for sale
Assets are classified as held for sale when the Company commits to a plan to sell the asset, the asset is available for immediate sale in its present condition and an active program to locate a buyer at a reasonable price has been initiated. The sale of these assets is generally expected to be completed within one year. Once it has been determined that assets meet the criteria to be classified as held for sale, and prior to classifying as such, the Company considers whether the assets are impaired and recognizes any impairment. Assets classified as held for sale are not depreciated. However, interest attributable to the liabilities associated with assets classified as held for sale and other related expenses are recorded as expenses in the Company’s consolidated statements of operations and comprehensive loss.
(v) Discontinued operations
The Company accounts for discontinued operations when there is a disposal of a component group or a group of components that represents a strategic shift that will have a major effect on the Company’s operations and financial results. The Company aggregates the results of operations for discontinued operations into a single line item in the consolidated statements of operations and comprehensive loss for all periods presented. General corporate overhead is not allocated to discontinued operations. See Note 7 for additional information.
(w) Non-controlling interest and redeemable non-controlling interest
The Company consolidates entities in which the Company has a controlling financial interest. The Company consolidates subsidiaries in which the Company holds, directly or indirectly, more than 50% of the voting rights, and VIEs in which the Company is the primary beneficiary. Non-controlling interests represent third-party equity ownership interests (including equity ownership interests held by certain VIEs) in the Company’s consolidated entities. Net income attributable to non-controlling interests is disclosed in the consolidated statement of operations and comprehensive loss.
Non-controlling interest is presented in mezzanine equity as redeemable non-controlling interest (“redeemable NCI”) when it is contingently redeemable and the contingency is not within the Company’s control. Redeemable NCI is initially recognized at fair value and is subsequently adjusted for the non-controlling interest’s share of net income or net loss. At the end of each reporting period, the Company determines the redemption amount and if the redemption amount is greater than the carrying value, the redeemable NCI is remeasured and changes are recognized immediately.
(x) Critical accounting estimates and judgments
The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make judgments, estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements. Although these estimates are based on management’s best knowledge of the amount, event or actions, actual results may differ from those estimates. Estimates and judgments are continuously evaluated and are based on management’s experience and other factors, including expectations of future events that management considers to be reasonable.
Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.
Variable interest entities
The Company assesses all variable interests in entities and uses judgment when determining if the Company is the primary beneficiary. Qualitative factors that are considered include decision-making responsibilities, the VIE capital structure, risk and rewards sharing, contractual agreements with the VIE, voting rights and the level of involvement of other parties. Refer to Note 27 for further details.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(x) Critical accounting estimates and judgments (continued)
Business combinations
In determining the fair value of net identifiable assets acquired in a business combination, including any acquisition-related contingent consideration, estimates including market based and appraisal values are used. One of the most significant areas of judgment and estimation relates to the determination of the fair value of these assets and liabilities, including the fair value of contingent consideration, if applicable. If any intangible assets are identified, depending on the type of intangible asset and the complexity of determining its fair value, an independent external valuation expert may develop the fair value, using appropriate valuation techniques, which are generally based on a forecast of the total expected future net cash flows. These valuations are linked closely to the assumptions made by management regarding the future performance of the assets concerned and any changes in the discount rate applied.
In addition, management applies judgment in determining the amount, if any, that leases acquired in a business combination are off-market resulting in an adjustment to the right-of-use assets. In particular, management’s judgment is used in determining the premium over basic market rents that would be applied by a lessor where the leased premise is being used for cannabis-related businesses. Finally, determining whether amounts should be included as part of consideration requires judgment.
Leases
The Company applies judgment in determining whether a contract contains a lease and whether a lease is classified as an operating lease or a finance lease. The Company determines the lease term as the non-cancellable term of the lease, which may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The lease term is used in determining classification between operating lease and finance lease, calculating the lease liability and determining the incremental borrowing rate.
The Company has several lease contracts that include extension and termination options. The Company applies judgment in evaluating whether it is reasonably certain to exercise the option to renew or terminate the lease. That is, it considers all relevant factors that create an economic incentive for it to exercise either the renewal or termination. After the commencement date of the lease, the Company reassesses the lease term if there is a significant event or change in circumstances that is within its control and affects its ability to exercise or not to exercise the option to renew or to terminate (e.g., construction of significant leasehold improvements or significant customization to the leased asset).
The Company is required to discount lease payments using the rate implicit in the lease if that rate is readily available. If that rate cannot be readily determined, the lessee is required to use its incremental borrowing rate. The Company generally uses the incremental borrowing rate when initially recording real estate leases. Information from the lessor regarding the fair value of underlying assets and initial direct costs incurred by the lessor related to the leased assets is not available. The Company determines the incremental borrowing rate of each lease by estimating the credit rating of the Company at the time the lease is recognized, referencing market yields corresponding to the credit rating and weighted average life of the lease, and factoring in other lease-specific factors such as assumed collateral.
Share-based compensation
In determining the fair value of share-based payments, the Company makes assumptions, such as the expected life of the award, the volatility of the Company’s share price, the risk-free interest rate, and the rate of forfeitures. Refer to Note 21 for further information.
Goodwill
Goodwill is tested for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of goodwill may have been impaired. In order to determine that the value of goodwill may have been impaired, the Company performs a qualitative assessment to determine whether it is more-likely-than-not that the reporting unit’s fair value is less than its carrying value, indicating the potential for goodwill impairment. A number of factors, including historical results, business plans, forecasts and market data are used to determine the fair value of the reporting unit. Changes in the conditions for these judgments and estimates can significantly affect the assessed value of goodwill. Refer to Note 11 for further information.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(x) Critical accounting estimates and judgments (continued)
Long-lived assets
Depreciation and amortization of property and equipment, right-of-use assets and intangible assets are dependent upon estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that consider factors such as economic and market conditions and the useful lives of assets. The Company uses judgment in: (i) assessing whether there are impairment triggers affecting long-lived assets, (ii) determining the asset groups and (iii) determining the recoverable amount and if necessary, estimating the fair value. Refer to Notes 9, 10 and 11 for further information.
Fair value measurement
The Company uses valuation techniques to determine the fair value of financial instruments (where active market quotes are not available) and non-financial assets. This involves developing estimates and assumptions consistent with how market participants would price the instrument. The Company bases its assumptions on observable data as far as possible, but this is not always available. In that case, the Company uses the best information available.
Estimated fair values may vary from the actual prices that would be achieved in an arm’s length transaction at the reporting date. Refer to Note 30 for further information on recurring and non-recurring fair value measurements.
Deferred tax assets and uncertain tax positions
The Company recognizes deferred tax assets and liabilities based on the differences between the financial statement carrying amounts and the respective tax bases of its assets and liabilities. The Company measures deferred tax assets and liabilities using current enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. The Company routinely evaluates the likelihood of realizing the benefit of its deferred tax assets and may record a valuation allowance if, based on all available evidence, it determines that some portion of the tax benefit will not be realized.
In evaluating the ability to recover deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax-planning strategies and results of operations. In projecting future taxable income, the Company considers historical results and incorporates assumptions about the amount of future state, federal and foreign pretax operating income adjusted for items that do not have tax consequences. The Company’s assumptions regarding future taxable income are consistent with the plans and estimates that are used to manage its underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income/(loss). The income tax expense, deferred tax assets and liabilities and liabilities for unrecognized tax benefits reflect the Company’s best assessment of estimated current and future taxes to be paid. Deferred tax asset valuation allowances and liabilities for unrecognized tax benefits require significant judgment regarding applicable statutes and their related interpretation, the status of various income tax audits and the Company’s particular facts and circumstances. Although the Company believes that the judgments and estimates discussed herein are reasonable, actual results, including forecasted COVID-19 business recovery, could differ, and the Company may be exposed to losses or gains that could be material. To the extent the Company prevails in matters for which a liability has been established or is required to pay amounts in excess of the established liability, the effective income tax rate in a given financial statement period could be materially affected.
(y) Accounting standards adopted
Debt with conversion options and other options
In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which is intended to address issues identified as a result of the complexity associated with applying GAAP for certain financial instruments with characteristics of liabilities and equity. The Company adopted ASU 2020-06 effective January 1, 2022, and such adoption did not have a material effect on its consolidated financial statements.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
3. Significant accounting policies (continued)
(y) Accounting standards adopted (continued)
Leases
The FASB issued ASU 2016‑02 Leases (ASC 842) (“ASC 2016-02”) which modifies the classification criteria and requires lessees to recognize right‑of‑use assets and lease liabilities arising from most leases on the balance sheet with additional disclosures about leasing arrangements. The effective date was subsequently amended by ASU 2021-05 for non-public business entities to be effective for fiscal years beginning after December 31, 2021, with earlier application permitted.
The Company elected to early adopt ASC 842 in accordance with the transition provisions of ASU 2016-02, with a date of initial application of January 1, 2021. The Company had no leases until it acquired subsidiaries in the business combination discussed in Note 26. As a result, there was no impact on its consolidated financial statements.
Income taxes
In December 2019, the FASB issued ASU 2019-12, Income Taxes - Simplifying the Accounting for Income Taxes (ASC 740) (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. The standard is effective for non-public business entities for annual reporting periods beginning after December 15, 2021, with early adoption permitted for periods for which financial statements have not yet been made available for issuance. The Company elected to early adopt ASU 2019-12 effective January 1, 2021, in accordance with its transition provisions. The adoption did not have a material effect on its consolidated financial statements.
Investments
In January 2020, the FASB issued ASU 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU 2020-01”), which is intended to clarify the interaction of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. ASU 2020-01 is effective for the non-public business entities for fiscal years beginning after December 15, 2021, with early adoption permitted for periods for which financial statements have not yet been made available for issuance. The Company elected to early adopt ASU 2020-01 effective January 1, 2021, in accordance with its transition provisions. The adoption did not have a material effect on its consolidated financial statements.
(z) Accounting standards issued but not yet effective
Allowance for credit losses
In September 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance was subsequently amended by ASU 2018-19, Codification Improvements, ASU 2019- 04, Codification Improvements, ASU 2019-05, Targeted Transition Relief, ASU 2019-10, Effective Dates, and ASU 2019-11, Codification Improvements. These ASUs are effective for Smaller Reporting Companies for fiscal years beginning after December 15, 2022, including interim periods therein. The adoption of this ASU is currently not expected to have a material impact on the consolidated financial statements.
Business combinations
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”). The amendments in this update require contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, Revenue from Contracts with Customers, as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date. These ASUs are effective for Smaller Reporting Companies for fiscal years beginning after December 15, 2023, including interim periods therein. This ASU is currently not expected to have a material impact on the consolidated financial statements.
The Company considers the applicability and impacts of all ASUs. All other ASUs were assessed and determined to be either not applicable or are not expected to have a material impact on the consolidated financial statements.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
4. Inventory
| | December 31, 2022 | | | December 31, 2021 | |
Packaging supplies | | $ | 2,109,465 | | | $ | 2,784,846 | |
Biological assets | | | 22,844 | | | | 1,371,749 | |
Raw materials | | | 48,936 | | | | 2,009,754 | |
Work in progress | | | 227,936 | | | | 1,969,696 | |
Finished goods | | | 6,318,677 | | | | 14,060,936 | |
| | $ | 8,727,858 | | | $ | 22,196,981 | |
During the year ended December 31, 2022, the Company recorded write-downs of $6,092,705 (December 31, 2021 - $5,949,741) on inventory which is included in cost of sales.
5. Notes and other receivables, net
| | December 31, 2022 | | | December 31, 2021 | |
Upfront payment (i) | | $ | 5,650,000 | | | $ | 5,650,000 | |
Prepayment (i) | | | 1,490,000 | | | | 1,490,000 | |
Promissory note receivables (ii) | | | 627,803 | | | | 543,560 | |
Other receivable (iii) | | | - | | | | 1,200,000 | |
Total notes receivable | | | 7,767,803 | | | | 8,883,560 | |
Less allowance for credit losses (i) | | | (7,140,000 | ) | | | (4,150,943 | ) |
Total notes receivable | | | 627,803 | | | | 4,732,617 | |
Note receivable – current portion | | | 108,957 | | | | 4,732,617 | |
Note receivable- non-current | | $ | 518,846 | | | $ | - | |
(i) | In May 2021, the Company entered into a series of arrangements to obtain the rights to four acres of land that is licensed for outdoor grow (the “Arrangement”). The purchase price for the Arrangement was $6,000,000 in cash (subject to holdbacks), shares with an estimated value of $2,500,000 to be issued when the transaction closes and up to 1,309,263 shares subject to earnouts. The upfront payment of $5,650,000, net of holdbacks of $350,000, is secured by a non-interest-bearing promissory note. The Company also entered into a cultivation and supply agreement for a period of three years, with the option to extend for two additional one-year terms under the same contractual terms. As part of the agreement, the Company has a minimum purchase commitment of 12,000 lbs per growing period of conforming cannabis as defined in the cultivation and supply agreement, equal to approximately $3,500,000. |
| |
| The closing of the transaction was dependent on the satisfaction of various conditions, which were not met by the second quarter of 2022 as required by the Arrangement. Further, the counterparty was unable to produce sufficient quantities of biomass that met both the Company’s standards and the requirements of the cultivation supply agreements, resulting in an overpayment of amounts prepaid under the Arrangement of $1,490,000 (“Prepayment”). The Company has provided notice of termination of the Arrangement and requested that the counterparty present an acceptable restructure to the arrangements and/or a payback plan for the Upfront payment. The counterparty has contested certain of the Company’s positions and has claimed an inability to pay the owed cash amounts. The Company recorded an allowance for credit losses of $5,650,000 (December 31, 2021 - $2,660,943) related to the Upfront payment and $1,490,000 related to the Prepayment (December 31, 2021- $1,490,000). |
(ii) | During the year ended December 31, 2022, the Company entered into a sale-leaseback arrangement. In partial consideration of the arrangement, the Company received a promissory note for $500,000 which is payable over five years. The fair value of the promissory note on initial recognition was $389,816. The balance as at December 31, 2022 related to this promissory note, including accrued interest, is $423,484. Refer to Note 10. |
| |
| During the year ended December 31, 2022, the Company issued a promissory note for $200,000. The note is unsecured, bearing interest at 10% per annum and payable in full maturity, July 1, 2024. The balance as at December 31, 2022 related to this promissory note, including accrued interest, is $204,319. During the year ended December 31, 2021, the Company disposed of its non-THC business. As part of the proceeds received, the Company entered into a promissory note. The note is unsecured, bearing interest at 2% per annum and payable in 5 equal quarterly instalments beginning on July 31, 2021. The balance as at December 31, 2022 related to this promissory note is $nil (December 31, 2021- $543,560). During the year ended December 31, 2022, the Company received $559,318 in payments (December 31, 2021 - $374,984). |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
5. Notes and other receivables, net (continued)
(iii) | During the year ended December 31, 2021, the Company was successful in a legal matter and agreed to a settlement of $2,200,000, of which $1,000,000 was received prior to December 31, 2021. The remaining settlement was received in full by December 2022. |
6. Prepaid expenses and other current assets
| | December 31, 2022 | | | December 31, 2021 | |
Prepaid expenses | | $ | 51,456 | | | $ | 109,929 | |
Prepaid insurance | | | 771,752 | | | | 1,560,840 | |
Prepaid inventory | | | 89,386 | | | | 2,188,881 | |
Prepaid rent | | | 54,160 | | | | 650,000 | |
Other prepaid assets | | | 1,357,586 | | | | 1,386,238 | |
Indemnification assets | | | 6,044,155 | | | | 6,044,155 | |
| | $ | 8,368,495 | | | $ | 11,940,043 | |
7. Assets held for sale and discontinued operations
The following table outlines the carrying amounts of major classes of assets and liabilities included in disposal groups:
| | December 31, 2022 Assets held for sale (a) | | | December 31, 2021 Discontinued operations (b) | |
Current assets of disposal groups classified as held for sale | | | | | | |
Inventory | | $ | - | | | $ | 5,042,670 | |
Right-of-use assets - operating | | | 1,240,211 | | | | - | |
Intangible assets | | | 11,443,681 | | | | - | |
Total carrying value of current assets | | | 12,683,892 | | | | 5,042,670 | |
Impairment recognized on classification as held for sale | | | (6,581,128 | ) | | | - | |
Total current assets | | $ | 6,102,764 | | | $ | 5,042,670 | |
| | | | | | | | |
Non-current assets of disposal groups classified as held for sale | | | | | | | | |
Right-of-use asset | | $ | - | | | $ | 701,439 | |
Property and equipment | | | - | | | | 887,795 | |
Intangible assets | | | - | | | | 9,555,020 | |
Total non-current assets | | $ | - | | | $ | 11,144,254 | |
| | | | | | | | |
Total assets of disposal groups | | $ | 6,102,764 | | | $ | 16,186,924 | |
| | | | | | | | |
Current liabilities of disposal groups classified as held for sale | | | | | | | | |
Operating lease liability – current portion | | $ | 1,309,077 | | | $ | 264,044 | |
Total current liabilities | | $ | 1,309,077 | | | $ | 264,044 | |
| | | | | | | | |
Non-current liabilities of disposal groups classified as held for sale | | | | | | | | |
Operating lease liability | | $ | - | | | $ | 644,219 | |
Total non-current liabilities | | $ | - | | | $ | 644,219 | |
| | | | | | | | |
Total liabilities of disposal groups | | $ | 1,309,077 | | | $ | 908,263 | |
(a) Assets held for sale
During the year ended December 31, 2022, the Company became committed to plans to sell four licenses and transfer certain right of use asset and lease liabilities related to the licenses. Prior to reclassification to assets held for sale, the assets were tested for impairment. As a result, the cost bases of the asset groups were written down to $4,793,687 resulting in an impairment loss of $6,815,904 on intangible assets which is included in impairment in net loss from continuing operations. Of the impairment recognized, $6,581,128 relates to assets that continue to be held for sale as at December 31, 2022.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
7. Assets held for sale and discontinued operations (continued)
(b) Discontinued operations
On October 31, 2022, the Company sold its wholly owned subsidiary, SISU Extractions LLC (“SISU”) for $316,005 cash and in addition, the purchaser agreed to enter into a multi-strategic supply agreement providing the Company the right, but not the obligation, to purchase cannabis oil and flower brokerage services for a period of 24 months on preferred terms. The disposition of the operations represented a major strategic shift in the business and met the criteria of discontinued operations. The Company has re-presented the December 31, 2021 consolidated balance sheet and consolidated statement of operations and comprehensive loss.
Summarized results of the discontinued operations were as follows:
| | December 31, 2022 | | | December 31, 2021 | |
Sales, net of discounts | | $ | 23,898,318 | | | $ | 93,489,940 | |
Cost of sales | | | 23,002,763 | | | | 86,275,537 | |
Gross profit | | | 895,555 | | | | 7,214,403 | |
| | | | | | | | |
Impairment loss | | | - | | | | (78,818,403 | ) |
Operating expenses | | | (5,522,335 | ) | | | (13,028,989 | ) |
Loss from operations | | | (4,626,780 | ) | | | (84,632,989 | ) |
| | | | | | | | |
Other expense | | | (119,247 | ) | | | (27,260 | ) |
Income tax expense | | | (341,381 | ) | | | (4,045,615 | ) |
| | | | | | | | |
Loss from discontinued operations, net of income tax | | $ | (5,087,408 | ) | | $ | (88,705,864 | ) |
| | | | | | | | |
Loss from disposal of discontinued operations, net of income tax recovery of $8,856,409 | | $ | (151,971 | ) | | $ | - | |
8. Investments
| | Marketable securities | | | Non-marketable securities | | | Available for sale securities | | | Other | | | Total | |
Balance, December 31, 2020 | | $ | - | | | $ | - | | | $ | - | | | $ | - | | | $ | - | |
Acquired in the period | | | 2,159,514 | | | | 591,545 | | | | 1,000,000 | | | | - | | | | 3,751,059 | |
Interest income | | | - | | | | - | | | | 48,028 | | | | - | | | | 48,028 | |
Change in fair value | | | (1,299,018 | ) | | | - | | | | - | | | | - | | | | (1,299,018 | ) |
Balance, December 31, 2021 | | $ | 860,496 | | | $ | 591,545 | | | $ | 1,048,028 | | | $ | - | | | $ | 2,500,069 | |
| | | | | | | | | | | | | | | | | | | | |
Acquired in the period | | | - | | | | - | | | | - | | | | 150,000 | | | | 150,000 | |
Interest income | | | - | | | | - | | | | 80,000 | | | | - | | | | 80,000 | |
Change in fair value and credit loss | | | (556,444 | ) | | | - | | | | (391,369 | ) | | | - | | | | (947,813 | ) |
Dispositions | | | (304,052 | ) | | | - | | | | - | | | | - | | | | (304,052 | ) |
Balance, December 31, 2022 | | $ | - | | | $ | 591,545 | | | $ | 736,659 | | | $ | 150,000 | | | $ | 1,478,204 | |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
9. Property and equipment
| | December 31, 2022 | | | December 31, 2021 | |
Gross carrying amounts | | | | | | |
Leasehold improvements | | $ | 16,444,132 | | | $ | 13,726,734 | |
Production equipment | | | 2,261,005 | | | | 2,500,473 | |
Furniture and fixtures | | | 871,689 | | | | 858,859 | |
Vehicles | | | 333,325 | | | | 425,886 | |
Office equipment | | | 933,634 | | | | 1,030,216 | |
Building | | | - | | | | 6,549,489 | |
| | | 20,843,785 | | | | 25,091,657 | |
| | | | | | | | |
Accumulated depreciation | | | | | | | | |
Leasehold improvements | | | (3,646,995 | ) | | | (1,724,692 | ) |
Production equipment | | | (1,176,720 | ) | | | (671,688 | ) |
Furniture and fixtures | | | (373,634 | ) | | | (196,124 | ) |
Vehicles | | | (103,069 | ) | | | (51,573 | ) |
Office equipment | | | (397,283 | ) | | | (206,244 | ) |
Building | | | - | | | | (81,866 | ) |
| | | (5,697,701 | ) | | | (2,932,187 | ) |
| | | | | | | | |
Property and equipment, net | | $ | 15,146,084 | | | $ | 22,159,470 | |
The Company recorded depreciation expense related to continuing operations of $3,089,011 year ended December 31, 2022 (December 31, 2021 - $1,831,071).
As at December 31, 2022, the Company has leasehold improvements of $699,259 (December 31, 2021 - $966,192) in progress which are not available for use and therefore not depreciated.
10. Leases
The Company leases real estate used for dispensaries, production plants, and corporate offices. Lease terms for real estate generally range from 1 to 14.75 years. Most leases include options to renew for varying terms at the Company’s sole discretion. Certain leases include escalation clauses or payment of executory costs such as property taxes, utilities, or insurance and maintenance. Rent expense for leases with escalation clauses is accounted for on a straight-line basis over the lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The following table provides the components of lease cost:
| | December 31, 2022 | | | December 31, 2021 | |
Operating lease costs | | $ | 6,857,552 | | | $ | 4,507,630 | |
Short term lease expense | | | 1,210,853 | | | | 139,603 | |
Lease expense | | | 8,068,405 | | | | 4,647,233 | |
| | | | | | | | |
Finance lease cost: | | | | | | | | |
Amortization of lease assets | | | 1,568,759 | | | | 1,619,093 | |
Interest on lease liabilities | | | 4,479,732 | | | | 4,515,112 | |
Finance lease cost | | | 6,048,491 | | | | 6,134,205 | |
| | | | | | | | |
Total lease costs | | $ | 14,116,896 | | | $ | 10,781,438 | |
The Company recorded operating lease sublease income of $704,697 for the year ended December 31, 2022 (December 31, 2021 - $222,787) included in other income on the consolidated statements of operations and comprehensive loss.
Other information related to operating and finance leases as of and for the year ended December 31, 2022 are as follows:
| | Operating Lease | | | Finance Lease | |
Weighted average discount rate | | | 11.89 | % | | | 13.02 | % |
Weighted average remaining lease term (in years) | | | 9.01 | | | | 14.75 | |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
10. Leases (continued)
Cash paid for amounts included in the measurement of lease liabilities:
| | December 31, 2022 | | | December 31, 2021 | |
Operating cash flows from operating leases | | $ | 6,707,387 | | | $ | 4,836,963 | |
Financing cash flows from finance lease | | | 4,490,443 | | | | 4,385,528 | |
The maturity of the contractual undiscounted lease liabilities as of December 31, 2022:
| | Operating Lease | | | Finance Lease | |
| | | | | | |
2023 | | $ | 5,521,022 | | | $ | 4,625,156 | |
2024 | | | 5,002,948 | | | | 4,763,910 | |
2025 | | | 5,139,443 | | | | 4,906,828 | |
2026 | | | 5,288,213 | | | | 5,054,033 | |
2027 | | | 4,775,402 | | | | 5,205,654 | |
Thereafter | | | 18,295,466 | | | | 59,679,244 | |
Total undiscounted lease liabilities | | | 44,022,494 | | | | 84,234,825 | |
Interest on lease liabilities | | | 16,863,505 | | | | 47,460,111 | |
Total present value of minimum lease payments | | | 27,158,989 | | | | 36,774,714 | |
Lease liability – current portion | | | 2,355,174 | | | | 156,184 | |
Lease liability | | $ | 24,803,815 | | | $ | 36,618,530 | |
Additional information on the right-of-use assets is as follows:
| | Operating lease | | | Finance lease | |
| | | | | | |
Gross carrying amount | | | | | | |
Balance, December 31, 2021 | | $ | 30,099,933 | | | $ | 26,258,698 | |
| | | | | | | | |
Measurement period adjustment (Note 27) | | | 411,322 | | | | - | |
Additions (i) | | | 2,163,935 | | | | - | |
Disposals | | | (1,882,008 | ) | | | - | |
Impairment (Note 18) | | | (5,162,379 | ) | | | - | |
Termination of lease | | | (218,157 | ) | | | - | |
Lease extension | | | 3,518,350 | | | | - | |
Adjustment for lease term | | | (615,481 | ) | | | - | |
Transfer to assets held for sale (Note 7) | | | (1,763,717 | ) | | | - | |
Balance, December 31, 2022 | | $ | 26,551,798 | | | $ | 26,258,698 | |
| | | | | | | | |
Depreciation | | | | | | | | |
Balance, December 31, 2021 | | $ | 2,437,086 | | | $ | 1,619,093 | |
Transfer to assets held for sale (Note 7) | | | (271,201 | ) | | | - | |
Additions | | | 3,696,827 | | | | 1,568,759 | |
Balance, December 31, 2022 | | $ | 5,862,712 | | | $ | 3,187,852 | |
| | | | | | | | |
Carrying amount December 31, 2022 | | $ | 20,689,086 | | | $ | 23,070,846 | |
Carrying amount December 31, 2021 | | $ | 27,662,847 | | | $ | 24,639,605 | |
The Company capitalized $704,732 of amortization to inventory for the year ended December 31, 2022 (December 31, 2021 - $1,350,735).
(i) During the year ended December 31, 2022, the Company entered into a sale-leaseback arrangement whereby it sold its building for $6,500,000 less closing costs and entered into a lease with the buyer for a non-cancellable period of five years with the option to extend the lease for three additional five-year periods. The Company received $6,000,000 upfront and received a promissory note for $500,000 which is payable over five years. The fair value of the promissory note on initial recognition was $389,816. The Company recorded a loss on sale which is included in loss on disposal of assets on the consolidated statement of comprehensive operations and loss and was calculated as follows:
Sale price | | $ | 6,389,816 | |
Selling costs | | | (230,960 | ) |
Carrying value of building | | | (6,413,329 | ) |
Loss on disposal of asset | | $ | (254,473 | ) |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
10. Leases (continued)
(ii) During the year ended December 31, 2022, the Company terminated one of its leases early by agreeing to pay the lessor $200,000 upon termination and issuing a promissory note for $950,000 due January 2, 2023. The fair value of the promissory note on initial recognition was $931,103. The Company recorded a loss on termination of $41,074 which is included in other income in the consolidated statement of operations and comprehensive loss.
During the year ended December 31, 2022, the Company terminated three of its leases, two of which had no termination penalties and one with a $350,000 termination penalty accrued at year end and additional expense of $162,500 related to prepaid rent for total additional expense of $512,500. The Company recorded a total gain on terminations of $158,880 which is included in other income in the consolidated statement of operations and comprehensive loss.
11. Goodwill and intangible assets
| | December 31, 2022 | | | December 31, 2021 | |
Opening gross goodwill | | | 607,413,242 | | | | - | |
Acquired in the Qualifying Transaction (Note 26) | | | - | | | | 570,307,290 | |
Acquired in other business combinations (Note 27) | | | - | | | | 45,666,784 | |
Measurement period adjustment (Note 27) | | | (22,633,099 | ) | | | - | |
Disposals | | | (35,000 | ) | | | (8,560,832 | ) |
| | | 584,745,143 | | | | 607,413,242 | |
| | | | | | | | |
Opening accumulated impairment | | | (563,361,597 | ) | | | - | |
Impairment non-THC business (Note 18) | | | - | | | | (5,555,437 | ) |
Impairment (Note 18) | | | (21,418,546 | ) | | | (563,361,597 | ) |
Disposals | | | 35,000 | | | | 5,555,437 | |
| | | (584,745,143 | ) | | | (563,361,597 | ) |
| | | | | | | | |
Goodwill, net | | $ | - | | | $ | 44,051,645 | |
| | | | | | | | |
Intangible assets gross carrying amounts (i) | | | | | | | | |
License | | | 82,563,527 | | | | 112,161,292 | |
Brand | | | 50,400,559 | | | | 116,700,360 | |
Customer relations | | | 2,920,000 | | | | 2,920,000 | |
| | | 135,884,086 | | | | 231,781,652 | |
| | | | | | | | |
Intangible assets accumulated amortization | | | | | | | | |
License | | | (26,654,299 | ) | | | (13,620,757 | ) |
Brand | | | (9,218,821 | ) | | | (5,264,606 | ) |
Customer relations | | | (632,868 | ) | | | (308,424 | ) |
| | | (36,505,988 | ) | | | (19,193,787 | ) |
| | | | | | | | |
Intangible assets, net | | $ | 99,378,098 | | | $ | 212,587,865 | |
The Company recorded amortization expense related to continuing operations of $22,842,919 during the year ended December 31, 2022 (December 31, 2021 - $19,226,357).
(i) | During the year, the Company recognized an increase in intangible assets of $31,673,000 as a result of measurement period adjustments related to business combinations, refer to Note 27. In addition, the Company recognized a decrease of $97,169,997 as a result of impairment, refer to Note 18. |
The following table outlines the estimated future annual amortization expense as of December 31, 2022:
| | Estimated Amortization | |
2023 | | $ | (7,257,882 | ) |
2024 | | | (7,191,983 | ) |
2025 | | | (7,191,983 | ) |
2026 | | | (7,191,983 | ) |
2027 | | | (7,174,094 | ) |
Thereafter | | | (63,370,173 | ) |
| | $ | (99,378,098 | ) |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
12. Accounts payable and accrued liabilities
| | December 31, 2022 | | | December 31, 2021 | |
Trade payables | | $ | 4,249,794 | | | $ | 8,390,991 | |
Other accrued expenses | | | 4,872,988 | | | | 7,288,466 | |
Accrued payroll expenses | | | 2,666,974 | | | | 1,326,493 | |
Accrued severance expenses | | | 692,220 | | | | 1,331,365 | |
Accrued income and other taxes | | | 9,974,817 | | | | 19,062,306 | |
Goods received but not yet invoiced | | | 2,103,566 | | | | 4,225,696 | |
| | $ | 24,560,359 | | | $ | 41,625,317 | |
13. Long term strategic contracts
(i) Marketing Agreement (“MA”)
The Company had engaged a third-party for strategic and promotional services. During the year ended December 31, 2021, the Company issued 2,376,425 common shares in settlement of the initial $25,000,000. As the shares vested immediately, the full amount of the $25,000,000 was recognized as an expense in operating expenses during the year ended December 31, 2021.
The Company was obligated to issue shares to the value of $1,875,000 quarterly over the second and third year of the contract. During year ended December 31, 2022, the Company issued 7,355,453 common shares to settle the first year of quarterly payments. These common shares are restricted under applicable US securities laws.
The Company recognized an expense of $3,718,402 during the year ended December 31, 2022 (December 31, 2021 - $5,166,666) in operating expenses as a sales and marketing expense. As of December 31, 2022, the cash-settled liability is $nil (December 31, 2021 - $5,166,666).
(ii) Brand Strategy Agreement (“BSA”)
The Company was party to the BSA, whereby the Company received the services of Shawn C. Carter p/k/a JAY-Z’s related promotion and advertising for the remaining non-cancellable period of 5 years. The Company was committed to settle $21,500,000 in either cash or common shares at the option of the counterparty over the remaining non-cancellable period. The Company was recognizing the cost associated with the arrangement over the same period it was receiving services.
During the year ended December 31, 2022, the Company recognized an expense of $4,416,667 (December 31, 2021 - $4,183,565) in operating expenses related to this arrangement. and $nil in accounts payable and accrued liabilities as of December 31, 2022 (December 31, 2021 - $2,183,565). During the year ended December 31, 2022, the Company made a cash payment of $3,000,000 (December 31, 2021 - $nil).
On December 29, 2022, the Company entered into modification agreements (the "Modification Agreements") to restructure the relationship between the Company and the counterparties to the above contracts. Refer to Note 22.
14. Income taxes
Net income (loss) from continuing operations before income taxes was generated as follows:
| | December 31, 2022 | | | December 31, 2021 | |
| | | | | | |
Domestic - Canada | | $ | (23,940,689 | ) | | $ | 165,628,760 | |
Foreign – outside of Canada | | | (228,726,498 | ) | | | (670,373,397 | ) |
| | $ | (252,667,187 | ) | | $ | (504,744,637 | ) |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
14. Income taxes (continued)
Income tax (recovery) expense is comprised of the following:
| | December 31, 2022 | | | December 31, 2021 | |
Current tax expense | | | | | | |
Domestic – Canada | | $ | - | | | $ | - | |
Foreign – outside of Canada | | | 17,358,657 | | | | (827,758 | ) |
| | | 17,358,657 | | | | (827,758 | ) |
| | | | | | | | |
Deferred tax recovery | | | | | | | | |
Domestic – Canada | | | - | | | | - | |
Foreign – outside of Canada | | | (32,326,436 | ) | | | (5,590,409 | ) |
| | | (32,326,436 | ) | | | (5,590,409 | ) |
| | | | | | | | |
Income tax recovery | | $ | (14,967,779 | ) | | $ | (6,418,167 | ) |
A reconciliation of income taxes at the statutory rate with the reported taxes is as follows.
| | December 31, 2022 | | | December 31, 2021 | |
| | | | | | |
Loss before tax | | $ | (252,667,187 | ) | | $ | (504,744,637 | ) |
Statutory income tax rate | | | 21 | % | | | 21 | % |
Income tax recovery based on statutory rate | | | (53,060,109 | ) | | | (105,996,374 | ) |
| | | | | | | | |
Increase (decrease) resulting from: | | | | | | | | |
§280E permanent adjustment | | | 22,073,497 | | | | 22,558,050 | |
Impairment | | | 7,179,876 | | | | 159,241,026 | |
Share-based compensation expense | | | 149,863 | | | | 4,128,200 | |
Fair value change of contingent consideration | | | - | | | | (62,150,629 | ) |
Non-taxable items | | | (225,201 | ) | | | (1,286,100 | ) |
Change in valuation allowance | | | 35,376,675 | | | | 25,812,740 | |
Other | | | 115,792 | | | | (647,879 | ) |
Effect of state income taxes | | | (25,141,653 | ) | | | (58,081,560 | ) |
Tax rate differences and tax rate changes | | | (1,436,519 | ) | | | 10,004,359 | |
Income tax expense | | $ | (14,967,779 | ) | | $ | (6,418,167 | ) |
Deferred taxes result from the temporary differences between financial reporting carrying amounts and the tax basis of existing assets and liabilities. The table below summarizes the principal components of the deferred tax assets (liabilities) as follows:
| | December 31, 2022 | | | December 31, 2021 | |
Deferred tax assets | | | | | | |
Loss carryforwards | | $ | 64,992,935 | | | $ | 25,917,608 | |
Tangible assets | | | - | | | | 1,148,865 | |
Intangible assets | | | - | | | | 5,883,006 | |
Financing costs | | | 3,343,107 | | | | 5,194,236 | |
Marketing prepaid | | | 2,250,000 | | | | 4,500,000 | |
Cash settled share-based payments | | | - | | | | 1,395,000 | |
Other | | | 3,728,027 | | | | 3,176,964 | |
Deferred tax assets | | | 74,314,069 | | | | 47,215,679 | |
Valuation allowance | | | (66,459,411 | ) | | | (32,392,015 | ) |
Net deferred tax asset | | | 7,854,658 | | | | 14,823,664 | |
| | | | | | | | |
Deferred tax liabilities | | | | | | | | |
Intangible assets | | | (28,827,287 | ) | | | (58,294,219 | ) |
Other | | | - | | | | (377,311 | ) |
Deferred tax liabilities | | | (28,827,287 | ) | | | (58,671,530 | ) |
Deferred tax assets | | | 7,854,658 | | | | 14,823,664 | |
Net deferred tax liability | | $ | (20,972,629 | ) | | $ | (43,847,866 | ) |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
14. Income taxes (continued)
Deferred income taxes have not been recorded on the basis differences for investments in consolidated subsidiaries as these basis differences are indefinitely reinvested or will reverse in a non-taxable manner. Quantification of the deferred income tax liability, if any, associated with indefinitely reinvested basis differences is not practicable.
A valuation allowance has been taken against the California deferred tax assets of $26,865,066. In addition, a valuation allowance of $10,750,005 has been taken against the federal deferred tax assets relating to net operating losses that might not be available. A valuation allowance has been taken against the Canadian deferred tax assets of $28,844,340.
As at December 31, 2022, the Company has Canadian federal and provincial non-capital loss carryforwards of $84,406,384 (December 31, 2021 - $44,402,766). The Canadian non-capital loss carryforwards expire between 2039 and 2042.
As at December 31, 2022, the Company has the following U.S. federal and state losses carried forward available to reduce future years' taxable income, which losses expire as follows:
| | Federal | | | State and Local | | | Total | |
2034 | | $ | - | | | | 48,671 | | | $ | 48,671 | |
2035 | | | - | | | | 3,382,027 | | | | 3,382,027 | |
2036 | | | - | | | | 8,787,634 | | | | 8,787,634 | |
2037 | | | - | | | | 12,061,282 | | | | 12,061,282 | |
2038 | | | - | | | | 31,194,997 | | | | 31,194,997 | |
2039 | | | - | | | | 64,493,970 | | | | 64,493,970 | |
2040 | | | - | | | | 54,470,985 | | | | 54,470,985 | |
2041 | | | - | | | | 74,068,585 | | | | 74,068,585 | |
2042 | | | | | | | 102,053,042 | | | | 102,053,042 | |
Indefinite | | | 53,398,098 | | | | - | | | | 53,398,098 | |
| | $ | 53,398,098 | | | $ | 350,561,193 | | | $ | 403,959,291 | |
Section 280E of the U.S. Internal Revenue Code (“IRC”) prohibits businesses engaged in the trafficking of Schedule I or Schedule II controlled substances from deducting normal business expenses, such as payroll and rent, from gross income (revenue less cost of goods sold). Section 280E was originally intended to penalize criminal market operators, but because cannabis remains a Schedule I controlled substance for Federal purposes, the Internal Revenue Service (“IRS”) has subsequently applied Section 280E to state-legal cannabis businesses. Cannabis businesses operating in states that align their tax codes with the IRC are also unable to deduct normal business expenses from taxable income subject to state taxes.
The non-deductible expenses shown in the effective rate reconciliation above is comprised primarily of the impact of applying IRC Section 280E to the Company's businesses that are involved in selling cannabis, along with other typical non-deductible expenses such as lobbying expenses. As the application and IRS interpretations on Section 280E continue to evolve, the impact of this cannot be reliably estimated. Any changes to the application of Section 280E may have a material effect on the Company’s consolidated financial statements
The statute of limitations on tax returns for the IRS and California Franchise Tax Board are 3 and 4 years respectively. Net operating losses remains open for examination beyond these statute of limitations for both the IRS and California Franchise Tax Board.
Utilization of net operating loss carryforwards may be subject to limitations in the event of a change in ownership as defined under U.S. IRC Section 382, and similar state provisions. An "ownership change" is generally defined as a cumulative change in the ownership interest of significant shareholders of more than 50 percentage points over a three-year period. The Company experienced ownership change during 2017. Such ownership change could result in a limitation of the Company's ability to reduce future income by net operating loss carryforwards. A formal Section 382 study has not been prepared, so the exact effects of the ownership change are not known at this time. The deferred tax assets include net operating losses of the Company as of the conversion date to a C corporation.
In March 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (the “Act”). The Act, among other provisions, reinstates the ability of corporations to carry net operating losses back to the five preceding tax years, has increased the excess interest limitation on modified taxable income from 30 percent to 50 percent. The Company has made a reasonable estimate of the effects on existing deferred tax balances and has concluded that the Act has not had a significant on the deferred tax balances.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
14. Income taxes (continued)
The Company operates in a number of tax jurisdictions and is subject to examination of its income tax returns by tax authorities in those jurisdictions who may challenge any item on these returns. Because the tax matters challenged by tax authorities are typically complex, the ultimate outcome of these challenges is uncertain. The Company recognizes the benefit of uncertain tax positions in the consolidated financial statements after determining that it is more-likely-than-not the uncertain tax positions will be sustained.
The Company has recorded a reserve for an uncertain tax positions in accrued income and other taxes within accounts payable and accrued liabilities and corresponding indemnification assets of $6,044,155 within prepaids related to acquisitions, refer to Notes 26 and 27. A continuity of the reserve for uncertain tax positions is presented below:
| | December 31, 2022 | | | December 31, 2021 | |
Opening, balance | | $ | 7,071,735 | | | $ | - | |
Acquired in a business combination | | | - | | | | 8,881,814 | |
Current year additions | | | 9,466,028 | | | | - | |
Reclass to payables for positions no longer uncertain | | | (653,616 | ) | | | - | |
Settlements with taxing authorities | | | (1,494,837 | ) | | | (1,810,079 | ) |
Balance, December 31 | | $ | 14,389,310 | | | $ | 7,071,735 | |
The Company intends to be treated as a U.S. corporation for U.S. federal income tax purposes under section 7874 of the U.S. IRC and is expected to be subject to U.S. federal income tax on its worldwide income. However, the Company is expected, regardless of any application of section 7874 of the U.S. IRC, to be treated as tax resident of Canada for Canadian income tax purposes. Accordingly, the Company is subject to taxation both in Canada and the U.S.
15. Redeemable non-controlling interest
The following table explains the movement in redeemable NCI during the year ended December 31, 2022:
| | Coastal Holding (a) | | | Varda Inc. (b) | | | Calma (c) | | | Total | |
Balance, December 31, 2021 | | $ | 35,307,459 | | | $ | 4,648,928 | | | $ | 1,500,000 | | | $ | 41,456,387 | |
Net (loss) income attributable to redeemable non-controlling interest | | | (354,963 | ) | | | 48,010 | | | | - | | | | (306,953 | ) |
Redeemed | | | (34,952,496 | ) | | | (4,696,938 | ) | | | (1,500,000 | ) | | | (41,149,434 | ) |
Balance, December 31, 2022 | | $ | - | | | $ | - | | | $ | - | | | $ | - | |
a) | The Company was obligated to acquire 100% of the equity in Coastal Holding when the transaction legally closed, which was contingent upon various conditions. The transaction legally closed on November 14, 2022 and was settled by issuing $3,750,000 of cash, assuming $150,000 of liabilities, and issuing 24,796,902 common shares of the Company’s subsidiary, Coast L Acquisition Corp (“Coast L”). Each Coast L share is exchangeable at any time on a one-for-one basis into common shares of the Company. As at December 31, 2022, no shares have been exchanged. |
b) | The Company was obligated to acquire the remaining 90.5% of Varda Inc. when regulatory approval was received for the license to transfer. On June 20, 2022, regulatory approval was received and as a result the associated redeemable NCI was redeemed for $4,680,000 of cash. Refer to Note 27. |
c) | The Company was obligated to acquire the Class A shares of Calma when regulatory approval was received for the license to transfer. During the year ended December 31, 2022, the Company issued 1,762,425 common shares to redeem the Calma NCI. |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
16. Shareholders’ equity
Common shares
a) Authorized
The Company is authorized to issue an unlimited number of common shares with no par value.
b) Common shares issued
| | Number of common shares | |
Balance December 31, 2021 | | | 97,065,092 | |
(i) Shares issued to settle contingent consideration | | | 305,325 | |
(ii) Shares issued to settle contingent consideration | | | 255,040 | |
| | | | |
Shares issued for Marketing Arrangement (Note 13) | | | 7,355,453 | |
Shares issued for vested RSUs and PSUs (Note 21) | | | 773,848 | |
Shares issued for acquisition of Calma (Note 27) | | | 1,762,425 | |
Shares returned to Treasury | | | (850 | ) |
Balance, December 31, 2022 | | | 107,516,333 | |
| (i) | During the year ended December 31, 2022, the Company issued 305,325 common shares related to contingent consideration in the acquisition of Caliva. The common shares were included in shares to be issued as at December 31, 2021. |
| (ii) | During the year ended December 31, 2022, the Company issued 255,040 common shares related to contingent consideration in the acquisition of LCV. The common shares were issued as the related contingency was resolved. |
The Company has reserved 24,796,902 common shares to be issued in exchange for shares of its subsidiary, Coast L Acquisition Corp. Refer to Note 15.
On January 28, 2022, the Company announced a voluntary extension of the lock-up agreements with certain members of the Company’s leadership team and the entire board of directors, covering over approximately 34,000,000 issued and outstanding common shares. Pursuant to the lock-up agreements, each counterparty has agreed that, subject to certain exceptions, they will not, without the written consent of the Company, among other things, assign or dispose of any of their locked-up shares until January 28, 2023.
| | Number of common shares | |
Balance, December 31, 2020 | | | - | |
(i) Conversion of Class B shares | | | 14,655,547 | |
(ii) Shares issued in a private placement | | | 6,313,500 | |
(iii) Conversion of Class A restricted voting shares | | | 31,407,336 | |
(iv) Shares issued to extinguish liabilities in the Qualifying Transaction | | | 336,856 | |
(v) Shares issued for the Qualifying Transaction | | | 42,891,175 | |
(vi) Contingent shares issued in the Qualifying Transaction | | | 25,000 | |
(vii) Share repurchases under repurchase agreements | | | (1,725,000 | ) |
(viii) Share repurchases under normal course issuer bids | | | (157,600 | ) |
(ix) Shares issued for contingent consideration | | | 24,584 | |
(x) Shares issued for acquisition of Calma | | | 458,898 | |
| | | | |
Shares issued for Marketing Service Agreement (Note 13) | | | 2,376,425 | |
Shares issued for vested RSUs (Note 21) | | | 455,058 | |
Shares issued for options exercised (Note 21) | | | 3,313 | |
Balance, December 31, 2021 | | | 97,065,092 | |
| (i) | Class B shares were converted into 14,655,547 common shares upon the closing of the Qualifying Transaction. |
| (ii) | On January 15, 2021, the Company closed a private placement of 6,313,500 shares for subscription receipts and Class A restricted voting shares for consideration of $63,135,000 (Note 26). The subscription receipts and Class A restricted voting shares converted to common shares upon the closing of the Qualifying Transaction. |
| (iii) | Upon the closing of the Qualifying Transaction, 31,407,336 Class A restricted voting shares were converted into common shares of the Company. The remaining 26,092,664 Class A restricted voting shares were redeemed for cash of $264,318,686. |
| (iv) | The Company issued 336,856 common shares to settle a liability on behalf of SISU as part of the Qualifying Transaction. |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
16. Shareholders’ equity (continued)
| (v) | On January 15, 2021, the Company acquired Caliva and OGE, LCV and SISU as part of the Qualifying Transaction (Note 26). During the year ended December 31, 2021, the Company issued 42,891,175 common shares related to this transaction. |
| (vi) | During the year ended December 31, 2021, the Company settled a portion of the contingent shares to be issued as part of the Qualifying Transaction and issued 25,000 common shares. |
| (vii) | During the year ended December 31, 2021, the Company repurchased 1,725,000 common shares under the share repurchase agreements (Note 17). |
Common shares (continued)
| (viii) | During the year ended December 31, 2021, the Neo Exchange Inc. accepted the Company’s notice of intention to commence Normal Course Issuer Bids (“NCIBs”) for the Company’s common shares and warrants. Pursuant to the NCIBs, the Company may repurchase on the open market (or as otherwise permitted), up to 4,912,255 common shares and 1,791,875 warrants, representing approximately 5% of the issued and outstanding of each of the common shares and the warrants subject to the normal terms and limitations of such bids and an aggregate cap of $25,000,000. Any common shares or warrants purchased under the NCIB will be cancelled. The NCIBs were effective on August 18, 2021 and end on the earlier of (i) August 17, 2022, (ii) $25,000,000 of purchases under the Bids, and (iii) the completion of purchases under the applicable Bid. As at December 31, 2021, the Company repurchased 157,600 common shares under this program for $603,165. |
| (ix) | During the year ended December 31, 2021, the Company issued 24,584 common shares related to contingent consideration in the acquisition of LCV. The common shares were issued as the related contingency was resolved. |
| (x) | On October 1, 2021, the Company acquired Calma (Note 27) and issued 458,898 common shares. |
During the year ended December 31, 2021, and in conjunction with the closing of the Qualifying Transaction described in Note 26, certain shareholders entered into a Lockup and Forfeiture Agreement (the “First Lockup Agreement”), that generally restricted their ability to transfer or trade their shareholdings for a period of nine-months. The trade and transfer restriction period ended on July 15, 2021.
In accordance with the First Lockup Agreement, certain shareholders also agreed to forfeit up to 5,430,450 common shares of the Company upon the third anniversary of the Qualifying Transaction if certain trading targets are not met.
One-third of such common shares will cease to be subject to forfeiture if the 20-Day VWAP of the common shares is equal to or exceeds $13.00, an additional one-third will cease to be subject to forfeiture if the 20-Day VWAP of the common shares is equal to or exceeds $17.00 and an additional one-third will cease to be subject to forfeiture if the 20-Day VWAP of the common shares is equal to or exceeds $21.00.
On July 28, 2021, the Company entered into lock-up agreements (the “Second Lockup Agreements”) with certain members of the Company's leadership team and the entire board of directors covering over approximately 33,000,000 issued and outstanding common shares. Pursuant to the Second Lockup Agreements, each counterparty has agreed that, subject to certain exceptions, they would not, without the written consent of the Company, sell, pledge, grant any option, right or warrant for the sale of or otherwise lend, transfer, assign or dispose of any of their locked-up shares until January 28, 2023.
Class B shares
a) Authorized
The Company is authorized to issue an unlimited number of Class B shares with no par value.
b) Class B shares issued
No Class B shares issued during the year ended December 31, 2022.
| | Number of Class B shares | |
Balance, December 31, 2020 | | | 15,218,750 | |
Conversion of Class B shares | | | (14,655,547 | ) |
Founders’ shares forfeited | | | (563,203 | ) |
Balance, December 31, 2021 | | | - | |
Pursuant to the First Lockup Agreement, the Sponsor also forfeited 563,203 common shares to the Company for cancellation on closing of the Qualifying Transaction.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
17. Share repurchase
On July 29, 2021, the Company entered into automatic share repurchase agreements with certain employees to repurchase no more than 1,725,000 common shares that had been issued as part of the Qualifying Transaction. The common shares were repurchased at market value over a three-month period beginning September 1, 2021, and then subsequently cancelled.
The Company initially recognized the obligation to repurchase its share at the market price on July 29, 2021 for $7,055,250 with a corresponding entry to additional paid in capital. The Company accounts for its share repurchases on the trade date and allocates any excess over par value of the originally issued share to additional paid in capital.
The Company’s share repurchase activity was as follows:
| | December 31, 2021 | |
Share repurchased | | | 1,725,000 | |
Average price | | $ | 3.44 | |
Aggregate value | | $ | 5,939,031 | |
During the year ended December 31, 2021, the Company recorded $1,116,219 of interest income related to the revaluation of the share repurchase liability.
18. Impairment
| | December 31, 2022 | | | December 31, 2021 | |
Right-of-use assets (i) | | $ | 4,307,578 | | | $ | - | |
Impairment (ii) | | | 119,443,343 | | | | 567,947,515 | |
Impairment prior to classification as held for sale (Note 7(a)) | | | 6,815,904 | | | | 1,995,945 | |
Non-THC business (iii) | | | - | | | | 5,555,437 | |
| | $ | 130,566,825 | | | $ | 575,498,897 | |
For the year ended December 31, 2022
(i) Right of use assets – During the year ended December 31, 2022, the Company recorded impairment of $4,307,578 related to properties which are no longer being used by the Company.
(ii) Impairment of long-lived assets – At each reporting period end, the Company considers if there have been any triggers that indicate that its long-lived assets are not recoverable. Based on the softening of the California cannabis market and cost pressures due to higher US inflation during the three months ended September 30, 2022, the Company determined that an impairment test was appropriate.
The following table outlines the impairment of long-lived assets by class of asset, recognized during the year ended December 31, 2022, as a result of impairment testing:
Asset | | Carrying value before impairment | | | Carrying value after impairment | | | Total impairment loss | |
Right of use assets | | $ | 1,680,224 | | | $ | 825,424 | | | $ | 854,800 | |
License | | | 52,304,385 | | | | 9,699,829 | | | | 42,604,556 | |
Brand | | | 78,189,441 | | | | 23,624,000 | | | | 54,565,441 | |
Goodwill | | | 21,418,546 | | | | - | | | | 21,418,546 | |
| | $ | 153,592,596 | | | $ | 34,149,253 | | | $ | 119,443,343 | |
The impairment test for long-lived assets is a two-step test, whereby management first determines the recoverable amount (undiscounted cash flows) of each asset group. If the recoverable amount is lower than the carrying value, impairment is indicated. For those asset groups where impairment is indicated, the Company then determines the fair value of each of those asset groups and allocates the impairment to the long-lived assets within that asset group. The assets are not written down below their individual fair value.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
18. Impairment (continued)
The fair value of each asset group was determined using a combination of a market and income approach. For the purposes of allocation of impairment, the fair value of the specific assets that were impaired was determined using a market approach. The key assumptions used are as follows:
Asset | Approach | Discount Rate | Forecasted Sales Growth Rate | Terminal Value Growth Rate |
Right of use assets | Market | N/A | N/A | N/A |
License | Market | N/A | N/A | N/A |
Brand | Income | 11.75% | Average of 4% | 3% |
Impairment of goodwill
The Company conducts goodwill impairment testing annually during the third quarter, or more often if events, changes or circumstances indicated that it is more likely than not that the fair value of a reporting unit is lower than its carrying amount. At the time of the annual impairment test, the Company determined that the existence of impairment on certain long-lived assets, together with the softening of the California cannabis market, cost pressures due to higher US inflation and changes in market expectations of cash flows since the Company acquired the goodwill, indicated the fair value of its reporting unit might be lower than the carrying value.
As at September 30, 2022, the Company identified one reporting unit and allocated the carrying value of goodwill to the reporting unit:
Direct-to-consumer (“DTC”) | | $ | 21,418,546 | |
The Company determined the fair value of the reporting unit and compared it to the carrying value. The fair value of the reporting unit was determined using a discounted cash flow technique based on the following key assumptions:
Reporting unit | Discount Rate | Forecasted Sales Growth Rate | Terminal Value Growth Rate |
DTC | 10.75% | Average of 4% | 3% |
As a result of the impairment test, goodwill impairment of $21,418,546 was recognized during the year ended December 31, 2022.
For the year ended December 31, 2021
Impairment of long-lived assets
During the three months ended September 30, 2021, the Company determined that an impairment test was appropriate based on the softening of the California cannabis market.
As a result of this assessment, the Company determined that long-lived assets with a carrying amount of $55,163,000 were no longer recoverable and adjusted the carrying value to the estimated fair value of $18,431,000, resulting in an impairment loss of $36,732,000 recognized during the year end December 31, 2021. Of the total impairment loss, $4,586,000 was included above and $32,146,000 was included as a net loss from discontinued operations.
The fair value of each asset group was determined using cash flows expected to be generated by market participants, discounted at a weighted average cost of capital. For the purposes of allocation of impairment, the fair value of the specific assets that were impaired was determined using a discounted cash flow technique based on the following key assumptions:
Asset | Discount Rate | Forecasted Sales Growth Rate | Terminal Value Growth Rate |
Licenses | 15.5% - 20.5% | Average of -4% to 24% | 3% |
Cultivation Network | 20.5% | Average of -42% to 6% | 3% |
Impairment of goodwill
During the year ended December 31, 2021, the Company performed its annual impairment test as at September 30, 2021. The Company identified three reporting units and allocated the carrying value of goodwill to the respective reporting units:
Direct-to-consumer (“DTC”) | | $ | 470,577,972 | |
Wholesale – Branded products | | $ | 92,783,625 | |
Wholesale – Non-branded products | | $ | 46,672,403 | |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
18. Impairment (continued)
The Company determined the fair value of each reporting unit and compared it to the carrying value. The fair value of each reporting unit was determined using a discounted cash flow technique based on the following key assumptions:
Reporting unit | Discount Rate | Forecasted Sales Growth Rate | Terminal Value Growth Rate |
DTC | 13.5% | Average of 24% | 3% |
Wholesale- Branded products | 13.5% | Average of 17% | 3% |
Wholesale- Non-branded products | 18.5% | Average -4% | 3% |
As a result of the impairment tests, goodwill impairment of $610,033,918 was recognized during the year ended December 31, 2021. Of the total impairment loss, $563,361,515 was included above and $46,672,403 was included as a net loss from discontinued operations.
(iii) Non-THC business – In February 2021, the Company became committed to a plan to sell its non-THC business, which was acquired as part of the Caliva and OGE and LCV acquisitions on January 15, 2021. As a result of the decision to sell, the assets were tested for impairment and an impairment loss of $58,030,387 was recognized during the year ended December 31, 2021.
19. Operating expenses
| | December 31, 2022 | | | December 31, 2021 | |
General and administrative | | $ | 42,170,219 | | | $ | 42,395,204 | |
Allowance for accounts receivable and notes receivable | | | 3,216,310 | | | | 3,933,081 | |
Sales and marketing | | | 12,679,477 | | | | 42,413,733 | |
Salaries and benefits | | | 39,441,476 | | | | 35,119,133 | |
Share-based compensation (Note 21) | | | 6,009,593 | | | | 20,456,297 | |
Lease expense (Note 10) | | | 8,068,405 | | | | 4,647,233 | |
Depreciation of property and equipment and amortization of right-of-use assets | | | 3,953,038 | | | | 3,213,376 | |
Amortization of intangible assets (Note 11) | | | 22,842,919 | | | | 19,226,357 | |
| | $ | 138,381,437 | | | $ | 171,404,414 | |
20. Loss per share
| | December 31, 2022 | | | December 31, 2021 | |
Loss from continuing operations available to common shareholders | | $ | (237,392,455 | ) | | $ | (498,354,260 | ) |
Loss from discontinued operations available to common shareholders | | | (5,239,379 | ) | | | (88,705,864 | ) |
Loss available to common shareholders | | $ | (242,631,834 | ) | | $ | (587,060,124 | ) |
| | | | | | | | |
Weighted average number of shares, basic and diluted | | | 102,632,433 | | | | 95,006,080 | |
| | | | | | | | |
Basic and diluted loss per share from continuing operations | | $ | (2.31 | ) | | $ | (5.25 | ) |
Basic and diluted loss per share from discontinued operations | | | (0.05 | ) | | | (0.93 | ) |
Basic and diluted loss per share | | $ | (2.36 | ) | | $ | (6.18 | ) |
Approximately 64,104,779 of potentially dilutive securities as at December 31, 2022 were excluded in the calculation of diluted loss per share as their impact would have been anti-dilutive.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
21. Share-based compensation
Effective January 2021, the Company established the Equity Incentive Plan (the “Plan”), which provides for the granting of incentive share options, nonqualified share options, share appreciation rights (“SARs”), restricted share units (“RSUs”), deferred share units (“DSUs”) and performance share units (“PSUs”), herein collectively referred to as “Awards”.
(a) Share options
The Company grants options to purchase its common shares at an exercise price that is generally at the fair value of the Company’s shares as at the date of grant. The maximum number of common shares that may be issued under the Plan is fixed by the Board to be 15% of the common shares outstanding, from time to time, subject to adjustments in accordance with the plan.
Options generally vest over a four-year period, specifically at a rate of 25% upon the first anniversary of the issuance date and 1/36th per month thereafter and expire after 10 years from the date of grant.
The Company’s options outstanding relate to replacement options issued in a business combination that occurred in 2021.
The following table reflects the continuity of the share options during the year ended December 31, 2022:
| | December 31, 2022 | |
| | Number of options | | | Weighted average exercise price $ | | | Weighted average remaining contractual term | | | Aggregate intrinsic value | |
Outstanding, beginning of period | | | 756,703 | | | | 7.85 | | | | | | | | | |
Expired | | | (213,566 | ) | | | 7.45 | | | | | | | | | |
Forfeited | | | (166,752 | ) | | | 8.01 | | | | | | | | | |
Outstanding, end of period | | | 376,385 | | | | 7.67 | | | | 3.85 | | | | - | |
Vested and expected to vest in the future | | | 376,385 | | | | 7.67 | | | | 4.70 | | | | - | |
Exercisable | | | 335,041 | | | | 7.70 | | | | 3.85 | | | | - | |
As at December 31, 2022, there was $nil of total unrecognized compensation cost related to non-vested replacement options.
(b) Equity-settled RSUs and PSUs
The following table reflects the continuity of RSUs and PSUs granted during the year ended December 31, 2022:
| | December 31, 2022 | |
| | Number of RSUs | | | Weighted average grant date fair value $ | | | Number of PSUs | | | Weighted average grant date fair value $ | |
Outstanding, beginning of period | | | 3,160,020 | | | | 7.21 | | | | 150,000 | | | | 7.01 | |
Granted | | | 2,322,750 | | | | 0.98 | | | | 2,517,500 | | | | 1.04 | |
Vested | | | (1,374,343 | ) | | | 7.78 | | | | (97,500 | ) | | | 7.01 | |
Forfeited | | | (1,014,435 | ) | | | 5.90 | | | | (245,000 | ) | | | 1.13 | |
Outstanding, end of period | | | 3,093,992 | | | | 2.71 | | | | 2,325,000 | | | | 1.16 | |
As at December 31, 2022, there was $3,742,952 of total unrecognized compensation cost related to non-vested RSUs and $2,422,588 of total unrecognized compensation cost related to non-vested PSUs. That cost is expected to be recognized over a weighted average period of 1.98 years and 0.71 years respectively. The total fair value of RSUs and PSUs vested during the year ended December 31, 2022 was $1,269,563 and $42,346.
Of the 1,471,843 RSUs and PSUs that vested, 773,848 were settled in shares, 640,944 were settled in cash to cover withholding taxes on behalf of the employees and 57,051 were not yet settled.
The range of grant date fair values related to RSUs and PSUs granted during the year ended December 31, 2022 was $0.33 - $1.41.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
21. Share-based compensation (continued)
During the year ended December 31, 2022, the Company recognized the following total compensation expense, net of estimated forfeitures:
| | December 31, 2022 | | | December 31, 2021 | |
Replacement options | | $ | 207,226 | | | $ | 1,920,392 | |
Equity-settled RSUs and PSUs | | | 5,802,367 | | | | 8,271,869 | |
Cash-settled RSUs | | | - | | | | 5,134,262 | |
Rights to contingent consideration | | | - | | | | 5,129,774 | |
| | $ | 6,009,593 | | | $ | 20,456,297 | |
22. Loss on disposal of assets
| | December 31, 2022 | | | December 31, 2021 | |
Long term strategic contracts (i) | | $ | 4,832,891 | | | $ | - | |
Sale-leaseback (Note 10) | | | 254,473 | | | | - | |
Other assets | | | 4,177 | | | | 385,812 | |
Non-THC business (ii) | | | - | | | | 2,070,689 | |
Sale of licenses | | | - | | | | (8,516 | ) |
| | $ | 5,091,541 | | | $ | 2,447,985 | |
(i) | On December 29, 2022, the Company entered into modification agreements (the "Modification Agreements") to restructure the relationship between the Company and the counterparties in Note 13. As part of the restructured arrangement, the Company is no longer obligated to issue additional shares or cash related to the long-term strategic contracts, and the counterparties agreed to return 7,121,239 common shares of the Company to treasury. In addition, ownership of the brand "Monogram" was transferred to an entity designated by one of the counterparties. The Company received an exclusive and royalty-free eight-year license to commercialize Monogram in California. The Company recognized a loss on disposal of assets of $4,832,891 related to the Modification Agreements. Refer to Note 13. |
| |
(ii) | During the year ended December 31, 2021, the Company sold its non-THC business, which was acquired as part of the Caliva and OGE and LCV acquisitions (Note 26). The Company disposed of these net assets for proceeds of $7,363,733, which comprised of cash, promissory note and common shares of Arcadia Wellness LLC. The Company recognized a net loss of $733,858, which is comprised of a loss on disposal of assets $2,070,689 offset by an associated deferred tax recovery of $1,336,831. |
23. Supplemental cash flow information
Change in working capital | | December 31, 2022 | | | December 31, 2021 | |
| | | | | | |
Accounts receivable | | $ | 2,557,739 | | | $ | (1,821,137 | ) |
Income tax receivable | | | 1,322,340 | | | | (1,322,340 | ) |
Notes and other receivables, net | | | - | | | | (1,200,000 | ) |
Inventory | | | 14,173,855 | | | | (1,368,449 | ) |
Prepaid expenses and other current assets | | | 4,274,164 | | | | (1,401,841 | ) |
Security deposits | | | (61,324 | ) | | | (36,336 | ) |
Other long term assets | | | (87,271 | ) | | | (675,635 | ) |
Cash settled share-based payments | | | - | | | | (1,682,898 | ) |
Accounts payable and accrued liabilities | | | 709,986 | | | | (33,908,958 | ) |
| | $ | 22,889,489 | | | $ | (43,417,594 | ) |
| | | | | | | | |
Income taxes paid | | $ | 6,000,000 | | | $ | 1,700,000 | |
Liabilities settled through non-cash transactions (Note 22(i)) | | $ | 6,721,441 | | | $ | - | |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
24. Warrants
The following table reflects the continuity of warrants:
| | Number of Warrants | | | Weighted Average Exercise Price | |
Balance, December 31, 2021 and December 31, 2022 | | | 35,837,500 | | | $ | 11.50 | |
The warrants expire on January 14, 2026. The Company has the right to accelerate expiry of the warrants (excluding the warrants held by the Subversive Capital Sponsor LLC in certain circumstances), if for any 20 trading days in a 30-day trading period the closing price of the share is $18.00 or greater.
25. Related party transactions and balances
The following table outlines the amounts paid to a related party:
| | December 31, 2022 | | | December 31, 2021 | |
Lease payments – interest and principal | | $ | 5,425,576 | | | $ | 4,863,938 | |
Administrative fees and other costs | | | - | | | | 5,000 | |
| | $ | 5,425,576 | | | $ | 4,868,938 | |
A director of the Company is a close family member to an owner of R&C Brown Associates, LP (“R&C”). The Company has 2 operating leases and 1 finance lease with R&C. Included in lease liabilities and right-of-use assets as at December 31, 2022 is $40,594,490 (December 31, 2021 - $41,053,363) and $24,324,186 (December 31, 2021 - $28,035,112), respectively, with respect to leases with R&C.
In addition to the items described above, the Company entered into the following transaction with a related party:
The counterparty to the Marketing Agreement described in Note 13 (the “Counterparty”) became a related party in May 2021, when its Chief Executive Officer joined the Company’s Board of Directors. On April 27, 2022, the individual resigned from the Company’s Board of Directors and at that time the Counterparty ceased to be a related party. During year ended December 31, 2022, the Company expensed $1,772,725 related to the Marketing Agreement up to April 27, 2022.
26. Qualifying Transaction
On November 24, 2020, the Company announced that it had entered into definitive transaction agreements in respect of each of CMG Partners, Inc. (“Caliva”) (the “Caliva Agreement”) and Left Coast Ventures, Inc. (“LCV”) (the “LCV Agreement”) pursuant to which the Company would acquire all of the equity of Caliva and LCV. At the same time, the Company executed an agreement with Caliva, OG Enterprises Branding, Inc. (“OGE”), SC Branding, LLC and SC Vessel 1, LLC to acquire the remaining shareholdings of OGE and entered into a Brand Strategy Agreement with SC Branding, LLC.
Additionally, concurrently with the completion of the LCV acquisition, LCV acquired SISU Extraction LLC (“SISU”) in accordance with the Agreement and Plan of Merger between LCV and SISU, dated November 24, 2020.
The above transactions closed on January 15, 2021, and the acquisition of SC Vessel 1, LLC’s interest in OGE closed on January 19, 2021. These acquisitions constituted the Company’s Qualifying Transaction.
Each of the acquisitions is a business combination accounted for using the acquisition method in accordance with ASC 805 Business Combinations (“ASC 805”).
Total acquisition-related transaction costs incurred by the Company in connection with the acquisitions was approximately $493,584 for the year ended December 31, 2021.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
26. Qualifying Transaction (continued)
The fair values of the assets acquired and the liabilities assumed by the Company in connection with the acquisitions are as follows:
| | Caliva/OGE | | | LCV | | | SISU | | | Total | |
| | | | | | | | | | | | |
Total consideration transferred (i) | | $ | 619,766,731 | | | $ | 120,651,941 | | | $ | 92,188,146 | | | $ | 832,606,818 | |
| | | | | | | | | | | | | | | | |
Assets acquired | | | | | | | | | | | | | | | | |
Cash, restricted cash and restricted cash equivalents | | | 11,164,957 | | | | 3,022,262 | | | | 976,906 | | | | 15,164,125 | |
Accounts receivable | | | 2,006,699 | | | | 1,090,811 | | | | 1,022,532 | | | | 4,120,042 | |
Inventory | | | 11,910,959 | | | | 6,258,063 | | | | 5,580,258 | | | | 23,749,280 | |
Prepaid expenses | | | 3,589,808 | | | | 215,938 | | | | 82,701 | | | | 3,888,447 | |
Indemnification assets | | | 2,199,029 | | | | 2,000,000 | | | | - | | | | 4,199,029 | |
Property and equipment | | | 7,785,157 | | | | 3,305,145 | | | | 1,163,902 | | | | 12,254,204 | |
Intangible assets | | | 187,600,000 | | | | 20,740,000 | | | | 46,200,000 | | | | 254,540,000 | |
Right-of-use assets – operating | | | 12,115,573 | | | | 4,461,809 | | | | 880,863 | | | | 17,458,245 | |
Right-of-use assets – finance | | | 26,176,837 | | | | - | | | | - | | | | 26,176,837 | |
Investment in associate | | | - | | | | 6,500,000 | | | | - | | | | 6,500,000 | |
Investment in non-marketable securities | | | 591,545 | | | | - | | | | - | | | | 591,545 | |
Security deposits and other | | | 869,238 | | | | 137,051 | | | | 34,175 | | | | 1,040,464 | |
Total assets acquired | | | 266,009,802 | | | | 47,731,079 | | | | 55,941,337 | | | | 369,682,218 | |
| | | | | | | | | | | | | | | | |
Liabilities assumed | | | | | | | | | | | | | | | | |
Accounts payable and accrued liabilities | | | 26,130,222 | | | | 14,817,802 | | | | 8,242,144 | | | | 49,190,168 | |
Consideration payable | | | 2,458,844 | | | | 2,972,782 | | | | - | | | | 5,431,626 | |
Loans payable | | | 3,060,250 | | | | 298,436 | | | | - | | | | 3,358,686 | |
Line of credit | | | - | | | | - | | | | 1,000,000 | | | | 1,000,000 | |
Deferred tax liability | | | 35,483,327 | | | | 4,199,766 | | | | - | | | | 39,683,093 | |
Lease liabilities | | | 49,746,261 | | | | 4,461,809 | | | | 1,183,451 | | | | 55,391,521 | |
Total liabilities assumed | | | 116,878,904 | | | | 26,750,595 | | | | 10,425,595 | | | | 154,055,094 | |
| | | | | | | | | | | | | | | | |
Goodwill | | $ | 470,635,833 | | | $ | 99,671,457 | | | $ | 46,672,404 | | | $ | 616,979,694 | |
(i) Total consideration comprised the following:
| | Caliva/OGE | | | LCV | | | SISU | | | Total | |
Upfront consideration | | | | | | | | | | | | |
Cash | | $ | 465,140 | | | $ | 177,970 | | | $ | 11,089,535 | | | $ | 11,732,645 | |
Liabilities settled in cash as part of the Qualifying Transaction | | | 12,614,773 | | | | 15,400,000 | | | | 3,560,593 | | | | 31,575,366 | |
Liabilities settled in shares as part of the Qualifying Transaction | | | - | | | | - | | | | 4,264,597 | | | | 4,264,597 | |
Common shares | | | 408,178,567 | | | | 57,529,825 | | | | 63,581,153 | | | | 529,289,545 | |
Common shares to be issued | | | 1,567,549 | | | | 5,897,750 | | | | 9,692,268 | | | | 17,157,567 | |
Consideration payable | | | 1,000 | | | | 5,120 | | | | - | | | | 6,120 | |
Contingent consideration (liability) – Trading price consideration | | | 191,077,970 | | | | 41,641,276 | | | | - | | | | 232,719,246 | |
Contingent consideration (liability) – Other | | | - | | | | - | | | | - | | | | - | |
Contingent consideration (equity) | | | 2,372,231 | | | | - | | | | - | | | | 2,372,231 | |
Replacement options | | | 3,489,501 | | | | - | | | | - | | | | 3,489,501 | |
Total consideration transferred | | $ | 619,766,731 | | | $ | 120,651,941 | | | $ | 92,188,146 | | | $ | 832,606,818 | |
Each of the acquisitions is subject to specific terms relating to satisfaction of the purchase price by the Company and incorporates payments in cash and common shares as well as certain contingent consideration. Contingent consideration has been classified as either a financial liability or equity consistent with the principles in ASC 480 Distinguishing Liabilities from Equity.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
26. Qualifying Transaction (continued)
The table above summarizes the fair value of the consideration given and the fair values of the assets acquired and liabilities assumed for each acquisition. Goodwill arose in these acquisitions because the cost of acquisition included a control premium. In addition, the consideration paid for the combination reflected the benefit of expected revenue growth and future market development. These benefits were not recognized separately from goodwill because they do not meet the recognition criteria for identifiable intangible assets.
The total consideration transferred for the acquisitions is summarized below:
Acquisition of Caliva and OGE
The acquisition of Caliva, including 50% interest in OGE, closed on January 15, 2021, and the acquisition of the additional 50% interest in OGE closed on January 19, 2021. However, the closing of the additional 50% interest in OGE was automatic and contingent on the closing of Caliva. As a result, the Company gained control of both Caliva and OGE on January 15, 2021.
The acquisitions of Caliva and OGE were accounted for as one transaction as the contracts were negotiated at the same time and in contemplation of one another in order to achieve the overall objective of obtaining control of both companies. The Company acquired all of the issued and outstanding equity interests of Caliva and OGE from the existing shareholders for up to 32,365,412 common shares of the Company, of which 117,756 were common shares to be issued as at December 31, 2021, and $466,140 of cash, with certain shareholders receiving cash at $10.00 per share in lieu of common shares for regulatory purposes. In addition, the consideration transferred included contingent consideration and replacement share options, as outlined below. The share consideration was valued based on the share price on the date of acquisition, January 15, 2021.
The Company also issued the following contingent consideration:
| a) | Trading price consideration – The Caliva and OGE shareholders received a contingent right for up to 18,356,299 additional common shares (the “pool of common shares”) in the event the 20-day volume weighted average trading price (“VWAP”) of the common shares reaches $13.00, $17.00 and $21.00 within three years of closing, with one-third issuable upon the achievement of each price threshold, respectively. The pool of common shares is to be shared with Caliva option holders who were employees of Caliva at the time of the transaction (“Caliva employee option holders”). In order to receive their share of the contingent consideration, Caliva employee option holders must be employed by the Company at the time the contingent consideration is paid out. The portion of the pool of common shares that may be paid to Caliva employee option holders is being accounted for as employee share-based compensation and is being expensed over the estimated vesting period. The portion of the pool of common shares that may be paid to former Caliva and OGE shareholders is being accounted for as contingent consideration in the amount of $191,077,970 and is included in the consideration transferred above. Refer to Note 30 for further details. |
| | |
| b) | Earn-out shares – The Caliva shareholders received a contingent right for up to 3,929,327 additional common shares if the aggregate consolidated cash of the Company at closing, net of short-term indebtedness, was less than $225,000,000. As the consolidated cash at the time of closing was above this amount, no additional common shares will be issued, and no value has been attributed to this in the transaction. |
| | |
| c) | Other – The Company held back 304,000 common shares related to U.S. Paycheck Protection Program (“PPP”) loans. The fair value associated with the contingent consideration at the transaction date was nil. |
| | |
| d) | 187,380 shares of TPCO have been placed into escrow and will be issued when subsidiaries of Caliva receive their licenses. This is presented as contingent shares to be issued in equity. If the licenses are not obtained, the shares will be issued to Caliva former shareholders, and therefore have been included as part of consideration. |
The Company issued replacement share options to Caliva employee option holders as discussed in Note 21. The Company recognized $3,489,501 in consideration. This represented the fair value of the awards as at January 15, 2021 that relates to past service of those employees.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
26. Qualifying Transaction (continued)
The following table illustrates the inputs used in the measurement of the grant date fair values of the share-based compensation plans granted during the year ended December 31, 2021:
| | Replacement Options | | | RSUs equity-settled | |
Dividend yield | | | - | | | | - | |
Expected volatility | | | 72 | % | | | - | |
Risk-free interest rate | | | 0.17% - 0.71 | % | | | - | |
Share price | | $ | 12.66 | | | | - | |
| | | | | | | | |
Grant date fair value | | $ | 7.75 - $9.54 | | | $ | 3.35 – $12.66 | |
Fair value on December 31, 2021 | | | N/A | | | | N/A | |
The Company estimated the expected term of its share options based on the vesting and contractual terms. Volatility is estimated based on the average of the historical volatilities of the common shares of entities with characteristics similar to those of the Company. The Company uses the U.S. Treasury yield for its risk-free interest rate and a dividend yield of zero, as it does not have a stated dividend rate for common shares.
Lastly, as part of the Qualifying Transaction, certain liabilities of Caliva were settled by the Company on behalf of Caliva. As a result, they have been included in consideration transferred and excluded from net assets acquired.
The goodwill acquired is associated with Caliva and OGE’s workforce and expected future growth potential and is not expected to be deductible for tax purposes.
Acquisition of LCV
The Company acquired all of the issued and outstanding equity interests of LCV from the existing shareholders of LCV for up to 5,010,077 common shares of the Company, of which 154,348 were common shares to be issued as at December 31, 2021, and $183,090 cash, with certain shareholders receiving cash at $10.00 per share in lieu of common shares for regulatory purposes. The share consideration was valued based on the share price on the date of acquisition, January 15, 2021.
The Company also issued the following contingent consideration:
| a) | Trading price consideration – The LCV shareholders will have a contingent right for up to 3,856,955 additional common shares in the event the 20-day VWAP of the common shares reaches $13.00, $17.00 and $21.00 within three years of closing, with one-third issuable upon the achievement of each price threshold, respectively. The fair value of the contingent consideration on January 15, 2021 was $41,641,276 and is included in consideration transferred above. Refer to Note 30 for further details. |
| | |
| b) | Other – The Company held back 299,800 of shares that are contingent on the outcome of certain events. The fair value associated with the contingent consideration at the transaction date is nil. Refer to Note 30 for further details. |
Lastly, as part of the Qualifying Transaction, certain liabilities of LCV were settled by the Company on behalf of LCV. As a result, they have been included in consideration transferred and excluded from net assets acquired.
The goodwill acquired is associated with LCV’s workforce and expected future growth potential and is not expected to be deductible for tax purposes.
Acquisition of SISU
The Company acquired all of the issued and outstanding units of SISU from the existing members of SISU for 5,787,790 common shares of the Company, of which 765,582 were common shares to be issued, and $11,089,535 in cash. The share consideration was valued based on the share price on the date of acquisition, January 15, 2021. The goodwill acquired is associated with SISU’s workforce and expected future growth potential and is expected to be fully deductible for tax purposes at the state level. The common shares to be issued were issued in June 2021.
Lastly, as part of the Qualifying Transaction, certain liabilities of SISU were settled by the Company on behalf of SISU through the issuance of 336,856 common shares and cash. As a result, these have been included in consideration transferred and excluded from net assets acquired.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
27. Other business combinations
The following table summarizes the consolidated balance sheet impact at acquisition of the Company’s business combinations that occurred during the year ended December 31, 2021:
| | Coastal (i) | | | Calma (ii) | | | Other (iii) | | | Total | |
Total consideration transferred (i) | | $ | 20,700,000 | | | $ | 9,968,474 | | | $ | 2,894,952 | | | $ | 33,563,426 | |
| | | | | | | | | | | | | | | | |
Redeemable non-controlling interest | | $ | 39,928,597 | | | $ | 1,500,000 | | | $ | - | | | $ | 41,428,597 | |
| | | | | | | | | | | | | | | | |
Assets acquired | | | | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | | | | |
Cash | | $ | - | | | $ | - | | | $ | 33,213 | | | $ | 33,213 | |
Restricted cash | | | 9,989,470 | | | | - | | | | - | | | | 9,989,470 | |
Inventory | | | 2,477,000 | | | | 379,617 | | | | 98,050 | | | | 2,954,667 | |
Prepaid expenses | | | 515,947 | | | | 109,929 | | | | - | | | | 625,876 | |
Indemnification assets | | | 980,000 | | | | - | | | | 865,126 | | | | 1,845,126 | |
Long-term assets | | | | | | | | | | | | | | | | |
Security deposits | | | - | | | | 61,185 | | | | - | | | | 61,185 | |
Property and equipment | | | 4,839,634 | | | | 457,551 | | | | 16,033 | | | | 5,313,218 | |
Right-of-use assets – operating lease | | | 12,491,344 | | | | 3,201,699 | | | | 433,934 | | | | 16,126,977 | |
Intangible assets | | | 52,100,000 | | | | 11,282,000 | | | | 1,718,570 | | | | 65,100,570 | |
Total assets acquired | | | 83,393,395 | | | | 15,491,981 | | | | 3,164,926 | | | | 102,050,302 | |
| | | | | | | | | | | | | | | | |
Liabilities assumed | | | | | | | | | | | | | | | | |
Accounts payable and accrued liabilities | | | 9,483,665 | | | | 1,115,477 | | | | 1,069,654 | | | | 11,668,796 | |
Consideration payable – current portion | | | 924,457 | | | | - | | | | - | | | | 924,457 | |
Consideration payable | | | 2,170,463 | | | | - | | | | - | | | | 2,170,463 | |
Lease liabilities | | | 12,835,761 | | | | 2,790,377 | | | | 433,934 | | | | 16,060,072 | |
Deferred tax liabilities | | | 15,630,157 | | | | 3,256,494 | | | | 381,525 | | | | 19,268,176 | |
Total liabilities assumed | | | 41,044,503 | | | | 7,162,348 | | | | 1,885,113 | | | | 50,091,964 | |
| | | | | | | | | | | | | | | | |
Goodwill | | $ | 18,279,705 | | | $ | 3,138,841 | | | $ | 1,615,139 | | | $ | 23,033,685 | |
(i) Total consideration transferred is comprised of the following:
| | Coastal | | | Calma | | | Other | | | Total | |
Cash | | $ | 4,500,000 | | | $ | 8,500,000 | | | $ | 1,435,550 | | | $ | 14,435,550 | |
Consideration payable | | | - | | | | - | | | | 1,459,402 | | | | 1,459,402 | |
Common shares | | | - | | | | 1,468,474 | | | | - | | | | 1,468,474 | |
Liabilities extinguished as part of the acquisition | | | 16,200,000 | | | | - | | | | - | | | | 16,200,000 | |
Total consideration | | $ | 20,700,000 | | | $ | 9,968,474 | | | $ | 2,894,952 | | | $ | 33,563,426 | |
(i) Coastal
On October 1, 2021, the Company executed a Unit Purchase Agreement (the “Purchase Agreement”) to acquire 100% equity interest in Coastal Holding Company, LLC (“Coastal Holding”). The closing of the transaction was subject to multiple conditions, including the receipt of municipal approval to transfer licenses at seven (7) locations.
At the same time, the Company advanced $20,700,000 of cash to Coastal Holding, as well as entered into Management Service Agreements (“MSA’s”) with Coastal Holding and certain of its subsidiaries (collectively “Coastal”). As part of the arrangement, the Company received 9.5% direct interest in Varda Inc., an operating dispensary, as well as an agreement to acquire the remaining 90.5% for $4,500,000 when approval for the transfer of that entity’s license is received.
The Purchase Agreement and the MSA’s granted the Company the power to manage and make decisions that affect the operations of Coastal and Varda Inc., including the management and development of dispensary operations. Pursuant to the Purchase Agreement and MSA’s with Coastal, the Company was entitled to a management fee equal to 100% of the revenues generated and is responsible for 100% of the costs and expenses of Coastal. With respect to Varda Inc., the Company was entitled to 100% of the revenues generated and is responsible for 100% of the costs and expenses, while the non-controlling interest (“NCI”) holder was entitled to 45.25% of any profit distributions.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
27. Other business combinations (continued)
(i) Coastal (continued)
As a result, the Company determined that Coastal and Varda Inc. were VIEs and the Company was the primary beneficiary by reference to the power and benefits criterion under ASC 810, Consolidation. The transaction was accounted for as a business combination under ASC 805 with 100% of the equity interest in Coastal and 90.5% of the equity interest in Varda Inc., being presented as redeemable NCI. During the year, approval for the transfer of the Varda Inc. license was received and the associated redeemable NCI was redeemed. Refer to Note 15.
During the year ended December 31, 2022, the Company finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method. The Company adjusted the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of the acquisition date.
The following adjustments were made to the provisional amounts:
| · | An adjustment was made to increase intangible assets by $25,618,000, due to new information regarding the fair value as at October 1, 2021. This resulted in a increase to the deferred tax liability on initial recognition of $7,644,411 and a net decrease to goodwill. |
As a result of the adjustments to the provisional amounts discussed above, $1,171,955 of additional amortization was recognized during the year ended December 31, 2022 relating to prior periods.
On November 14, 2022, the transaction legally closed and the Company acquired 100% of the equity interest in Coastal Holding. As a result, Coastal Holding is no longer considered a VIE, and the Company has a controlling financial interest via voting rights. Refer to Note 15.
(ii) Calma Weho, LLC (“Calma”)
On October 1, 2021, the Company acquired 85% of the equity interest of Calma, an operating dispensary located in West Hollywood, California.
Total consideration comprised $8,500,000 in cash and $1,468,474 in equity of the Company. In addition, the Company was committed to acquiring the remaining 15% when local regulations permit, for $1,500,000 in common shares of the Company. During the three months ended September 30, 2022, the Company acquired the remaining 15% in exchange for 1,762,495 common shares of the Company. These common shares are restricted under applicable US securities laws.
During the year ended December 31, 2022, the Company finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method. The Company adjusted the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of the acquisition date.
The following adjustments were made to the provisional amounts:
| · | An adjustment was made to increase intangible assets by $6,055,000 and increase right-of-use assets by $411,322, due to new information regarding the fair value as at October 1, 2021. This resulted in an increase to the deferred tax liability on initial recognition of $1,806,812 and a net decrease to goodwill. |
As a result of the adjustments to the provisional amounts discussed above, $121,892 of additional amortization of intangible assets and $35,700 of additional amortization of right of use assets has been recognized relating to prior periods.
(iii) Kase’s Journey
On August 2, 2021, the Company, through its wholly owned subsidiary Caliva CARECE1 LLC, acquired all of the issued and outstanding equity interests of Kase’s Journey Inc., an operating retail dispensary located in Ceres, California, from the existing shareholders for $1,300,000 cash, subject to adjustments, and $1,221,902 of consideration payable. During the year ended December 31, 2022, the Company finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
27. Other business combinations (continued)
Martian Delivery
On August 16, 2021, the Company, through its wholly owned subsidiary TPCO US Holding LLC, acquired all of the issued and outstanding membership interests of Martian Delivery LLC, an operating retail dispensary located in the City of Sacramento, California, from the existing shareholders for $237,500 cash and $237,500 in promissory notes payable. During the year ended December 31, 2022, the Company finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method.
28. Segment information
The Company’s operations comprise a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the State of California. All revenues were generated in the State of California for the year ended December 31, 2022 and December 31, 2021 and all property and equipment, right-of-use assets and intangible assets were located in the State of California.
29. Commitments and contingencies
a) California operating licenses
The Company's primary activity is engaging in state-legal commercial cannabis business, including the cultivation, manufacture, distribution, and sale of cannabis and cannabis products pursuant to California law. However, this activity is not in compliance with the United States Controlled Substances Act (the CSA). The Company's assets are potentially subject to seizure or confiscation by Federal governmental agencies, and the Company could face criminal and civil penalties for noncompliance with the CSA, although such events would be without relevant precedent. Management of the Company believes the Company is in compliance with all California and local jurisdiction laws and monitor the regulatory environment on an ongoing basis along with counsel to ensure the continued compliance with all applicable laws and licensing agreements.
The Company's operation is sanctioned by the State of California and local jurisdictions. There have been no instances of federal interference with those who adhere to those guidelines. Due to the uncertainty surrounding the Company's noncompliance with the CSA, the potential liability from any noncompliance cannot be reasonably estimated and the Company may be subject to regulatory fines, penalties or restrictions in the future.
Effective January 1, 2018, the State of California allowed for adult use cannabis sales. Beginning on January 1, 2018, the State began issuing temporary licenses that expired 120 days after issuance for retail, distribution, manufacturing and cultivation permits. Temporary licenses could be extended in 90-day increments by the State upon submission of an annual license application. All temporary licenses had been granted extensions by the State during 2018.
In September 2019, Senate Bill 1459 (SB 1459) was enacted which enabled state licensing authorities to issue provisional licenses through 2021. A provisional license could be issued if an applicant submitted a completed annual license application to the Bureau of Cannabis Control. A completed application for purposes of obtaining a provisional license is not the same as a sufficient application to obtain an annual license. The provisional cannabis license, which is valid for 12 months from the date issued, is said to be in between a temporary license and an annual license and allows a cannabis business to operate as they would under local and state regulations.
Licensees issued a provisional license are expected to be diligently working toward completing all annual license requirements in order to maintain a provisional license. The Company obtained its provisional licenses in 2019 and continues to work with the State to obtain annual licensing.
The Company's prior licenses obtained from the local jurisdictions it operated in have been continued by such jurisdictions and are necessary to obtain State licensing.
The Company has received annual licenses from each local jurisdiction in which it actively operates. Although the Company believes it will continue to receive the necessary licenses from the State and applicable local jurisdictions to conduct its business in a timely fashion, there is no guarantee its clients will be able to do so and any failure to do so may have a negative effect on its business and results of operations.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
29. Commitments and contingencies (continued)
b) Other legal matters
From time to time in the normal course of business, the Company may be subject to legal matters such as threatened or pending claims or proceedings. The Company is not currently a party to any material legal proceedings or claims, nor are we aware of any pending or threatened litigation or claims that could have a material adverse effect on our business, operating results, cash flows or financial condition should such litigation or claim be resolved unfavorably.
c) Social equity fund
The Company formed Social Equity Ventures LLC (“SEV”) in 2021 as its social equity investment vehicle. The Company intends to fund SEV with $10,000,000 and contribute 2% of its net income to allow SEV to make further social equity investments. During the year ended December 31, 2022, SEV made social equity investments totalling $350,000 (December 31, 2021 - SEV made social equity investments totalling $1,000,000).
30. Financial instruments
a) Contingent consideration
Financial instruments recorded at fair value in the consolidated balance sheet are classified using a fair value hierarchy that reflects the observability of significant inputs used in making the measurements. The fair value hierarchy requires the use of observable market inputs whenever such inputs exist. A financial instrument is classified based on the lowest level of the hierarchy for which a significant input has been considered in measuring fair value.
All contingent consideration is classified as level 3 in the fair value hierarchy as volatility is a key input into the valuation models and volatility is an unobservable input.
The following provides a breakdown of contingent consideration as at December 31, 2022 and 2021:
| | Contingent consideration | | | | |
| | Trading price consideration (i) | | | Other (ii) | | | Total | |
Balance December 31, 2020 | | $ | - | | | $ | - | | | $ | - | |
Additions | | | 232,719,246 | | | | - | | | | 232,719,246 | |
Change in fair value | | | (232,144,559 | ) | | | 2,325,489 | | | | (229,819,070 | ) |
Transferred to equity | | | - | | | | (1,957,045 | ) | | | (1,957,045 | ) |
Balance December 31, 2021 | | $ | 574,687 | | | | 368,444 | | | | 943,131 | |
| | | | | | | | | | | | |
Change in fair value | | | 1,037,156 | | | | (69,430 | ) | | | 967,726 | |
Transferred to equity | | | - | | | | (299,014 | ) | | | (299,014 | ) |
Balance, December 31, 2022 | | $ | 1,611,843 | | | $ | - | | | $ | 1,611,843 | |
(i) Trading price consideration – As part of the acquisition of Caliva and OGE and LCV during the three months ended March 31, 2021, the former shareholders received a contingent right for up to 18,356,299 and 3,856,955 additional common shares, respectively, in the event the 20-day volume weighted average trading price (“VWAP”) of the common shares reaches $13.00,
$17.00 and $21.00 within three years of closing, with one-third issuable upon the achievement of each price threshold, respectively. In addition, the contingent consideration becomes issuable upon a change in control event.
The fair value of the trading price consideration was determined using a Monte Carlo simulation methodology that included simulating the share price using a risk-neutral Geometric Brownian Motion-based pricing model over 500,000 iterations.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
30. Financial instruments (continued)
b) Contingent consideration (continued)
The methodology recorded the likelihood of the share price achieving the price hurdle associated with the payout and calculated the discounted value of the payout based on the share price on the date the price hurdle was met and the corresponding 20-day volume-weighted average price.
Key Inputs | | December 31, 2022 | | | December 31, 2021 | |
Key unobservable inputs | | | | | | |
Expected volatility | | | 100 | % | | | 65 | % |
| | | | | | | | |
Key observable inputs | | | | | | | | |
Share price | | $ | 0.15 | | | $ | 1.39 | |
Risk-free interest rate | | | 4.66 | % | | | 0.79 | % |
Dividend yield | | | 0 | % | | | 0 | % |
Number of shares | | | 22,080,037 | | | | 21,850,404 | |
A 15% change in the volatility assumption will have the following impact on the fair value of the contingent consideration:
Change in volatility | | | December 31, 2022 | | | December 31, 2021 | |
+15% | | | $ | 595 | | | $ | 1,597,743 | |
-15% | | | $ | - | | | $ | (528,968 | ) |
(ii) Other – As part of the acquisition of LCV that occurred on January 15, 2021, the Company could be required to issue shares to former shareholders based on certain liabilities, the final settlement of which is contingent on the outcome of certain events. During the three months ended March 31, 2022, the remaining contingency was resolved and as a result, the number of shares to be issued related to that portion became fixed. The contingent consideration was remeasured to $299,014 based on the fixed number of shares to be issued to the former LCV shareholders and reclassified as equity. The remeasurement is included in the change in fair value of contingent consideration in the consolidated statement of operations and comprehensive loss.
c) Credit risk
Credit risk arises from deposits with banks, security deposits, trade receivables, notes receivable and other receivables. As at December 31, 2022, the balances was as follows:
| | Gross | | | Allowance | | | Net | |
Cash | | $ | 93,697,529 | | | $ | - | | | $ | 93,697,529 | |
Accounts receivable (i) | | | 2,506,136 | | | | (1,300,436 | ) | | | 1,205,700 | |
Security deposits | | | 1,181,078 | | | | - | | | | 1,181,078 | |
Notes receivables (ii) | | | 6,277,803 | | | | (5,650,000 | ) | | | 627,803 | |
| | $ | 103,662,546 | | | $ | (6,950,436 | ) | | $ | 96,712,110 | |
As at December 31, 2021:
| | Gross | | | Allowance | | | Net | |
Cash | | $ | 165,310,609 | | | $ | - | | | $ | 165,310,609 | |
Restricted cash and restricted cash equivalents | | | 9,581,689 | | | | - | | | | 9,581,689 | |
Accounts receivable (i) | | | 6,721,754 | | | | (2,016,191 | ) | | | 4,705,563 | |
Security deposits | | | 1,119,754 | | | | - | | | | 1,119,754 | |
Notes and other receivables (ii) | | | 7,393,560 | | | | (2,660,943 | ) | | | 4,732,617 | |
| | $ | 190,127,366 | | | $ | (4,677,134 | ) | | $ | 185,450,232 | |
(i) For trade receivables, the Company does not hold any collateral as security but mitigates this risk by dealing with counterparts that management has determined to be financially sound. The Company determines the allowance for doubtful accounts by firstly allowing for specific receivables that are at-risk of non-collection, and then applying a standard percentage by bucket of aging to the remainder. The gross accounts receivable by aging are laid out below.
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
30. Financial instruments (continued)
c) Credit risk (continued)
The Company’s aging of receivables was as follows:
| | December 31, 2022 | | | December 31, 2021 | |
0 - 30 days | | $ | 1,145,909 | | | $ | 4,723,810 | |
31 - 60 days | | | 253,942 | | | | 278,958 | |
61 - 90 days | | | 81,242 | | | | 242,467 | |
91 – 120 days | | | 8,858 | | | | 256,424 | |
Over 120 days | | | 1,016,185 | | | | 1,220,095 | |
Gross receivables | | | 2,506,136 | | | | 6,721,754 | |
Less allowance for doubtful accounts | | | (1,300,436 | ) | | | (2,016,191 | ) |
| | $ | 1,205,700 | | | $ | 4,705,563 | |
(ii) For notes and other receivables, the Company determines the allowance for doubtful accounts by considering, for each debtor, if there has been any indication that a loss has been incurred. In making that determination, the Company considers the credit rating of the debtor as well as any collateral that underlies the receivable. Refer to Note 5 for additional information.
31. Fair value measurement
Recurring fair value measurements
The following table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis as at December 31, 2022 and the associated gains (losses) for the year ended December 31, 2022:
| | Carrying amount | | | Fair value | | | Level 1 | | | Level 3 | | | Fair value change/ credit loss | |
| | | | | | | | | | | | | | | |
Equity securities | | $ | - | | | $ | - | | | $ | - | | | $ | - | | | $ | 556,444 | |
Debt securities | | | 736,659 | | | | 736,659 | | | | - | | | | 736,659 | | | | 391,369 | |
Total investments | | $ | 736,659 | | | $ | 736,659 | | | $ | - | | | $ | 736,659 | | | $ | 947,813 | |
| | | | | | | | | | | | | | | | | | | | |
Contingent consideration – trading price consideration | | $ | 1,611,843 | | | $ | 1,611,843 | | | $ | - | | | $ | 1,611,843 | | | $ | 1,037,156 | |
Contingent consideration - other | | | - | | | | - | | | | - | | | | - | | | | (69,430 | ) |
Total contingent consideration (Note 30) | | $ | 1,611,843 | | | $ | 1,611,843 | | | $ | | | | $ | 1,611,843 | | | $ | 967,726 | |
Non-recurring fair value measurements
Certain assets are measured at fair value on a non-recurring basis and therefore are not included in the tables above. These assets were adjusted to fair value as a result of impairment recognized in the year ended December 31, 2022, refer to Note 18.
The following table presents the level within the fair value hierarchy for these fair value measurements as at their respective measurement dates, along with their carrying value at December 31, 2022:
| | Carrying amount | | | Fair value | | | Level 3 | |
Licenses | | $ | 9,506,477 | | | $ | 9,699,829 | | | $ | 9,699,829 | |
Brands | | $ | 23,291,833 | | | $ | 23,624,000 | | | $ | 23,624,000 | |
Right of use assets - operating | | $ | 811,667 | | | $ | 825,424 | | | $ | 825,424 | |
TPCO Holding Corp. Notes to the consolidated financial statements (in United States dollars) For the years ended December 31, 2022 and 2021 |
32. COVID-19
In March 2020, the World Health Organization categorized coronavirus disease 2019 (“COVID-19”) as a pandemic. COVID‑19 continues to impact the U.S. and other countries across the world, and the duration and severity of its effects remain unknown. The Company continues to implement and evaluate actions to maintain its financial position and support the continuity of its business and operations in the face of this pandemic and other events.
The Company’s priorities during the COVID-19 pandemic continue to be protecting the health and safety of its employees and its customers, following the recommended actions of government and health authorities. In the future, the pandemic may cause reduced demand for the Company’s products and services if, for example, the pandemic results in a recessionary economic environment or potential new restrictions on business operations or the movement of individuals.
The COVID-19 outbreak in the United States has caused business disruption both to the Company and throughout its customer base and supply chain through mandated and voluntary closings of many businesses. While this disruption is expected to negatively impact The Company’s operating results, the related financial impact and duration cannot be reasonably estimated at this time. The Company has taken and continues to take, important steps to protect its employees, customers and business operations since the beginning of the pandemic.
The Company has incurred incremental costs to implement proactive measures to prevent the spread of COVID-19. Additionally, the Company closely monitors its supply chain and third-party product availability in light of the pandemic. To date, the business has not experienced negative consequences due to interruptions in its supply chain. However, the Company continues to undertake preemptive measures to ensure alternate supply sources as needed.
33. Subsequent events
Shares issued
Subsequent to December 31, 2022, the Company issued 165,217 shares for RSUs and PSUs that were vested.
Return of shares
On January 5, 2023, 7,121,239 common shares of the Company that are discussed in Note 22 (i) and are classified as “to be returned” in these financial statements, were returned to treasury.
Sale of Culver City
On February 22, 2023, the Company finalized the sale of Culver City for $350,000 cash.
Proposed Business Combination with Gold Flora, LLC
On February 21, 2023, the Company entered into a business combination agreement pursuant to which Gold Flora, LLC, a California limited liability company (“Gold Flora”) and TPCO will combine by way of a plan of arrangement under the Business Corporations Act (British Columbia) and a plan of merger pursuant to the provisions of the California Revised Uniform Limited Liability Company Act, as amended (the “Business Combination”). Following the Business Combination, the Company’s shareholders will own approximately 49%, and Gold Flora holders will own approximately 51%, of the outstanding common equity of the combined company on a pro forma basis. The Business Combination is expected to close before the end of the third quarter of 2023, following the satisfaction or waiver of closing conditions including, among others, approval by two-thirds of the votes cast by the shareholders of the Company, the approval of the Supreme Court of British Columbia, and the approval of the NEO Exchange.